id	sid	tid	token	lemma	pos
bptjm-31	1	1	berkeley	berkeley	PROPN
bptjm-31	1	2	pharma	pharma	PROPN
bptjm-31	1	3	tech	tech	NOUN
bptjm-31	1	4	journal	journal	NOUN
bptjm-31	1	5	of	of	ADP
bptjm-31	1	6	medicine	medicine	NOUN
bptjm-31	1	7	correspondence	correspondence	NOUN
bptjm-31	1	8	:	:	PUNCT
bptjm-31	2	1	venkatarepaka@gmail.com	venkatarepaka@gmail.com	X
bptjm-31	2	2	keywords	keyword	NOUN
bptjm-31	2	3	:	:	PUNCT
bptjm-31	2	4	lewy	lewy	PROPN
bptjm-31	2	5	body	body	PROPN
bptjm-31	2	6	dementia	dementia	PROPN
bptjm-31	2	7	alpha	alpha	NOUN
bptjm-31	2	8	-	-	PUNCT
bptjm-31	2	9	synuclein	synuclein	VERB
bptjm-31	2	10	neurodegenerative	neurodegenerative	ADJ
bptjm-31	2	11	disorders	disorder	NOUN
bptjm-31	2	12	acetylcholine	acetylcholine	NOUN
bptjm-31	2	13	pathways	pathway	NOUN
bptjm-31	2	14	dopamine	dopamine	NOUN
bptjm-31	2	15	pathways	pathway	NOUN
bptjm-31	2	16	submitted	submit	VERB
bptjm-31	2	17	:	:	PUNCT
bptjm-31	2	18	september	september	PROPN
bptjm-31	2	19	12	12	NUM
bptjm-31	2	20	,	,	PUNCT
bptjm-31	2	21	2022	2022	NUM
bptjm-31	2	22	accepted	accept	VERB
bptjm-31	2	23	:	:	PUNCT
bptjm-31	2	24	november	november	PROPN
bptjm-31	2	25	28	28	NUM
bptjm-31	2	26	,	,	PUNCT
bptjm-31	2	27	2022	2022	NUM
bptjm-31	2	28	published	publish	VERB
bptjm-31	2	29	:	:	PUNCT
bptjm-31	2	30	december	december	PROPN
bptjm-31	2	31	28	28	NUM
bptjm-31	2	32	,	,	PUNCT
bptjm-31	2	33	2022	2022	NUM
bptjm-31	2	34	full	full	ADJ
bptjm-31	2	35	open	open	ADJ
bptjm-31	2	36	access	access	NOUN
bptjm-31	2	37	creative	creative	ADJ
bptjm-31	2	38	commons	common	NOUN
bptjm-31	2	39	attribution	attribution	NOUN
bptjm-31	2	40	license	license	VERB
bptjm-31	2	41	4.0	4.0	NUM
bptjm-31	2	42	abstract	abstract	ADJ
bptjm-31	2	43	lewy	lewy	ADJ
bptjm-31	2	44	body	body	NOUN
bptjm-31	2	45	dementia	dementia	NOUN
bptjm-31	2	46	(	(	PUNCT
bptjm-31	2	47	lbd	lbd	PROPN
bptjm-31	2	48	)	)	PUNCT
bptjm-31	2	49	is	be	AUX
bptjm-31	2	50	a	a	DET
bptjm-31	2	51	neurodegenerative	neurodegenerative	ADJ
bptjm-31	2	52	disorder	disorder	NOUN
bptjm-31	2	53	in	in	ADP
bptjm-31	2	54	which	which	PRON
bptjm-31	2	55	the	the	DET
bptjm-31	2	56	brain	brain	NOUN
bptjm-31	2	57	has	have	VERB
bptjm-31	2	58	abundant	abundant	ADJ
bptjm-31	2	59	misfolded	misfolde	VERB
bptjm-31	2	60	alpha	alpha	NOUN
bptjm-31	2	61	-	-	PUNCT
bptjm-31	2	62	synuclein	synuclein	NOUN
bptjm-31	2	63	proteins	protein	NOUN
bptjm-31	2	64	.	.	PUNCT
bptjm-31	3	1	while	while	SCONJ
bptjm-31	3	2	lbd	lbd	PROPN
bptjm-31	3	3	has	have	VERB
bptjm-31	3	4	similar	similar	ADJ
bptjm-31	3	5	symptoms	symptom	NOUN
bptjm-31	3	6	to	to	ADP
bptjm-31	3	7	other	other	ADJ
bptjm-31	3	8	degenerative	degenerative	ADJ
bptjm-31	3	9	neurological	neurological	ADJ
bptjm-31	3	10	disorders	disorder	NOUN
bptjm-31	3	11	,	,	PUNCT
bptjm-31	3	12	such	such	ADJ
bptjm-31	3	13	as	as	ADP
bptjm-31	3	14	alzheimer	alzheimer	PROPN
bptjm-31	3	15	’s	’s	PART
bptjm-31	3	16	disease	disease	NOUN
bptjm-31	3	17	(	(	PUNCT
bptjm-31	3	18	ad	ad	NOUN
bptjm-31	3	19	)	)	PUNCT
bptjm-31	3	20	and	and	CCONJ
bptjm-31	3	21	parkinson	parkinson	NOUN
bptjm-31	3	22	’s	’s	PART
bptjm-31	3	23	disease	disease	NOUN
bptjm-31	3	24	(	(	PUNCT
bptjm-31	3	25	pd	pd	PROPN
bptjm-31	3	26	)	)	PUNCT
bptjm-31	3	27	,	,	PUNCT
bptjm-31	3	28	they	they	PRON
bptjm-31	3	29	are	be	AUX
bptjm-31	3	30	not	not	PART
bptjm-31	3	31	the	the	DET
bptjm-31	3	32	same	same	ADJ
bptjm-31	3	33	medical	medical	ADJ
bptjm-31	3	34	diagnosis	diagnosis	NOUN
bptjm-31	3	35	.	.	PUNCT
bptjm-31	4	1	lbd	lbd	PROPN
bptjm-31	4	2	is	be	AUX
bptjm-31	4	3	characterized	characterize	VERB
bptjm-31	4	4	by	by	ADP
bptjm-31	4	5	all	all	DET
bptjm-31	4	6	the	the	DET
bptjm-31	4	7	motor	motor	NOUN
bptjm-31	4	8	deficit	deficit	NOUN
bptjm-31	4	9	symptoms	symptom	NOUN
bptjm-31	4	10	of	of	ADP
bptjm-31	4	11	parkinson	parkinson	NOUN
bptjm-31	4	12	's	's	PART
bptjm-31	4	13	disease	disease	NOUN
bptjm-31	4	14	(	(	PUNCT
bptjm-31	4	15	pd	pd	NOUN
bptjm-31	4	16	)	)	PUNCT
bptjm-31	4	17	,	,	PUNCT
bptjm-31	4	18	but	but	CCONJ
bptjm-31	4	19	the	the	DET
bptjm-31	4	20	opposite	opposite	NOUN
bptjm-31	4	21	can	can	AUX
bptjm-31	4	22	not	not	PART
bptjm-31	4	23	be	be	AUX
bptjm-31	4	24	said	say	VERB
bptjm-31	4	25	,	,	PUNCT
bptjm-31	4	26	as	as	SCONJ
bptjm-31	4	27	pd	pd	PROPN
bptjm-31	4	28	is	be	AUX
bptjm-31	4	29	more	more	ADV
bptjm-31	4	30	complex	complex	ADJ
bptjm-31	4	31	and	and	CCONJ
bptjm-31	4	32	has	have	VERB
bptjm-31	4	33	more	more	ADV
bptjm-31	4	34	underlying	underlying	ADJ
bptjm-31	4	35	symptoms	symptom	NOUN
bptjm-31	4	36	.	.	PUNCT
bptjm-31	5	1	clinical	clinical	ADJ
bptjm-31	5	2	trials	trial	NOUN
bptjm-31	5	3	and	and	CCONJ
bptjm-31	5	4	in	in	ADP
bptjm-31	5	5	vivo	vivo	ADJ
bptjm-31	5	6	experiments	experiment	NOUN
bptjm-31	5	7	have	have	AUX
bptjm-31	5	8	shown	show	VERB
bptjm-31	5	9	that	that	SCONJ
bptjm-31	5	10	specific	specific	ADJ
bptjm-31	5	11	genes	gene	NOUN
bptjm-31	5	12	related	relate	VERB
bptjm-31	5	13	to	to	ADP
bptjm-31	5	14	these	these	DET
bptjm-31	5	15	misfolded	misfolde	VERB
bptjm-31	5	16	proteins	protein	NOUN
bptjm-31	5	17	are	be	AUX
bptjm-31	5	18	potentially	potentially	ADV
bptjm-31	5	19	good	good	ADJ
bptjm-31	5	20	genetic	genetic	ADJ
bptjm-31	5	21	treatment	treatment	NOUN
bptjm-31	5	22	and	and	CCONJ
bptjm-31	5	23	therapeutic	therapeutic	ADJ
bptjm-31	5	24	targets	target	NOUN
bptjm-31	5	25	.	.	PUNCT
bptjm-31	6	1	this	this	DET
bptjm-31	6	2	review	review	NOUN
bptjm-31	6	3	article	article	NOUN
bptjm-31	6	4	seeks	seek	VERB
bptjm-31	6	5	to	to	PART
bptjm-31	6	6	provide	provide	VERB
bptjm-31	6	7	an	an	DET
bptjm-31	6	8	overview	overview	NOUN
bptjm-31	6	9	of	of	ADP
bptjm-31	6	10	the	the	DET
bptjm-31	6	11	current	current	ADJ
bptjm-31	6	12	state	state	NOUN
bptjm-31	6	13	of	of	ADP
bptjm-31	6	14	novel	novel	NOUN
bptjm-31	6	15	therapeutic	therapeutic	ADJ
bptjm-31	6	16	,	,	PUNCT
bptjm-31	6	17	genetic	genetic	ADJ
bptjm-31	6	18	strategies	strategy	NOUN
bptjm-31	6	19	to	to	PART
bptjm-31	6	20	reduce	reduce	VERB
bptjm-31	6	21	the	the	DET
bptjm-31	6	22	effects	effect	NOUN
bptjm-31	6	23	of	of	ADP
bptjm-31	6	24	lewy	lewy	ADJ
bptjm-31	6	25	body	body	NOUN
bptjm-31	6	26	dementia	dementia	NOUN
bptjm-31	6	27	.	.	PUNCT
bptjm-31	7	1	novel	novel	ADJ
bptjm-31	7	2	genetic	genetic	ADJ
bptjm-31	7	3	therapeutic	therapeutic	ADJ
bptjm-31	7	4	strategies	strategy	NOUN
bptjm-31	7	5	for	for	ADP
bptjm-31	7	6	lewy	lewy	ADJ
bptjm-31	7	7	body	body	NOUN
bptjm-31	7	8	dementia	dementia	NOUN
bptjm-31	7	9	by	by	ADP
bptjm-31	7	10	:	:	PUNCT
bptjm-31	7	11	venkata	venkata	PROPN
bptjm-31	7	12	repaka	repaka	PROPN
bptjm-31	7	13	,	,	PUNCT
bptjm-31	7	14	carlota	carlota	PROPN
bptjm-31	7	15	sagarduy	sagarduy	NOUN
bptjm-31	7	16	and	and	CCONJ
bptjm-31	7	17	gatik	gatik	PROPN
bptjm-31	7	18	trivedi	trivedi	PROPN
bptjm-31	7	19	berkeley	berkeley	PROPN
bptjm-31	7	20	pharma	pharma	PROPN
bptjm-31	7	21	tech	tech	NOUN
bptjm-31	7	22	journal	journal	NOUN
bptjm-31	7	23	of	of	ADP
bptjm-31	7	24	medicine	medicine	NOUN
bptjm-31	7	25	|	|	ADV
bptjm-31	7	26	2	2	NUM
bptjm-31	7	27	1	1	NUM
bptjm-31	7	28	.	.	PUNCT
bptjm-31	8	1	introduction	introduction	NOUN
bptjm-31	8	2	there	there	PRON
bptjm-31	8	3	are	be	VERB
bptjm-31	8	4	three	three	NUM
bptjm-31	8	5	main	main	ADJ
bptjm-31	8	6	goals	goal	NOUN
bptjm-31	8	7	we	we	PRON
bptjm-31	8	8	would	would	AUX
bptjm-31	8	9	like	like	VERB
bptjm-31	8	10	to	to	PART
bptjm-31	8	11	achieve	achieve	VERB
bptjm-31	8	12	with	with	ADP
bptjm-31	8	13	this	this	DET
bptjm-31	8	14	review	review	NOUN
bptjm-31	8	15	paper	paper	NOUN
bptjm-31	8	16	.	.	PUNCT
bptjm-31	9	1	the	the	DET
bptjm-31	9	2	first	first	ADJ
bptjm-31	9	3	is	be	AUX
bptjm-31	9	4	to	to	PART
bptjm-31	9	5	lay	lay	VERB
bptjm-31	9	6	out	out	ADP
bptjm-31	9	7	a	a	DET
bptjm-31	9	8	list	list	NOUN
bptjm-31	9	9	of	of	ADP
bptjm-31	9	10	possible	possible	ADJ
bptjm-31	9	11	and	and	CCONJ
bptjm-31	9	12	current	current	ADJ
bptjm-31	9	13	treatments	treatment	NOUN
bptjm-31	9	14	available	available	ADJ
bptjm-31	9	15	for	for	ADP
bptjm-31	9	16	lewy	lewy	ADJ
bptjm-31	9	17	body	body	NOUN
bptjm-31	9	18	dementia	dementia	NOUN
bptjm-31	9	19	(	(	PUNCT
bptjm-31	9	20	lbd	lbd	PROPN
bptjm-31	9	21	)	)	PUNCT
bptjm-31	9	22	to	to	PART
bptjm-31	9	23	reduce	reduce	VERB
bptjm-31	9	24	its	its	PRON
bptjm-31	9	25	effects	effect	NOUN
bptjm-31	9	26	.	.	PUNCT
bptjm-31	10	1	next	next	ADV
bptjm-31	10	2	,	,	PUNCT
bptjm-31	10	3	we	we	PRON
bptjm-31	10	4	aim	aim	VERB
bptjm-31	10	5	to	to	PART
bptjm-31	10	6	understand	understand	VERB
bptjm-31	10	7	how	how	SCONJ
bptjm-31	10	8	lbd	lbd	PROPN
bptjm-31	10	9	can	can	AUX
bptjm-31	10	10	affect	affect	VERB
bptjm-31	10	11	other	other	ADJ
bptjm-31	10	12	conditions	condition	NOUN
bptjm-31	10	13	,	,	PUNCT
bptjm-31	10	14	such	such	ADJ
bptjm-31	10	15	as	as	ADP
bptjm-31	10	16	parkinson	parkinson	NOUN
bptjm-31	10	17	’s	’s	PART
bptjm-31	10	18	disease	disease	NOUN
bptjm-31	10	19	(	(	PUNCT
bptjm-31	10	20	pd	pd	NOUN
bptjm-31	10	21	)	)	PUNCT
bptjm-31	10	22	and	and	CCONJ
bptjm-31	10	23	alzheimer	alzheimer	PROPN
bptjm-31	10	24	’s	’s	PART
bptjm-31	10	25	disease	disease	NOUN
bptjm-31	10	26	(	(	PUNCT
bptjm-31	10	27	ad	ad	NOUN
bptjm-31	10	28	)	)	PUNCT
bptjm-31	10	29	,	,	PUNCT
bptjm-31	10	30	and	and	CCONJ
bptjm-31	10	31	the	the	DET
bptjm-31	10	32	connection	connection	NOUN
bptjm-31	10	33	between	between	ADP
bptjm-31	10	34	such	such	ADJ
bptjm-31	10	35	diseases	disease	NOUN
bptjm-31	10	36	.	.	PUNCT
bptjm-31	11	1	lastly	lastly	ADV
bptjm-31	11	2	,	,	PUNCT
bptjm-31	11	3	we	we	PRON
bptjm-31	11	4	seek	seek	VERB
bptjm-31	11	5	to	to	PART
bptjm-31	11	6	understand	understand	VERB
bptjm-31	11	7	the	the	DET
bptjm-31	11	8	molecular	molecular	ADJ
bptjm-31	11	9	mechanism	mechanism	NOUN
bptjm-31	11	10	of	of	ADP
bptjm-31	11	11	the	the	DET
bptjm-31	11	12	initiation	initiation	NOUN
bptjm-31	11	13	of	of	ADP
bptjm-31	11	14	lbd	lbd	PROPN
bptjm-31	11	15	.	.	PROPN
bptjm-31	12	1	due	due	ADP
bptjm-31	12	2	to	to	ADP
bptjm-31	12	3	limited	limited	ADJ
bptjm-31	12	4	research	research	NOUN
bptjm-31	12	5	and	and	CCONJ
bptjm-31	12	6	investigation	investigation	NOUN
bptjm-31	12	7	on	on	ADP
bptjm-31	12	8	the	the	DET
bptjm-31	12	9	topic	topic	NOUN
bptjm-31	12	10	,	,	PUNCT
bptjm-31	12	11	there	there	PRON
bptjm-31	12	12	is	be	VERB
bptjm-31	12	13	currently	currently	ADV
bptjm-31	12	14	no	no	DET
bptjm-31	12	15	cure	cure	NOUN
bptjm-31	12	16	for	for	ADP
bptjm-31	12	17	lbd	lbd	PROPN
bptjm-31	12	18	.	.	PUNCT
bptjm-31	13	1	because	because	SCONJ
bptjm-31	13	2	of	of	ADP
bptjm-31	13	3	the	the	DET
bptjm-31	13	4	related	related	ADJ
bptjm-31	13	5	symptoms	symptom	NOUN
bptjm-31	13	6	among	among	ADP
bptjm-31	13	7	lbd	lbd	PROPN
bptjm-31	13	8	,	,	PUNCT
bptjm-31	13	9	ad	ad	NOUN
bptjm-31	13	10	,	,	PUNCT
bptjm-31	13	11	and	and	CCONJ
bptjm-31	13	12	pd	pd	NOUN
bptjm-31	13	13	,	,	PUNCT
bptjm-31	13	14	some	some	DET
bptjm-31	13	15	medications	medication	NOUN
bptjm-31	13	16	used	use	VERB
bptjm-31	13	17	to	to	PART
bptjm-31	13	18	treat	treat	VERB
bptjm-31	13	19	ad	ad	NOUN
bptjm-31	13	20	and	and	CCONJ
bptjm-31	13	21	pd	pd	NOUN
bptjm-31	13	22	can	can	AUX
bptjm-31	13	23	be	be	AUX
bptjm-31	13	24	used	use	VERB
bptjm-31	13	25	for	for	ADP
bptjm-31	13	26	lbd	lbd	PROPN
bptjm-31	13	27	.	.	PROPN
bptjm-31	14	1	one	one	NUM
bptjm-31	14	2	medication	medication	NOUN
bptjm-31	14	3	is	be	AUX
bptjm-31	14	4	an	an	DET
bptjm-31	14	5	fda	fda	PROPN
bptjm-31	14	6	-	-	PUNCT
bptjm-31	14	7	approved	approve	VERB
bptjm-31	14	8	drug	drug	NOUN
bptjm-31	14	9	to	to	PART
bptjm-31	14	10	treat	treat	VERB
bptjm-31	14	11	ad	ad	NOUN
bptjm-31	14	12	called	call	VERB
bptjm-31	14	13	rivastigmine	rivastigmine	NOUN
bptjm-31	14	14	(	(	PUNCT
bptjm-31	14	15	exelon	exelon	NOUN
bptjm-31	14	16	)	)	PUNCT
bptjm-31	14	17	.	.	PUNCT
bptjm-31	15	1	it	it	PRON
bptjm-31	15	2	is	be	AUX
bptjm-31	15	3	a	a	DET
bptjm-31	15	4	reversible	reversible	ADJ
bptjm-31	15	5	cholinesterase	cholinesterase	NOUN
bptjm-31	15	6	inhibitor	inhibitor	NOUN
bptjm-31	15	7	that	that	PRON
bptjm-31	15	8	acts	act	VERB
bptjm-31	15	9	on	on	ADP
bptjm-31	15	10	a	a	DET
bptjm-31	15	11	chemical	chemical	NOUN
bptjm-31	15	12	in	in	ADP
bptjm-31	15	13	the	the	DET
bptjm-31	15	14	brain	brain	NOUN
bptjm-31	15	15	critical	critical	ADJ
bptjm-31	15	16	for	for	ADP
bptjm-31	15	17	memory	memory	NOUN
bptjm-31	15	18	formation	formation	NOUN
bptjm-31	15	19	and	and	CCONJ
bptjm-31	15	20	cognitive	cognitive	ADJ
bptjm-31	15	21	thinking1,2	thinking1,2	PROPN
bptjm-31	15	22	.	.	PUNCT
bptjm-31	16	1	this	this	PRON
bptjm-31	16	2	is	be	AUX
bptjm-31	16	3	a	a	DET
bptjm-31	16	4	reversible	reversible	ADJ
bptjm-31	16	5	cholinesterase	cholinesterase	NOUN
bptjm-31	16	6	inhibitor	inhibitor	NOUN
bptjm-31	16	7	that	that	PRON
bptjm-31	16	8	is	be	AUX
bptjm-31	16	9	known	know	VERB
bptjm-31	16	10	chemically	chemically	ADV
bptjm-31	16	11	as	as	ADP
bptjm-31	16	12	(	(	PUNCT
bptjm-31	16	13	s)3[1(dimethylamino	s)3[1(dimethylamino	PROPN
bptjm-31	16	14	)	)	PUNCT
bptjm-31	16	15	ethyl]phenyl	ethyl]phenyl	PROPN
bptjm-31	16	16	ethyl	ethyl	PROPN
bptjm-31	16	17	methyl	methyl	NOUN
bptjm-31	16	18	carbamate3	carbamate3	PROPN
bptjm-31	16	19	.	.	PUNCT
bptjm-31	17	1	another	another	DET
bptjm-31	17	2	medication	medication	NOUN
bptjm-31	17	3	,	,	PUNCT
bptjm-31	17	4	carbidopa	carbidopa	NOUN
bptjm-31	17	5	-	-	PUNCT
bptjm-31	17	6	levodopa	levodopa	NOUN
bptjm-31	17	7	,	,	PUNCT
bptjm-31	17	8	is	be	AUX
bptjm-31	17	9	used	use	VERB
bptjm-31	17	10	to	to	PART
bptjm-31	17	11	treat	treat	VERB
bptjm-31	17	12	pd	pd	PROPN
bptjm-31	17	13	and	and	CCONJ
bptjm-31	17	14	could	could	AUX
bptjm-31	17	15	be	be	AUX
bptjm-31	17	16	used	use	VERB
bptjm-31	17	17	for	for	ADP
bptjm-31	17	18	lbd	lbd	PROPN
bptjm-31	17	19	movement	movement	NOUN
bptjm-31	17	20	-	-	PUNCT
bptjm-31	17	21	related	relate	VERB
bptjm-31	17	22	treatment1,2	treatment1,2	PROPN
bptjm-31	17	23	.	.	PUNCT
bptjm-31	18	1	levodopa	levodopa	NOUN
bptjm-31	18	2	is	be	AUX
bptjm-31	18	3	the	the	DET
bptjm-31	18	4	precursor	precursor	NOUN
bptjm-31	18	5	of	of	ADP
bptjm-31	18	6	dopamine	dopamine	NOUN
bptjm-31	18	7	and	and	CCONJ
bptjm-31	18	8	can	can	AUX
bptjm-31	18	9	cross	cross	VERB
bptjm-31	18	10	the	the	DET
bptjm-31	18	11	blood	blood	NOUN
bptjm-31	18	12	-	-	PUNCT
bptjm-31	18	13	brain	brain	NOUN
bptjm-31	18	14	barrier	barrier	NOUN
bptjm-31	18	15	to	to	PART
bptjm-31	18	16	create	create	VERB
bptjm-31	18	17	more	more	ADJ
bptjm-31	18	18	dopamine	dopamine	NOUN
bptjm-31	18	19	in	in	ADP
bptjm-31	18	20	dopaminedeficient	dopaminedeficient	NOUN
bptjm-31	18	21	areas	area	NOUN
bptjm-31	18	22	in	in	ADP
bptjm-31	18	23	the	the	DET
bptjm-31	18	24	brain4	brain4	NOUN
bptjm-31	18	25	.	.	PUNCT
bptjm-31	19	1	some	some	DET
bptjm-31	19	2	clinical	clinical	ADJ
bptjm-31	19	3	features	feature	NOUN
bptjm-31	19	4	of	of	ADP
bptjm-31	19	5	lbd	lbd	PROPN
bptjm-31	19	6	include	include	VERB
bptjm-31	19	7	visual	visual	ADJ
bptjm-31	19	8	hallucinations	hallucination	NOUN
bptjm-31	19	9	and	and	CCONJ
bptjm-31	19	10	parkinsonism	parkinsonism	NOUN
bptjm-31	19	11	.	.	PUNCT
bptjm-31	20	1	recurrent	recurrent	ADJ
bptjm-31	20	2	,	,	PUNCT
bptjm-31	20	3	complex	complex	ADJ
bptjm-31	20	4	visual	visual	ADJ
bptjm-31	20	5	hallucinations	hallucination	NOUN
bptjm-31	20	6	occur	occur	VERB
bptjm-31	20	7	in	in	ADP
bptjm-31	20	8	up	up	ADP
bptjm-31	20	9	to	to	PART
bptjm-31	20	10	80	80	NUM
bptjm-31	20	11	%	%	NOUN
bptjm-31	20	12	of	of	ADP
bptjm-31	20	13	patients	patient	NOUN
bptjm-31	20	14	with	with	ADP
bptjm-31	20	15	lbd	lbd	PROPN
bptjm-31	20	16	and	and	CCONJ
bptjm-31	20	17	are	be	AUX
bptjm-31	20	18	a	a	DET
bptjm-31	20	19	frequent	frequent	ADJ
bptjm-31	20	20	clinical	clinical	ADJ
bptjm-31	20	21	signpost	signpost	NOUN
bptjm-31	20	22	to	to	ADP
bptjm-31	20	23	diagnosis5	diagnosis5	PROPN
bptjm-31	20	24	.	.	PUNCT
bptjm-31	21	1	they	they	PRON
bptjm-31	21	2	are	be	AUX
bptjm-31	21	3	typically	typically	ADV
bptjm-31	21	4	well	well	ADV
bptjm-31	21	5	-	-	PUNCT
bptjm-31	21	6	formed	form	VERB
bptjm-31	21	7	,	,	PUNCT
bptjm-31	21	8	featuring	feature	VERB
bptjm-31	21	9	people	people	NOUN
bptjm-31	21	10	,	,	PUNCT
bptjm-31	21	11	children	child	NOUN
bptjm-31	21	12	,	,	PUNCT
bptjm-31	21	13	or	or	CCONJ
bptjm-31	21	14	animals	animal	NOUN
bptjm-31	21	15	,	,	PUNCT
bptjm-31	21	16	sometimes	sometimes	ADV
bptjm-31	21	17	accompanied	accompany	VERB
bptjm-31	21	18	by	by	ADP
bptjm-31	21	19	related	related	ADJ
bptjm-31	21	20	phenomena	phenomenon	NOUN
bptjm-31	21	21	including	include	VERB
bptjm-31	21	22	passage	passage	NOUN
bptjm-31	21	23	hallucinations	hallucination	NOUN
bptjm-31	21	24	,	,	PUNCT
bptjm-31	21	25	sense	sense	NOUN
bptjm-31	21	26	of	of	ADP
bptjm-31	21	27	presence	presence	NOUN
bptjm-31	21	28	,	,	PUNCT
bptjm-31	21	29	and	and	CCONJ
bptjm-31	21	30	visual	visual	ADJ
bptjm-31	21	31	illusions	illusion	NOUN
bptjm-31	21	32	.	.	PUNCT
bptjm-31	22	1	spontaneous	spontaneous	ADJ
bptjm-31	22	2	parkinsonian	parkinsonian	ADJ
bptjm-31	22	3	features	feature	NOUN
bptjm-31	22	4	are	be	AUX
bptjm-31	22	5	common	common	ADJ
bptjm-31	22	6	in	in	ADP
bptjm-31	22	7	lbd	lbd	PROPN
bptjm-31	22	8	,	,	PUNCT
bptjm-31	22	9	eventually	eventually	ADV
bptjm-31	22	10	occurring	occur	VERB
bptjm-31	22	11	in	in	ADP
bptjm-31	22	12	over	over	ADP
bptjm-31	22	13	85	85	NUM
bptjm-31	22	14	%	%	NOUN
bptjm-31	22	15	(	(	PUNCT
bptjm-31	22	16	parkinsonism	parkinsonism	NOUN
bptjm-31	22	17	in	in	ADP
bptjm-31	22	18	parkinson	parkinson	NOUN
bptjm-31	22	19	's	's	PART
bptjm-31	22	20	disease	disease	NOUN
bptjm-31	22	21	(	(	PUNCT
bptjm-31	22	22	pd	pd	NOUN
bptjm-31	22	23	)	)	PUNCT
bptjm-31	22	24	is	be	AUX
bptjm-31	22	25	defined	define	VERB
bptjm-31	22	26	as	as	ADP
bptjm-31	22	27	bradykinesia	bradykinesia	NOUN
bptjm-31	22	28	in	in	ADP
bptjm-31	22	29	combination	combination	NOUN
bptjm-31	22	30	with	with	ADP
bptjm-31	22	31	rest	rest	NOUN
bptjm-31	22	32	tremor	tremor	NOUN
bptjm-31	22	33	,	,	PUNCT
bptjm-31	22	34	rigidity	rigidity	NOUN
bptjm-31	22	35	,	,	PUNCT
bptjm-31	22	36	or	or	CCONJ
bptjm-31	22	37	both)5	both)5	PROPN
bptjm-31	22	38	.	.	PROPN
bptjm-31	23	1	lbd	lbd	PROPN
bptjm-31	23	2	is	be	AUX
bptjm-31	23	3	defined	define	VERB
bptjm-31	23	4	as	as	ADP
bptjm-31	23	5	a	a	DET
bptjm-31	23	6	progressive	progressive	ADJ
bptjm-31	23	7	disease	disease	NOUN
bptjm-31	23	8	in	in	ADP
bptjm-31	23	9	which	which	PRON
bptjm-31	23	10	symptoms	symptom	NOUN
bptjm-31	23	11	worsen	worsen	VERB
bptjm-31	23	12	as	as	ADP
bptjm-31	23	13	one	one	NUM
bptjm-31	23	14	ages	age	NOUN
bptjm-31	23	15	.	.	PUNCT
bptjm-31	24	1	1,2	1,2	NUM
bptjm-31	24	2	hallucinations	hallucination	NOUN
bptjm-31	24	3	are	be	AUX
bptjm-31	24	4	common	common	ADJ
bptjm-31	24	5	in	in	ADP
bptjm-31	24	6	the	the	DET
bptjm-31	24	7	early	early	ADJ
bptjm-31	24	8	stages	stage	NOUN
bptjm-31	24	9	of	of	ADP
bptjm-31	24	10	lbd	lbd	PROPN
bptjm-31	24	11	,	,	PUNCT
bptjm-31	24	12	as	as	SCONJ
bptjm-31	24	13	are	be	AUX
bptjm-31	24	14	restlessness	restlessness	NOUN
bptjm-31	24	15	,	,	PUNCT
bptjm-31	24	16	acting	act	VERB
bptjm-31	24	17	out	out	ADP
bptjm-31	24	18	dreams	dream	NOUN
bptjm-31	24	19	during	during	ADP
bptjm-31	24	20	sleep	sleep	NOUN
bptjm-31	24	21	(	(	PUNCT
bptjm-31	24	22	called	call	VERB
bptjm-31	24	23	rem	rem	NOUN
bptjm-31	24	24	sleep	sleep	NOUN
bptjm-31	24	25	disorder	disorder	NOUN
bptjm-31	24	26	)	)	PUNCT
bptjm-31	24	27	,	,	PUNCT
bptjm-31	24	28	and	and	CCONJ
bptjm-31	24	29	berkeley	berkeley	PROPN
bptjm-31	24	30	pharma	pharma	PROPN
bptjm-31	24	31	tech	tech	NOUN
bptjm-31	24	32	journal	journal	NOUN
bptjm-31	24	33	of	of	ADP
bptjm-31	24	34	medicine	medicine	NOUN
bptjm-31	24	35	|	|	ADV
bptjm-31	24	36	3	3	NUM
bptjm-31	24	37	movement	movement	NOUN
bptjm-31	24	38	difficulties5	difficulties5	PROPN
bptjm-31	24	39	.	.	PUNCT
bptjm-31	25	1	others	other	NOUN
bptjm-31	25	2	may	may	AUX
bptjm-31	25	3	develop	develop	VERB
bptjm-31	25	4	urinary	urinary	ADJ
bptjm-31	25	5	urgency	urgency	NOUN
bptjm-31	25	6	and	and	CCONJ
bptjm-31	25	7	incontinence	incontinence	NOUN
bptjm-31	25	8	.	.	PUNCT
bptjm-31	26	1	unlike	unlike	ADP
bptjm-31	26	2	ad	ad	NOUN
bptjm-31	26	3	,	,	PUNCT
bptjm-31	26	4	memory	memory	NOUN
bptjm-31	26	5	is	be	AUX
bptjm-31	26	6	usually	usually	ADV
bptjm-31	26	7	still	still	ADV
bptjm-31	26	8	fairly	fairly	ADV
bptjm-31	26	9	intact	intact	ADJ
bptjm-31	26	10	in	in	ADP
bptjm-31	26	11	the	the	DET
bptjm-31	26	12	early	early	ADJ
bptjm-31	26	13	stages	stage	NOUN
bptjm-31	26	14	.	.	PUNCT
bptjm-31	27	1	however	however	ADV
bptjm-31	27	2	,	,	PUNCT
bptjm-31	27	3	confusion	confusion	NOUN
bptjm-31	27	4	and	and	CCONJ
bptjm-31	27	5	some	some	DET
bptjm-31	27	6	mild	mild	ADJ
bptjm-31	27	7	cognitive	cognitive	ADJ
bptjm-31	27	8	changes	change	NOUN
bptjm-31	27	9	may	may	AUX
bptjm-31	27	10	be	be	AUX
bptjm-31	27	11	present	present	ADJ
bptjm-31	27	12	.	.	PUNCT
bptjm-31	28	1	as	as	ADP
bptjm-31	28	2	lbd	lbd	PROPN
bptjm-31	28	3	progresses	progress	NOUN
bptjm-31	28	4	,	,	PUNCT
bptjm-31	28	5	symptoms	symptom	NOUN
bptjm-31	28	6	develop	develop	VERB
bptjm-31	28	7	and	and	CCONJ
bptjm-31	28	8	more	more	ADV
bptjm-31	28	9	strongly	strongly	ADV
bptjm-31	28	10	resemble	resemble	VERB
bptjm-31	28	11	parkinson	parkinson	NOUN
bptjm-31	28	12	's	's	PART
bptjm-31	28	13	disease5	disease5	NOUN
bptjm-31	28	14	.	.	PUNCT
bptjm-31	29	1	these	these	DET
bptjm-31	29	2	symptoms	symptom	NOUN
bptjm-31	29	3	include	include	VERB
bptjm-31	29	4	increased	increase	VERB
bptjm-31	29	5	problems	problem	NOUN
bptjm-31	29	6	with	with	ADP
bptjm-31	29	7	motor	motor	NOUN
bptjm-31	29	8	functions	function	NOUN
bptjm-31	29	9	,	,	PUNCT
bptjm-31	29	10	difficulty	difficulty	NOUN
bptjm-31	29	11	with	with	ADP
bptjm-31	29	12	speech	speech	NOUN
bptjm-31	29	13	,	,	PUNCT
bptjm-31	29	14	swallowing	swallow	VERB
bptjm-31	29	15	problems	problem	NOUN
bptjm-31	29	16	,	,	PUNCT
bptjm-31	29	17	and	and	CCONJ
bptjm-31	29	18	greater	great	ADJ
bptjm-31	29	19	paranoia	paranoia	NOUN
bptjm-31	29	20	and	and	CCONJ
bptjm-31	29	21	delusions6	delusions6	NOUN
bptjm-31	29	22	.	.	PUNCT
bptjm-31	30	1	cognition	cognition	NOUN
bptjm-31	30	2	also	also	ADV
bptjm-31	30	3	continues	continue	VERB
bptjm-31	30	4	to	to	PART
bptjm-31	30	5	decline	decline	VERB
bptjm-31	30	6	,	,	PUNCT
bptjm-31	30	7	with	with	ADP
bptjm-31	30	8	shorter	short	ADJ
bptjm-31	30	9	attention	attention	NOUN
bptjm-31	30	10	and	and	CCONJ
bptjm-31	30	11	significant	significant	ADJ
bptjm-31	30	12	periods	period	NOUN
bptjm-31	30	13	of	of	ADP
bptjm-31	30	14	confusion	confusion	NOUN
bptjm-31	30	15	occurring	occur	VERB
bptjm-31	30	16	.	.	PUNCT
bptjm-31	31	1	in	in	ADP
bptjm-31	31	2	the	the	DET
bptjm-31	31	3	later	later	ADJ
bptjm-31	31	4	stages	stage	NOUN
bptjm-31	31	5	of	of	ADP
bptjm-31	31	6	lbd	lbd	PROPN
bptjm-31	31	7	,	,	PUNCT
bptjm-31	31	8	extreme	extreme	ADJ
bptjm-31	31	9	muscle	muscle	NOUN
bptjm-31	31	10	rigidity	rigidity	NOUN
bptjm-31	31	11	and	and	CCONJ
bptjm-31	31	12	sensitivity	sensitivity	NOUN
bptjm-31	31	13	to	to	PART
bptjm-31	31	14	touch	touch	VERB
bptjm-31	31	15	develops	develop	NOUN
bptjm-31	31	16	.	.	PUNCT
bptjm-31	32	1	patients	patient	NOUN
bptjm-31	32	2	need	need	VERB
bptjm-31	32	3	assistance	assistance	NOUN
bptjm-31	32	4	with	with	ADP
bptjm-31	32	5	almost	almost	ADV
bptjm-31	32	6	all	all	PRON
bptjm-31	32	7	activities	activity	NOUN
bptjm-31	32	8	of	of	ADP
bptjm-31	32	9	daily	daily	ADJ
bptjm-31	32	10	living	living	NOUN
bptjm-31	32	11	.	.	PUNCT
bptjm-31	33	1	speech	speech	NOUN
bptjm-31	33	2	is	be	AUX
bptjm-31	33	3	often	often	ADV
bptjm-31	33	4	very	very	ADV
bptjm-31	33	5	difficult	difficult	ADJ
bptjm-31	33	6	and	and	CCONJ
bptjm-31	33	7	may	may	AUX
bptjm-31	33	8	be	be	AUX
bptjm-31	33	9	whispered	whisper	VERB
bptjm-31	33	10	.	.	PUNCT
bptjm-31	34	1	some	some	DET
bptjm-31	34	2	lbd	lbd	PROPN
bptjm-31	34	3	patients	patient	NOUN
bptjm-31	34	4	stop	stop	VERB
bptjm-31	34	5	talking	talk	VERB
bptjm-31	34	6	altogether7	altogether7	NOUN
bptjm-31	34	7	.	.	PUNCT
bptjm-31	35	1	both	both	DET
bptjm-31	35	2	lbd	lbd	PROPN
bptjm-31	35	3	and	and	CCONJ
bptjm-31	35	4	pd	pd	PROPN
bptjm-31	35	5	are	be	AUX
bptjm-31	35	6	quite	quite	ADV
bptjm-31	35	7	similar	similar	ADJ
bptjm-31	35	8	and	and	CCONJ
bptjm-31	35	9	have	have	VERB
bptjm-31	35	10	overlapping	overlap	VERB
bptjm-31	35	11	characteristics	characteristic	NOUN
bptjm-31	35	12	,	,	PUNCT
bptjm-31	35	13	but	but	CCONJ
bptjm-31	35	14	there	there	PRON
bptjm-31	35	15	are	be	VERB
bptjm-31	35	16	specific	specific	ADJ
bptjm-31	35	17	key	key	ADJ
bptjm-31	35	18	differences	difference	NOUN
bptjm-31	35	19	that	that	PRON
bptjm-31	35	20	can	can	AUX
bptjm-31	35	21	differentiate	differentiate	VERB
bptjm-31	35	22	lbd	lbd	PROPN
bptjm-31	35	23	and	and	CCONJ
bptjm-31	35	24	pd	pd	PROPN
bptjm-31	35	25	in	in	ADP
bptjm-31	35	26	the	the	DET
bptjm-31	35	27	spectrum1,2	spectrum1,2	PROPN
bptjm-31	35	28	.	.	PUNCT
bptjm-31	36	1	there	there	PRON
bptjm-31	36	2	is	be	VERB
bptjm-31	36	3	a	a	DET
bptjm-31	36	4	frequent	frequent	ADJ
bptjm-31	36	5	coexistence	coexistence	NOUN
bptjm-31	36	6	of	of	ADP
bptjm-31	36	7	the	the	DET
bptjm-31	36	8	pathology	pathology	NOUN
bptjm-31	36	9	of	of	ADP
bptjm-31	36	10	amyloid	amyloid	NOUN
bptjm-31	36	11	plaques	plaque	NOUN
bptjm-31	36	12	and	and	CCONJ
bptjm-31	36	13	neurofibrillary	neurofibrillary	ADJ
bptjm-31	36	14	tangles	tangle	NOUN
bptjm-31	36	15	in	in	ADP
bptjm-31	36	16	lbd	lbd	PROPN
bptjm-31	36	17	compared	compare	VERB
bptjm-31	36	18	with	with	ADP
bptjm-31	36	19	parkinson	parkinson	NOUN
bptjm-31	36	20	's	's	PART
bptjm-31	36	21	disease	disease	NOUN
bptjm-31	36	22	dementia	dementia	NOUN
bptjm-31	36	23	.	.	PUNCT
bptjm-31	37	1	amyloid	amyloid	NOUN
bptjm-31	37	2	plaque	plaque	NOUN
bptjm-31	37	3	are	be	AUX
bptjm-31	37	4	misfolded	misfolde	VERB
bptjm-31	37	5	proteins	protein	NOUN
bptjm-31	37	6	in	in	ADP
bptjm-31	37	7	the	the	DET
bptjm-31	37	8	synaptic	synaptic	ADJ
bptjm-31	37	9	clefts	cleft	NOUN
bptjm-31	37	10	of	of	ADP
bptjm-31	37	11	neurons	neuron	NOUN
bptjm-31	37	12	.	.	PUNCT
bptjm-31	38	1	this	this	PRON
bptjm-31	38	2	would	would	AUX
bptjm-31	38	3	effectively	effectively	ADV
bptjm-31	38	4	block	block	VERB
bptjm-31	38	5	the	the	DET
bptjm-31	38	6	transmission	transmission	NOUN
bptjm-31	38	7	of	of	ADP
bptjm-31	38	8	neurotransmitters	neurotransmitter	NOUN
bptjm-31	38	9	from	from	ADP
bptjm-31	38	10	neuron	neuron	PROPN
bptjm-31	38	11	to	to	PART
bptjm-31	38	12	neuron	neuron	PROPN
bptjm-31	38	13	.	.	PUNCT
bptjm-31	39	1	additionally	additionally	ADV
bptjm-31	39	2	,	,	PUNCT
bptjm-31	39	3	the	the	DET
bptjm-31	39	4	accumulation	accumulation	NOUN
bptjm-31	39	5	of	of	ADP
bptjm-31	39	6	the	the	DET
bptjm-31	39	7	protein	protein	NOUN
bptjm-31	39	8	tau	tau	PROPN
bptjm-31	39	9	within	within	ADP
bptjm-31	39	10	neurons	neuron	NOUN
bptjm-31	39	11	are	be	AUX
bptjm-31	39	12	called	call	VERB
bptjm-31	39	13	neurofibrillary	neurofibrillary	ADJ
bptjm-31	39	14	tangles	tangle	NOUN
bptjm-31	39	15	.	.	PUNCT
bptjm-31	40	1	the	the	DET
bptjm-31	40	2	tau	tau	PROPN
bptjm-31	40	3	protein	protein	NOUN
bptjm-31	40	4	works	work	VERB
bptjm-31	40	5	to	to	PART
bptjm-31	40	6	help	help	VERB
bptjm-31	40	7	the	the	DET
bptjm-31	40	8	neuron	neuron	NOUN
bptjm-31	40	9	’s	’s	PART
bptjm-31	40	10	microtubules	microtubule	NOUN
bptjm-31	40	11	which	which	PRON
bptjm-31	40	12	help	help	VERB
bptjm-31	40	13	guide	guide	VERB
bptjm-31	40	14	nutrients	nutrient	NOUN
bptjm-31	40	15	and	and	CCONJ
bptjm-31	40	16	vitamins	vitamin	NOUN
bptjm-31	40	17	move	move	VERB
bptjm-31	40	18	in	in	ADP
bptjm-31	40	19	the	the	DET
bptjm-31	40	20	neuron	neuron	NOUN
bptjm-31	40	21	.	.	PUNCT
bptjm-31	41	1	particularly	particularly	ADV
bptjm-31	41	2	,	,	PUNCT
bptjm-31	41	3	because	because	SCONJ
bptjm-31	41	4	tau	tau	PROPN
bptjm-31	41	5	proteins	protein	NOUN
bptjm-31	41	6	are	be	AUX
bptjm-31	41	7	‘	'	PUNCT
bptjm-31	41	8	sticky	sticky	ADJ
bptjm-31	41	9	’	'	PUNCT
bptjm-31	41	10	in	in	ADP
bptjm-31	41	11	character	character	NOUN
bptjm-31	41	12	they	they	PRON
bptjm-31	41	13	will	will	AUX
bptjm-31	41	14	bind	bind	VERB
bptjm-31	41	15	to	to	ADP
bptjm-31	41	16	each	each	DET
bptjm-31	41	17	other	other	ADJ
bptjm-31	41	18	while	while	SCONJ
bptjm-31	41	19	they	they	PRON
bptjm-31	41	20	are	be	AUX
bptjm-31	41	21	connected	connect	VERB
bptjm-31	41	22	to	to	ADP
bptjm-31	41	23	microtubules	microtubule	NOUN
bptjm-31	41	24	and	and	CCONJ
bptjm-31	41	25	create	create	VERB
bptjm-31	41	26	tangles	tangle	NOUN
bptjm-31	41	27	of	of	ADP
bptjm-31	41	28	the	the	DET
bptjm-31	41	29	microtubules	microtubule	NOUN
bptjm-31	41	30	inside	inside	ADP
bptjm-31	41	31	neurons	neuron	NOUN
bptjm-31	41	32	.	.	PUNCT
bptjm-31	42	1	this	this	PRON
bptjm-31	42	2	can	can	AUX
bptjm-31	42	3	harm	harm	VERB
bptjm-31	42	4	the	the	DET
bptjm-31	42	5	synaptic	synaptic	ADJ
bptjm-31	42	6	communication	communication	NOUN
bptjm-31	42	7	and	and	CCONJ
bptjm-31	42	8	internal	internal	ADJ
bptjm-31	42	9	cell	cell	NOUN
bptjm-31	42	10	communication	communication	NOUN
bptjm-31	42	11	of	of	ADP
bptjm-31	42	12	the	the	DET
bptjm-31	42	13	neuron31	neuron31	NOUN
bptjm-31	42	14	.	.	PUNCT
bptjm-31	43	1	alzheimer	alzheimer	PROPN
bptjm-31	43	2	’s	’s	PART
bptjm-31	43	3	differs	differ	VERB
bptjm-31	43	4	from	from	ADP
bptjm-31	43	5	lbd	lbd	PROPN
bptjm-31	43	6	clinically	clinically	ADV
bptjm-31	43	7	because	because	SCONJ
bptjm-31	43	8	of	of	ADP
bptjm-31	43	9	its	its	PRON
bptjm-31	43	10	unique	unique	ADJ
bptjm-31	43	11	cognitive	cognitive	ADJ
bptjm-31	43	12	profile	profile	NOUN
bptjm-31	43	13	and	and	CCONJ
bptjm-31	43	14	its	its	PRON
bptjm-31	43	15	lack	lack	NOUN
bptjm-31	43	16	of	of	ADP
bptjm-31	43	17	parkinsonian	parkinsonian	ADJ
bptjm-31	43	18	features	feature	NOUN
bptjm-31	43	19	except	except	SCONJ
bptjm-31	43	20	in	in	ADP
bptjm-31	43	21	the	the	DET
bptjm-31	43	22	late	late	ADJ
bptjm-31	43	23	stages2	stages2	PROPN
bptjm-31	43	24	.	.	PUNCT
bptjm-31	44	1	this	this	DET
bptjm-31	44	2	paper	paper	NOUN
bptjm-31	44	3	provides	provide	VERB
bptjm-31	44	4	an	an	DET
bptjm-31	44	5	overview	overview	NOUN
bptjm-31	44	6	of	of	ADP
bptjm-31	44	7	novel	novel	ADJ
bptjm-31	44	8	therapeutic	therapeutic	ADJ
bptjm-31	44	9	genetic	genetic	ADJ
bptjm-31	44	10	strategies	strategy	NOUN
bptjm-31	44	11	to	to	PART
bptjm-31	44	12	reduce	reduce	VERB
bptjm-31	44	13	the	the	DET
bptjm-31	44	14	effect	effect	NOUN
bptjm-31	44	15	of	of	ADP
bptjm-31	44	16	lbd	lbd	PROPN
bptjm-31	44	17	by	by	ADP
bptjm-31	44	18	targeting	target	VERB
bptjm-31	44	19	topics	topic	NOUN
bptjm-31	44	20	of	of	ADP
bptjm-31	44	21	epigenetics	epigenetic	NOUN
bptjm-31	44	22	,	,	PUNCT
bptjm-31	44	23	cognitive	cognitive	ADJ
bptjm-31	44	24	enhancers	enhancer	NOUN
bptjm-31	44	25	,	,	PUNCT
bptjm-31	44	26	non	non	ADJ
bptjm-31	44	27	-	-	ADJ
bptjm-31	44	28	coding	coding	ADJ
bptjm-31	44	29	rnas	rna	NOUN
bptjm-31	44	30	,	,	PUNCT
bptjm-31	44	31	micronutrients	micronutrient	NOUN
bptjm-31	44	32	,	,	PUNCT
bptjm-31	44	33	making	make	VERB
bptjm-31	44	34	alterations	alteration	NOUN
bptjm-31	44	35	of	of	ADP
bptjm-31	44	36	central	central	ADJ
bptjm-31	44	37	cholinergic	cholinergic	NOUN
bptjm-31	44	38	(	(	PUNCT
bptjm-31	44	39	ach	ach	NOUN
bptjm-31	44	40	)	)	PUNCT
bptjm-31	44	41	and	and	CCONJ
bptjm-31	44	42	dopaminergic	dopaminergic	ADJ
bptjm-31	44	43	(	(	PUNCT
bptjm-31	44	44	da	da	ADJ
bptjm-31	44	45	)	)	PUNCT
bptjm-31	44	46	systems	system	NOUN
bptjm-31	44	47	,	,	PUNCT
bptjm-31	44	48	and	and	CCONJ
bptjm-31	44	49	looking	look	VERB
bptjm-31	44	50	at	at	ADP
bptjm-31	44	51	current	current	ADJ
bptjm-31	44	52	drugs	drug	NOUN
bptjm-31	44	53	and	and	CCONJ
bptjm-31	44	54	treatments	treatment	NOUN
bptjm-31	44	55	.	.	PUNCT
bptjm-31	45	1	this	this	DET
bptjm-31	45	2	review	review	NOUN
bptjm-31	45	3	will	will	AUX
bptjm-31	45	4	also	also	ADV
bptjm-31	45	5	be	be	AUX
bptjm-31	45	6	discussing	discuss	VERB
bptjm-31	45	7	how	how	SCONJ
bptjm-31	45	8	factors	factor	NOUN
bptjm-31	45	9	such	such	ADJ
bptjm-31	45	10	as	as	ADP
bptjm-31	45	11	age	age	NOUN
bptjm-31	45	12	,	,	PUNCT
bptjm-31	45	13	diet	diet	NOUN
bptjm-31	45	14	,	,	PUNCT
bptjm-31	45	15	and	and	CCONJ
bptjm-31	45	16	underlying	underlying	ADJ
bptjm-31	45	17	health	health	NOUN
bptjm-31	45	18	conditions	condition	NOUN
bptjm-31	45	19	can	can	AUX
bptjm-31	45	20	affect	affect	VERB
bptjm-31	45	21	the	the	DET
bptjm-31	45	22	intensity	intensity	NOUN
bptjm-31	45	23	of	of	ADP
bptjm-31	45	24	lewy	lewy	ADJ
bptjm-31	45	25	body	body	NOUN
bptjm-31	45	26	dementia	dementia	NOUN
bptjm-31	45	27	in	in	ADP
bptjm-31	45	28	a	a	DET
bptjm-31	45	29	patient	patient	NOUN
bptjm-31	45	30	.	.	PUNCT
bptjm-31	46	1	berkeley	berkeley	PROPN
bptjm-31	46	2	pharma	pharma	PROPN
bptjm-31	46	3	tech	tech	PROPN
bptjm-31	46	4	journal	journal	NOUN
bptjm-31	46	5	of	of	ADP
bptjm-31	46	6	medicine	medicine	NOUN
bptjm-31	46	7	|	|	ADV
bptjm-31	46	8	4	4	NUM
bptjm-31	46	9	2	2	NUM
bptjm-31	46	10	.	.	PUNCT
bptjm-31	47	1	molecular	molecular	ADJ
bptjm-31	47	2	components	component	NOUN
bptjm-31	47	3	of	of	ADP
bptjm-31	47	4	lbd	lbd	PROPN
bptjm-31	47	5	while	while	SCONJ
bptjm-31	47	6	there	there	PRON
bptjm-31	47	7	are	be	VERB
bptjm-31	47	8	many	many	ADJ
bptjm-31	47	9	molecular	molecular	ADJ
bptjm-31	47	10	pathways	pathway	NOUN
bptjm-31	47	11	of	of	ADP
bptjm-31	47	12	lbd	lbd	PROPN
bptjm-31	47	13	,	,	PUNCT
bptjm-31	47	14	research	research	NOUN
bptjm-31	47	15	has	have	AUX
bptjm-31	47	16	shown	show	VERB
bptjm-31	47	17	that	that	SCONJ
bptjm-31	47	18	alpha	alpha	ADJ
bptjm-31	47	19	-	-	PUNCT
bptjm-31	47	20	synuclein(as)-positive	synuclein(as)-positive	ADJ
bptjm-31	47	21	inclusions	inclusion	NOUN
bptjm-31	47	22	are	be	AUX
bptjm-31	47	23	the	the	DET
bptjm-31	47	24	main	main	ADJ
bptjm-31	47	25	indicator	indicator	NOUN
bptjm-31	47	26	of	of	ADP
bptjm-31	47	27	lewy	lewy	PROPN
bptjm-31	47	28	body8,9	body8,9	PROPN
bptjm-31	47	29	,	,	PUNCT
bptjm-31	47	30	causing	cause	VERB
bptjm-31	47	31	the	the	DET
bptjm-31	47	32	impairment	impairment	NOUN
bptjm-31	47	33	of	of	ADP
bptjm-31	47	34	protein	protein	NOUN
bptjm-31	47	35	degradation	degradation	NOUN
bptjm-31	47	36	pathways	pathway	NOUN
bptjm-31	47	37	,	,	PUNCT
bptjm-31	47	38	including	include	VERB
bptjm-31	47	39	both	both	CCONJ
bptjm-31	47	40	the	the	DET
bptjm-31	47	41	ubiquitin	ubiquitin	ADJ
bptjm-31	47	42	-	-	PUNCT
bptjm-31	47	43	proteasome	proteasome	NOUN
bptjm-31	47	44	system	system	NOUN
bptjm-31	47	45	and	and	CCONJ
bptjm-31	47	46	the	the	DET
bptjm-31	47	47	autophagy	autophagy	ADJ
bptjm-31	47	48	-	-	PUNCT
bptjm-31	47	49	lysosome	lysosome	NOUN
bptjm-31	47	50	pathway	pathway	NOUN
bptjm-31	47	51	.	.	PUNCT
bptjm-31	48	1	the	the	DET
bptjm-31	48	2	ubiquitin	ubiquitin	ADJ
bptjm-31	48	3	-	-	PUNCT
bptjm-31	48	4	proteasome	proteasome	NOUN
bptjm-31	48	5	pathway	pathway	NOUN
bptjm-31	48	6	(	(	PUNCT
bptjm-31	48	7	upp	upp	PROPN
bptjm-31	48	8	)	)	PUNCT
bptjm-31	48	9	is	be	AUX
bptjm-31	48	10	the	the	DET
bptjm-31	48	11	main	main	ADJ
bptjm-31	48	12	pathway	pathway	NOUN
bptjm-31	48	13	that	that	PRON
bptjm-31	48	14	destroys	destroy	VERB
bptjm-31	48	15	unneeded	unneeded	ADJ
bptjm-31	48	16	proteins	protein	NOUN
bptjm-31	48	17	and	and	CCONJ
bptjm-31	48	18	eliminates	eliminate	VERB
bptjm-31	48	19	misfolded	misfolde	VERB
bptjm-31	48	20	or	or	CCONJ
bptjm-31	48	21	misguided	misguided	ADJ
bptjm-31	48	22	proteins	protein	NOUN
bptjm-31	48	23	that	that	PRON
bptjm-31	48	24	are	be	AUX
bptjm-31	48	25	in	in	ADP
bptjm-31	48	26	the	the	DET
bptjm-31	48	27	wrong	wrong	ADJ
bptjm-31	48	28	locations	location	NOUN
bptjm-31	48	29	within	within	ADP
bptjm-31	48	30	the	the	DET
bptjm-31	48	31	cell	cell	NOUN
bptjm-31	48	32	with	with	ADP
bptjm-31	48	33	the	the	DET
bptjm-31	48	34	use	use	NOUN
bptjm-31	48	35	of	of	ADP
bptjm-31	48	36	a	a	DET
bptjm-31	48	37	protease	protease	NOUN
bptjm-31	48	38	or	or	CCONJ
bptjm-31	48	39	proteasome32	proteasome32	NOUN
bptjm-31	48	40	.	.	PUNCT
bptjm-31	49	1	this	this	DET
bptjm-31	49	2	mechanism	mechanism	NOUN
bptjm-31	49	3	works	work	VERB
bptjm-31	49	4	through	through	ADP
bptjm-31	49	5	the	the	DET
bptjm-31	49	6	formation	formation	NOUN
bptjm-31	49	7	of	of	ADP
bptjm-31	49	8	a	a	DET
bptjm-31	49	9	polyubiquitinated	polyubiquitinate	VERB
bptjm-31	49	10	protein	protein	NOUN
bptjm-31	49	11	,	,	PUNCT
bptjm-31	49	12	which	which	PRON
bptjm-31	49	13	serves	serve	VERB
bptjm-31	49	14	as	as	ADP
bptjm-31	49	15	a	a	DET
bptjm-31	49	16	recognition	recognition	NOUN
bptjm-31	49	17	signal	signal	NOUN
bptjm-31	49	18	for	for	SCONJ
bptjm-31	49	19	the	the	DET
bptjm-31	49	20	eventual	eventual	ADJ
bptjm-31	49	21	action	action	NOUN
bptjm-31	49	22	of	of	ADP
bptjm-31	49	23	the	the	DET
bptjm-31	49	24	proteasome	proteasome	NOUN
bptjm-31	49	25	to	to	PART
bptjm-31	49	26	degrade	degrade	VERB
bptjm-31	49	27	the	the	DET
bptjm-31	49	28	proteins	protein	NOUN
bptjm-31	49	29	into	into	ADP
bptjm-31	49	30	peptides	peptide	NOUN
bptjm-31	49	31	,	,	PUNCT
bptjm-31	49	32	as	as	SCONJ
bptjm-31	49	33	shown	show	VERB
bptjm-31	49	34	in	in	ADP
bptjm-31	49	35	figure	figure	NOUN
bptjm-31	49	36	1	1	NUM
bptjm-31	49	37	.	.	PUNCT
bptjm-31	50	1	this	this	PRON
bptjm-31	50	2	is	be	AUX
bptjm-31	50	3	an	an	DET
bptjm-31	50	4	important	important	ADJ
bptjm-31	50	5	mechanism	mechanism	NOUN
bptjm-31	50	6	as	as	SCONJ
bptjm-31	50	7	this	this	PRON
bptjm-31	50	8	can	can	AUX
bptjm-31	50	9	decrease	decrease	VERB
bptjm-31	50	10	the	the	DET
bptjm-31	50	11	number	number	NOUN
bptjm-31	50	12	of	of	ADP
bptjm-31	50	13	unnecessary	unnecessary	ADJ
bptjm-31	50	14	proteins	protein	NOUN
bptjm-31	50	15	and	and	CCONJ
bptjm-31	50	16	debris	debris	NOUN
bptjm-31	50	17	in	in	ADP
bptjm-31	50	18	the	the	DET
bptjm-31	50	19	body	body	NOUN
bptjm-31	50	20	that	that	PRON
bptjm-31	50	21	is	be	AUX
bptjm-31	50	22	unneeded	unneeded	ADJ
bptjm-31	50	23	.	.	PUNCT
bptjm-31	51	1	defects	defect	NOUN
bptjm-31	51	2	in	in	ADP
bptjm-31	51	3	the	the	DET
bptjm-31	51	4	upp	upp	PROPN
bptjm-31	51	5	can	can	AUX
bptjm-31	51	6	be	be	AUX
bptjm-31	51	7	detrimental	detrimental	ADJ
bptjm-31	51	8	to	to	ADP
bptjm-31	51	9	the	the	DET
bptjm-31	51	10	homeostasis	homeostasis	NOUN
bptjm-31	51	11	of	of	ADP
bptjm-31	51	12	the	the	DET
bptjm-31	51	13	amounts	amount	NOUN
bptjm-31	51	14	of	of	ADP
bptjm-31	51	15	tau	tau	PROPN
bptjm-31	51	16	protein	protein	NOUN
bptjm-31	51	17	in	in	ADP
bptjm-31	51	18	the	the	DET
bptjm-31	51	19	neuron	neuron	NOUN
bptjm-31	51	20	.	.	PUNCT
bptjm-31	52	1	a	a	DET
bptjm-31	52	2	possibility	possibility	NOUN
bptjm-31	52	3	of	of	ADP
bptjm-31	52	4	the	the	DET
bptjm-31	52	5	amount	amount	NOUN
bptjm-31	52	6	of	of	ADP
bptjm-31	52	7	extra	extra	ADJ
bptjm-31	52	8	tau	tau	NOUN
bptjm-31	52	9	protein	protein	NOUN
bptjm-31	52	10	in	in	ADP
bptjm-31	52	11	the	the	DET
bptjm-31	52	12	neuron	neuron	NOUN
bptjm-31	52	13	can	can	AUX
bptjm-31	52	14	be	be	AUX
bptjm-31	52	15	due	due	ADJ
bptjm-31	52	16	to	to	ADP
bptjm-31	52	17	a	a	DET
bptjm-31	52	18	mishap	mishap	NOUN
bptjm-31	52	19	of	of	ADP
bptjm-31	52	20	the	the	DET
bptjm-31	52	21	upp	upp	PROPN
bptjm-31	52	22	.	.	PROPN
bptjm-31	52	23	berkeley	berkeley	PROPN
bptjm-31	52	24	pharma	pharma	PROPN
bptjm-31	52	25	tech	tech	PROPN
bptjm-31	52	26	journal	journal	NOUN
bptjm-31	52	27	of	of	ADP
bptjm-31	52	28	medicine	medicine	NOUN
bptjm-31	52	29	|	|	ADV
bptjm-31	52	30	5	5	NUM
bptjm-31	52	31	figure	figure	NOUN
bptjm-31	52	32	1	1	NUM
bptjm-31	52	33	.	.	PUNCT
bptjm-31	53	1	the	the	DET
bptjm-31	53	2	ubiquitin	ubiquitin	ADJ
bptjm-31	53	3	-	-	PUNCT
bptjm-31	53	4	proteasome	proteasome	NOUN
bptjm-31	53	5	pathway	pathway	NOUN
bptjm-31	53	6	(	(	PUNCT
bptjm-31	53	7	upp	upp	PROPN
bptjm-31	53	8	)	)	PUNCT
bptjm-31	53	9	.	.	PUNCT
bptjm-31	54	1	ubiquitin	ubiquitin	PROPN
bptjm-31	54	2	,	,	PUNCT
bptjm-31	54	3	a	a	DET
bptjm-31	54	4	76	76	NUM
bptjm-31	54	5	amino	amino	NOUN
bptjm-31	54	6	acid	acid	NOUN
bptjm-31	54	7	protein	protein	NOUN
bptjm-31	54	8	,	,	PUNCT
bptjm-31	54	9	marks	mark	VERB
bptjm-31	54	10	the	the	DET
bptjm-31	54	11	molecule	molecule	NOUN
bptjm-31	54	12	to	to	PART
bptjm-31	54	13	be	be	AUX
bptjm-31	54	14	degraded	degrade	VERB
bptjm-31	54	15	by	by	ADP
bptjm-31	54	16	attaching	attach	VERB
bptjm-31	54	17	itself	itself	PRON
bptjm-31	54	18	to	to	ADP
bptjm-31	54	19	a	a	DET
bptjm-31	54	20	substrate	substrate	NOUN
bptjm-31	54	21	protein	protein	NOUN
bptjm-31	54	22	.	.	PUNCT
bptjm-31	55	1	in	in	ADP
bptjm-31	55	2	this	this	DET
bptjm-31	55	3	process	process	NOUN
bptjm-31	55	4	,	,	PUNCT
bptjm-31	55	5	e1	e1	PROPN
bptjm-31	55	6	–	–	PUNCT
bptjm-31	55	7	the	the	DET
bptjm-31	55	8	ubiquitin	ubiquitin	NOUN
bptjm-31	55	9	-	-	PUNCT
bptjm-31	55	10	activating	activate	VERB
bptjm-31	55	11	enzyme	enzyme	NOUN
bptjm-31	55	12	,	,	PUNCT
bptjm-31	55	13	e2	e2	PROPN
bptjm-31	55	14	–	–	PUNCT
bptjm-31	55	15	the	the	DET
bptjm-31	55	16	ubiquitin	ubiquitin	ADJ
bptjm-31	55	17	-	-	PUNCT
bptjm-31	55	18	conjugating	conjugate	VERB
bptjm-31	55	19	enzyme	enzyme	NOUN
bptjm-31	55	20	,	,	PUNCT
bptjm-31	55	21	and	and	CCONJ
bptjm-31	55	22	e3	e3	NOUN
bptjm-31	55	23	–	–	PUNCT
bptjm-31	55	24	the	the	DET
bptjm-31	55	25	ubiquitin	ubiquitin	ADJ
bptjm-31	55	26	-	-	PUNCT
bptjm-31	55	27	protein	protein	NOUN
bptjm-31	55	28	ligase	ligase	NOUN
bptjm-31	55	29	,	,	PUNCT
bptjm-31	55	30	cause	cause	VERB
bptjm-31	55	31	a	a	DET
bptjm-31	55	32	cascade	cascade	NOUN
bptjm-31	55	33	of	of	ADP
bptjm-31	55	34	reactions	reaction	NOUN
bptjm-31	55	35	,	,	PUNCT
bptjm-31	55	36	the	the	DET
bptjm-31	55	37	result	result	NOUN
bptjm-31	55	38	of	of	ADP
bptjm-31	55	39	which	which	PRON
bptjm-31	55	40	is	be	AUX
bptjm-31	55	41	the	the	DET
bptjm-31	55	42	linkage	linkage	NOUN
bptjm-31	55	43	of	of	ADP
bptjm-31	55	44	one	one	NUM
bptjm-31	55	45	molecule	molecule	NOUN
bptjm-31	55	46	of	of	ADP
bptjm-31	55	47	ubiquitin	ubiquitin	NOUN
bptjm-31	55	48	to	to	ADP
bptjm-31	55	49	the	the	DET
bptjm-31	55	50	protein	protein	NOUN
bptjm-31	55	51	(	(	PUNCT
bptjm-31	55	52	mono	mono	NOUN
bptjm-31	55	53	-	-	PUNCT
bptjm-31	55	54	ubiquitination	ubiquitination	NOUN
bptjm-31	55	55	)	)	PUNCT
bptjm-31	55	56	.	.	PUNCT
bptjm-31	56	1	polyubiquitination	polyubiquitination	NOUN
bptjm-31	56	2	occurs	occur	VERB
bptjm-31	56	3	when	when	SCONJ
bptjm-31	56	4	additional	additional	ADJ
bptjm-31	56	5	molecules	molecule	NOUN
bptjm-31	56	6	attach	attach	VERB
bptjm-31	56	7	to	to	ADP
bptjm-31	56	8	the	the	DET
bptjm-31	56	9	seven	seven	NUM
bptjm-31	56	10	lysine	lysine	NOUN
bptjm-31	56	11	residues	residue	NOUN
bptjm-31	56	12	or	or	CCONJ
bptjm-31	56	13	the	the	DET
bptjm-31	56	14	n	n	CCONJ
bptjm-31	56	15	-	-	PUNCT
bptjm-31	56	16	terminus	terminus	NOUN
bptjm-31	56	17	of	of	ADP
bptjm-31	56	18	the	the	DET
bptjm-31	56	19	ubiquitin	ubiquitin	ADJ
bptjm-31	56	20	molecule	molecule	NOUN
bptjm-31	56	21	to	to	PART
bptjm-31	56	22	form	form	VERB
bptjm-31	56	23	a	a	DET
bptjm-31	56	24	chain	chain	NOUN
bptjm-31	56	25	.	.	PUNCT
bptjm-31	57	1	polyubiquitination	polyubiquitination	NOUN
bptjm-31	57	2	is	be	AUX
bptjm-31	57	3	the	the	DET
bptjm-31	57	4	recognition	recognition	NOUN
bptjm-31	57	5	signal	signal	NOUN
bptjm-31	57	6	for	for	SCONJ
bptjm-31	57	7	the	the	DET
bptjm-31	57	8	proteasome	proteasome	NOUN
bptjm-31	57	9	to	to	PART
bptjm-31	57	10	degrade	degrade	VERB
bptjm-31	57	11	the	the	DET
bptjm-31	57	12	target	target	NOUN
bptjm-31	57	13	protein	protein	NOUN
bptjm-31	57	14	into	into	ADP
bptjm-31	57	15	peptides	peptide	NOUN
bptjm-31	57	16	.	.	PUNCT
bptjm-31	58	1	the	the	DET
bptjm-31	58	2	autophagy	autophagy	VERB
bptjm-31	58	3	-	-	PUNCT
bptjm-31	58	4	lysosome	lysosome	NOUN
bptjm-31	58	5	pathway	pathway	NOUN
bptjm-31	58	6	is	be	AUX
bptjm-31	58	7	another	another	DET
bptjm-31	58	8	important	important	ADJ
bptjm-31	58	9	catabolic	catabolic	ADJ
bptjm-31	58	10	pathway	pathway	NOUN
bptjm-31	58	11	that	that	PRON
bptjm-31	58	12	regulates	regulate	VERB
bptjm-31	58	13	the	the	DET
bptjm-31	58	14	quality	quality	NOUN
bptjm-31	58	15	and	and	CCONJ
bptjm-31	58	16	the	the	DET
bptjm-31	58	17	number	number	NOUN
bptjm-31	58	18	of	of	ADP
bptjm-31	58	19	proteins	protein	NOUN
bptjm-31	58	20	made	make	VERB
bptjm-31	58	21	within	within	ADP
bptjm-31	58	22	the	the	DET
bptjm-31	58	23	body	body	NOUN
bptjm-31	58	24	’s	’s	PART
bptjm-31	58	25	cells	cell	NOUN
bptjm-31	58	26	.	.	PUNCT
bptjm-31	59	1	there	there	PRON
bptjm-31	59	2	are	be	VERB
bptjm-31	59	3	three	three	NUM
bptjm-31	59	4	common	common	ADJ
bptjm-31	59	5	mechanisms	mechanism	NOUN
bptjm-31	59	6	of	of	ADP
bptjm-31	59	7	lysosomal	lysosomal	ADJ
bptjm-31	59	8	autophagy	autophagy	NOUN
bptjm-31	59	9	which	which	PRON
bptjm-31	59	10	are	be	AUX
bptjm-31	59	11	macroautophagy	macroautophagy	ADJ
bptjm-31	59	12	,	,	PUNCT
bptjm-31	59	13	microautophagy	microautophagy	ADJ
bptjm-31	59	14	,	,	PUNCT
bptjm-31	59	15	and	and	CCONJ
bptjm-31	59	16	chaperon	chaperon	NOUN
bptjm-31	59	17	-	-	PUNCT
bptjm-31	59	18	protein	protein	NOUN
bptjm-31	59	19	mediated	mediate	VERB
bptjm-31	59	20	autophagy	autophagy	NOUN
bptjm-31	59	21	.	.	PUNCT
bptjm-31	60	1	macroautophagy	macroautophagy	ADJ
bptjm-31	60	2	is	be	AUX
bptjm-31	60	3	where	where	SCONJ
bptjm-31	60	4	an	an	DET
bptjm-31	60	5	autophagosome	autophagosome	NOUN
bptjm-31	60	6	is	be	AUX
bptjm-31	60	7	created	create	VERB
bptjm-31	60	8	containing	contain	VERB
bptjm-31	60	9	the	the	DET
bptjm-31	60	10	surplus	surplus	ADJ
bptjm-31	60	11	amount	amount	NOUN
bptjm-31	60	12	of	of	ADP
bptjm-31	60	13	protein	protein	NOUN
bptjm-31	60	14	and	and	CCONJ
bptjm-31	60	15	a	a	DET
bptjm-31	60	16	lysosome	lysosome	NOUN
bptjm-31	60	17	will	will	AUX
bptjm-31	60	18	bind	bind	VERB
bptjm-31	60	19	to	to	ADP
bptjm-31	60	20	the	the	DET
bptjm-31	60	21	organelle	organelle	NOUN
bptjm-31	60	22	-	-	PUNCT
bptjm-31	60	23	like	like	ADJ
bptjm-31	60	24	structure	structure	NOUN
bptjm-31	60	25	to	to	PART
bptjm-31	60	26	degrade	degrade	VERB
bptjm-31	60	27	the	the	DET
bptjm-31	60	28	particles	particle	NOUN
bptjm-31	60	29	within	within	ADP
bptjm-31	60	30	it	it	PRON
bptjm-31	60	31	.	.	PUNCT
bptjm-31	61	1	all	all	DET
bptjm-31	61	2	these	these	DET
bptjm-31	61	3	pathways	pathway	NOUN
bptjm-31	61	4	separately	separately	ADV
bptjm-31	61	5	are	be	AUX
bptjm-31	61	6	important	important	ADJ
bptjm-31	61	7	to	to	PART
bptjm-31	61	8	degrade	degrade	VERB
bptjm-31	61	9	an	an	DET
bptjm-31	61	10	excess	excess	ADJ
bptjm-31	61	11	number	number	NOUN
bptjm-31	61	12	of	of	ADP
bptjm-31	61	13	large	large	ADJ
bptjm-31	61	14	proteins	protein	NOUN
bptjm-31	61	15	.	.	PUNCT
bptjm-31	62	1	in	in	ADP
bptjm-31	62	2	the	the	DET
bptjm-31	62	3	case	case	NOUN
bptjm-31	62	4	of	of	ADP
bptjm-31	62	5	smaller	small	ADJ
bptjm-31	62	6	proteins	protein	NOUN
bptjm-31	62	7	,	,	PUNCT
bptjm-31	62	8	a	a	DET
bptjm-31	62	9	bigger	big	ADJ
bptjm-31	62	10	lysosome	lysosome	NOUN
bptjm-31	62	11	will	will	AUX
bptjm-31	62	12	use	use	VERB
bptjm-31	62	13	phagocytosis	phagocytosis	NOUN
bptjm-31	62	14	to	to	PART
bptjm-31	62	15	degrade	degrade	VERB
bptjm-31	62	16	the	the	DET
bptjm-31	62	17	need	need	ADJ
bptjm-31	62	18	proteins	protein	NOUN
bptjm-31	62	19	.	.	PUNCT
bptjm-31	63	1	similarly	similarly	ADV
bptjm-31	63	2	,	,	PUNCT
bptjm-31	63	3	chaperon	chaperon	NOUN
bptjm-31	63	4	-mediated	-mediate	VERB
bptjm-31	63	5	pathway	pathway	NOUN
bptjm-31	63	6	will	will	AUX
bptjm-31	63	7	utilize	utilize	VERB
bptjm-31	63	8	a	a	DET
bptjm-31	63	9	longer	long	ADJ
bptjm-31	63	10	way	way	NOUN
bptjm-31	63	11	to	to	PART
bptjm-31	63	12	degrade	degrade	VERB
bptjm-31	63	13	proteins	protein	NOUN
bptjm-31	63	14	including	include	VERB
bptjm-31	63	15	another	another	DET
bptjm-31	63	16	chaperon	chaperon	NOUN
bptjm-31	63	17	protein	protein	NOUN
bptjm-31	63	18	which	which	PRON
bptjm-31	63	19	connects	connect	VERB
bptjm-31	63	20	the	the	DET
bptjm-31	63	21	excess	excess	ADJ
bptjm-31	63	22	amount	amount	NOUN
bptjm-31	63	23	of	of	ADP
bptjm-31	63	24	protein	protein	NOUN
bptjm-31	63	25	to	to	ADP
bptjm-31	63	26	a	a	DET
bptjm-31	63	27	channel	channel	NOUN
bptjm-31	63	28	that	that	PRON
bptjm-31	63	29	leads	lead	VERB
bptjm-31	63	30	to	to	ADP
bptjm-31	63	31	the	the	DET
bptjm-31	63	32	lysosome	lysosome	NOUN
bptjm-31	63	33	.	.	PUNCT
bptjm-31	64	1	this	this	DET
bptjm-31	64	2	lysosomal	lysosomal	ADJ
bptjm-31	64	3	pathway	pathway	NOUN
bptjm-31	64	4	uses	use	VERB
bptjm-31	64	5	a	a	DET
bptjm-31	64	6	lysosome	lysosome	NOUN
bptjm-31	64	7	to	to	PART
bptjm-31	64	8	engulf	engulf	VERB
bptjm-31	64	9	the	the	DET
bptjm-31	64	10	autophagosome	autophagosome	NOUN
bptjm-31	64	11	and	and	CCONJ
bptjm-31	64	12	destroy	destroy	VERB
bptjm-31	64	13	its	its	PRON
bptjm-31	64	14	contents	content	NOUN
bptjm-31	64	15	with	with	ADP
bptjm-31	64	16	enzymes33	enzymes33	NOUN
bptjm-31	64	17	.	.	PUNCT
bptjm-31	65	1	these	these	DET
bptjm-31	65	2	pathways	pathway	NOUN
bptjm-31	65	3	then	then	ADV
bptjm-31	65	4	will	will	AUX
bptjm-31	65	5	degrade	degrade	VERB
bptjm-31	65	6	the	the	DET
bptjm-31	65	7	neurons	neuron	NOUN
bptjm-31	65	8	present	present	ADJ
bptjm-31	65	9	in	in	ADP
bptjm-31	65	10	the	the	DET
bptjm-31	65	11	brain	brain	NOUN
bptjm-31	65	12	.	.	PUNCT
bptjm-31	66	1	berkeley	berkeley	PROPN
bptjm-31	66	2	pharma	pharma	PROPN
bptjm-31	66	3	tech	tech	PROPN
bptjm-31	66	4	journal	journal	NOUN
bptjm-31	66	5	of	of	ADP
bptjm-31	66	6	medicine	medicine	NOUN
bptjm-31	66	7	|	|	ADV
bptjm-31	66	8	6	6	NUM
bptjm-31	66	9	figure	figure	NOUN
bptjm-31	66	10	2	2	NUM
bptjm-31	66	11	.	.	PUNCT
bptjm-31	67	1	the	the	DET
bptjm-31	67	2	three	three	NUM
bptjm-31	67	3	different	different	ADJ
bptjm-31	67	4	autophagy	autophagy	ADJ
bptjm-31	67	5	-	-	PUNCT
bptjm-31	67	6	lysosome	lysosome	NOUN
bptjm-31	67	7	pathways	pathway	NOUN
bptjm-31	67	8	–	–	PUNCT
bptjm-31	67	9	macroautophagy	macroautophagy	ADJ
bptjm-31	67	10	,	,	PUNCT
bptjm-31	67	11	microautophagy	microautophagy	ADJ
bptjm-31	67	12	,	,	PUNCT
bptjm-31	67	13	and	and	CCONJ
bptjm-31	67	14	chaperone	chaperone	NOUN
bptjm-31	67	15	-	-	PUNCT
bptjm-31	67	16	mediated	mediate	VERB
bptjm-31	67	17	autophagy	autophagy	NOUN
bptjm-31	67	18	.	.	PUNCT
bptjm-31	68	1	alpha	alpha	NOUN
bptjm-31	68	2	-	-	PUNCT
bptjm-31	68	3	synuclein	synuclein	PROPN
bptjm-31	68	4	also	also	ADV
bptjm-31	68	5	is	be	AUX
bptjm-31	68	6	a	a	DET
bptjm-31	68	7	major	major	ADJ
bptjm-31	68	8	component	component	NOUN
bptjm-31	68	9	of	of	ADP
bptjm-31	68	10	the	the	DET
bptjm-31	68	11	filamentous	filamentous	ADJ
bptjm-31	68	12	glial	glial	ADJ
bptjm-31	68	13	cell	cell	NOUN
bptjm-31	68	14	inclusions	inclusion	NOUN
bptjm-31	68	15	(	(	PUNCT
bptjm-31	68	16	gcis	gcis	PROPN
bptjm-31	68	17	)	)	PUNCT
bptjm-31	68	18	that	that	PRON
bptjm-31	68	19	are	be	AUX
bptjm-31	68	20	abundant	abundant	ADJ
bptjm-31	68	21	in	in	ADP
bptjm-31	68	22	the	the	DET
bptjm-31	68	23	white	white	ADJ
bptjm-31	68	24	matter	matter	NOUN
bptjm-31	68	25	oligodendroglial	oligodendroglial	ADJ
bptjm-31	68	26	cells	cell	NOUN
bptjm-31	68	27	of	of	ADP
bptjm-31	68	28	multiple	multiple	ADJ
bptjm-31	68	29	system	system	NOUN
bptjm-31	68	30	atrophy	atrophy	NOUN
bptjm-31	68	31	(	(	PUNCT
bptjm-31	68	32	msa	msa	PROPN
bptjm-31	68	33	)	)	PUNCT
bptjm-31	68	34	brains	brain	NOUN
bptjm-31	68	35	.	.	PUNCT
bptjm-31	69	1	accumulation	accumulation	NOUN
bptjm-31	69	2	of	of	ADP
bptjm-31	69	3	alphasynuclein	alphasynuclein	NOUN
bptjm-31	69	4	into	into	ADP
bptjm-31	69	5	filamentous	filamentous	ADJ
bptjm-31	69	6	inclusions	inclusion	NOUN
bptjm-31	69	7	could	could	AUX
bptjm-31	69	8	play	play	VERB
bptjm-31	69	9	a	a	DET
bptjm-31	69	10	mechanistic	mechanistic	ADJ
bptjm-31	69	11	role	role	NOUN
bptjm-31	69	12	in	in	ADP
bptjm-31	69	13	the	the	DET
bptjm-31	69	14	pathogenesis	pathogenesis	NOUN
bptjm-31	69	15	of	of	ADP
bptjm-31	69	16	several	several	ADJ
bptjm-31	69	17	progressive	progressive	ADJ
bptjm-31	69	18	neurological	neurological	ADJ
bptjm-31	69	19	disorders	disorder	NOUN
bptjm-31	69	20	,	,	PUNCT
bptjm-31	69	21	such	such	ADJ
bptjm-31	69	22	as	as	ADP
bptjm-31	69	23	parkinson	parkinson	NOUN
bptjm-31	69	24	’s	’s	PART
bptjm-31	69	25	disease	disease	NOUN
bptjm-31	69	26	,	,	PUNCT
bptjm-31	69	27	lbd	lbd	PROPN
bptjm-31	69	28	,	,	PUNCT
bptjm-31	69	29	familial	familial	ADJ
bptjm-31	69	30	alzheimer	alzheimer	NOUN
bptjm-31	69	31	's	's	PART
bptjm-31	69	32	disease	disease	NOUN
bptjm-31	69	33	,	,	PUNCT
bptjm-31	69	34	lewy	lewy	PROPN
bptjm-31	69	35	body	body	NOUN
bptjm-31	69	36	disease	disease	NOUN
bptjm-31	69	37	variant	variant	NOUN
bptjm-31	69	38	of	of	ADP
bptjm-31	69	39	alzheimer	alzheimer	PROPN
bptjm-31	69	40	’s	’s	PART
bptjm-31	69	41	disease	disease	NOUN
bptjm-31	69	42	,	,	PUNCT
bptjm-31	69	43	sporadic	sporadic	ADJ
bptjm-31	69	44	alzheimer	alzheimer	PROPN
bptjm-31	69	45	's	's	PART
bptjm-31	69	46	disease	disease	NOUN
bptjm-31	69	47	,	,	PUNCT
bptjm-31	69	48	and	and	CCONJ
bptjm-31	69	49	multiple	multiple	ADJ
bptjm-31	69	50	system	system	NOUN
bptjm-31	69	51	atrophy10	atrophy10	NOUN
bptjm-31	69	52	.	.	PUNCT
bptjm-31	70	1	this	this	DET
bptjm-31	70	2	path	path	NOUN
bptjm-31	70	3	is	be	AUX
bptjm-31	70	4	obscure	obscure	ADJ
bptjm-31	70	5	,	,	PUNCT
bptjm-31	70	6	but	but	CCONJ
bptjm-31	70	7	upp	upp	PROPN
bptjm-31	70	8	and	and	CCONJ
bptjm-31	70	9	autosomal	autosomal	ADJ
bptjm-31	70	10	-	-	PUNCT
bptjm-31	70	11	lysosomal	lysosomal	ADJ
bptjm-31	70	12	pathways	pathway	NOUN
bptjm-31	70	13	are	be	AUX
bptjm-31	70	14	the	the	DET
bptjm-31	70	15	commonly	commonly	ADV
bptjm-31	70	16	known	know	VERB
bptjm-31	70	17	pathways	pathway	NOUN
bptjm-31	70	18	that	that	PRON
bptjm-31	70	19	lbd	lbd	PROPN
bptjm-31	70	20	is	be	AUX
bptjm-31	70	21	categorized	categorize	VERB
bptjm-31	70	22	into	into	ADP
bptjm-31	70	23	.	.	PUNCT
bptjm-31	71	1	lbd	lbd	PROPN
bptjm-31	71	2	specifically	specifically	ADV
bptjm-31	71	3	affects	affect	VERB
bptjm-31	71	4	the	the	DET
bptjm-31	71	5	thalamus	thalamus	NOUN
bptjm-31	71	6	structurally	structurally	ADV
bptjm-31	71	7	and	and	CCONJ
bptjm-31	71	8	functionally8,9	functionally8,9	PROPN
bptjm-31	71	9	.	.	PUNCT
bptjm-31	72	1	additionally	additionally	ADV
bptjm-31	72	2	,	,	PUNCT
bptjm-31	72	3	a	a	DET
bptjm-31	72	4	study	study	NOUN
bptjm-31	72	5	suspected	suspect	VERB
bptjm-31	72	6	there	there	PRON
bptjm-31	72	7	are	be	VERB
bptjm-31	72	8	five	five	NUM
bptjm-31	72	9	specific	specific	ADJ
bptjm-31	72	10	important	important	ADJ
bptjm-31	72	11	and	and	CCONJ
bptjm-31	72	12	targeted	target	VERB
bptjm-31	72	13	genes	gene	NOUN
bptjm-31	72	14	from	from	ADP
bptjm-31	72	15	lbd	lbd	PROPN
bptjm-31	72	16	patients	patient	NOUN
bptjm-31	72	17	:	:	PUNCT
bptjm-31	72	18	bin1	bin1	PROPN
bptjm-31	72	19	and	and	CCONJ
bptjm-31	72	20	tmem175	tmem175	PROPN
bptjm-31	72	21	,	,	PUNCT
bptjm-31	72	22	snca	snca	NOUN
bptjm-31	72	23	,	,	PUNCT
bptjm-31	72	24	apoe	apoe	ADJ
bptjm-31	72	25	,	,	PUNCT
bptjm-31	72	26	and	and	CCONJ
bptjm-31	72	27	gba	gba	PROPN
bptjm-31	72	28	510	510	NUM
bptjm-31	72	29	.	.	PUNCT
bptjm-31	73	1	this	this	PRON
bptjm-31	73	2	was	be	AUX
bptjm-31	73	3	done	do	VERB
bptjm-31	73	4	by	by	ADP
bptjm-31	73	5	uncovering	uncover	VERB
bptjm-31	73	6	participant	participant	ADJ
bptjm-31	73	7	samples	sample	NOUN
bptjm-31	73	8	from	from	ADP
bptjm-31	73	9	44	44	NUM
bptjm-31	73	10	different	different	ADJ
bptjm-31	73	11	european	european	PROPN
bptjm-31	73	12	ancestry	ancestry	NOUN
bptjm-31	73	13	banks	bank	NOUN
bptjm-31	73	14	;	;	PUNCT
bptjm-31	73	15	specifically	specifically	ADV
bptjm-31	73	16	,	,	PUNCT
bptjm-31	73	17	17	17	NUM
bptjm-31	73	18	in	in	ADP
bptjm-31	73	19	europe	europe	PROPN
bptjm-31	73	20	and	and	CCONJ
bptjm-31	73	21	27	27	NUM
bptjm-31	73	22	across	across	ADP
bptjm-31	73	23	north	north	PROPN
bptjm-31	73	24	america	america	PROPN
bptjm-31	73	25	.	.	PUNCT
bptjm-31	74	1	when	when	SCONJ
bptjm-31	74	2	the	the	DET
bptjm-31	74	3	sequences	sequence	NOUN
bptjm-31	74	4	from	from	ADP
bptjm-31	74	5	lbd	lbd	PROPN
bptjm-31	74	6	patients	patient	NOUN
bptjm-31	74	7	and	and	CCONJ
bptjm-31	74	8	control	control	NOUN
bptjm-31	74	9	patients	patient	NOUN
bptjm-31	74	10	were	be	AUX
bptjm-31	74	11	compared	compare	VERB
bptjm-31	74	12	,	,	PUNCT
bptjm-31	74	13	they	they	PRON
bptjm-31	74	14	found	find	VERB
bptjm-31	74	15	5	5	NUM
bptjm-31	74	16	consistent	consistent	ADJ
bptjm-31	74	17	different	different	ADJ
bptjm-31	74	18	genes	gene	NOUN
bptjm-31	74	19	that	that	PRON
bptjm-31	74	20	were	be	AUX
bptjm-31	74	21	among	among	ADP
bptjm-31	74	22	the	the	DET
bptjm-31	74	23	lbd	lbd	PROPN
bptjm-31	74	24	patients	patient	NOUN
bptjm-31	74	25	.	.	PUNCT
bptjm-31	75	1	to	to	PART
bptjm-31	75	2	confirm	confirm	VERB
bptjm-31	75	3	their	their	PRON
bptjm-31	75	4	results	result	NOUN
bptjm-31	75	5	and	and	CCONJ
bptjm-31	75	6	conclusions	conclusion	NOUN
bptjm-31	75	7	,	,	PUNCT
bptjm-31	75	8	the	the	DET
bptjm-31	75	9	researchers	researcher	NOUN
bptjm-31	75	10	also	also	ADV
bptjm-31	75	11	compared	compare	VERB
bptjm-31	75	12	those	those	DET
bptjm-31	75	13	5	5	NUM
bptjm-31	75	14	genes	gene	NOUN
bptjm-31	75	15	to	to	ADP
bptjm-31	75	16	another	another	DET
bptjm-31	75	17	970	970	NUM
bptjm-31	75	18	lbd	lbd	PROPN
bptjm-31	75	19	patients	patient	NOUN
bptjm-31	75	20	with	with	ADP
bptjm-31	75	21	a	a	DET
bptjm-31	75	22	new	new	ADJ
bptjm-31	75	23	control	control	NOUN
bptjm-31	75	24	set	set	VERB
bptjm-31	75	25	of	of	ADP
bptjm-31	75	26	8,928	8,928	NUM
bptjm-31	75	27	control	control	NOUN
bptjm-31	75	28	subjects10	subjects10	NOUN
bptjm-31	75	29	.	.	PUNCT
bptjm-31	76	1	berkeley	berkeley	PROPN
bptjm-31	76	2	pharma	pharma	PROPN
bptjm-31	76	3	tech	tech	PROPN
bptjm-31	76	4	journal	journal	NOUN
bptjm-31	76	5	of	of	ADP
bptjm-31	76	6	medicine	medicine	NOUN
bptjm-31	76	7	|	|	ADV
bptjm-31	76	8	7	7	NUM
bptjm-31	76	9	figure	figure	NOUN
bptjm-31	76	10	3	3	NUM
bptjm-31	76	11	.	.	PUNCT
bptjm-31	77	1	the	the	DET
bptjm-31	77	2	5	5	NUM
bptjm-31	77	3	genes	gene	NOUN
bptjm-31	77	4	gba	gba	NOUN
bptjm-31	77	5	,	,	PUNCT
bptjm-31	77	6	bin1	bin1	PROPN
bptjm-31	77	7	,	,	PUNCT
bptjm-31	77	8	tmem175	tmem175	PROPN
bptjm-31	77	9	,	,	PUNCT
bptjm-31	77	10	snca	snca	NOUN
bptjm-31	77	11	,	,	PUNCT
bptjm-31	77	12	and	and	CCONJ
bptjm-31	77	13	apoe	apoe	ADV
bptjm-31	77	14	on	on	ADP
bptjm-31	77	15	their	their	PRON
bptjm-31	77	16	respective	respective	ADJ
bptjm-31	77	17	chromosomes	chromosome	NOUN
bptjm-31	77	18	.	.	PUNCT
bptjm-31	78	1	widespread	widespread	ADJ
bptjm-31	78	2	mitochondrial	mitochondrial	ADJ
bptjm-31	78	3	dysfunction	dysfunction	NOUN
bptjm-31	78	4	is	be	AUX
bptjm-31	78	5	very	very	ADV
bptjm-31	78	6	closely	closely	ADV
bptjm-31	78	7	related	relate	VERB
bptjm-31	78	8	to	to	ADP
bptjm-31	78	9	disease	disease	NOUN
bptjm-31	78	10	development	development	NOUN
bptjm-31	78	11	as	as	ADV
bptjm-31	78	12	well	well	ADV
bptjm-31	78	13	.	.	PUNCT
bptjm-31	79	1	the	the	DET
bptjm-31	79	2	impairment	impairment	NOUN
bptjm-31	79	3	of	of	ADP
bptjm-31	79	4	protein	protein	NOUN
bptjm-31	79	5	degradation	degradation	NOUN
bptjm-31	79	6	pathways	pathway	NOUN
bptjm-31	79	7	,	,	PUNCT
bptjm-31	79	8	including	include	VERB
bptjm-31	79	9	both	both	CCONJ
bptjm-31	79	10	the	the	DET
bptjm-31	79	11	ubiquitin	ubiquitin	ADJ
bptjm-31	79	12	-	-	PUNCT
bptjm-31	79	13	proteasome	proteasome	NOUN
bptjm-31	79	14	system	system	NOUN
bptjm-31	79	15	and	and	CCONJ
bptjm-31	79	16	the	the	DET
bptjm-31	79	17	autophagylysosome	autophagylysosome	NOUN
bptjm-31	79	18	pathway	pathway	NOUN
bptjm-31	79	19	,	,	PUNCT
bptjm-31	79	20	also	also	ADV
bptjm-31	79	21	plays	play	VERB
bptjm-31	79	22	an	an	DET
bptjm-31	79	23	important	important	ADJ
bptjm-31	79	24	role	role	NOUN
bptjm-31	79	25	during	during	ADP
bptjm-31	79	26	the	the	DET
bptjm-31	79	27	development	development	NOUN
bptjm-31	79	28	of	of	ADP
bptjm-31	79	29	lewy	lewy	PROPN
bptjm-31	79	30	body	body	NOUN
bptjm-31	79	31	diseases11	diseases11	NOUN
bptjm-31	79	32	.	.	PUNCT
bptjm-31	80	1	differential	differential	ADJ
bptjm-31	80	2	expression	expression	NOUN
bptjm-31	80	3	changes	change	NOUN
bptjm-31	80	4	of	of	ADP
bptjm-31	80	5	isoforms	isoform	NOUN
bptjm-31	80	6	corresponding	correspond	VERB
bptjm-31	80	7	to	to	ADP
bptjm-31	80	8	genes	gene	NOUN
bptjm-31	80	9	primarily	primarily	ADV
bptjm-31	80	10	involved	involve	VERB
bptjm-31	80	11	in	in	ADP
bptjm-31	80	12	lewy	lewy	ADJ
bptjm-31	80	13	body	body	NOUN
bptjm-31	80	14	formation	formation	NOUN
bptjm-31	80	15	point	point	NOUN
bptjm-31	80	16	to	to	ADP
bptjm-31	80	17	alternative	alternative	ADJ
bptjm-31	80	18	splicing	splicing	NOUN
bptjm-31	80	19	as	as	ADP
bptjm-31	80	20	another	another	DET
bptjm-31	80	21	important	important	ADJ
bptjm-31	80	22	mechanism	mechanism	NOUN
bptjm-31	80	23	in	in	ADP
bptjm-31	80	24	the	the	DET
bptjm-31	80	25	development	development	NOUN
bptjm-31	80	26	of	of	ADP
bptjm-31	80	27	dementia	dementia	NOUN
bptjm-31	80	28	with	with	ADP
bptjm-31	80	29	lewy	lewy	PROPN
bptjm-31	80	30	bodies11	bodies11	PROPN
bptjm-31	80	31	.	.	PUNCT
bptjm-31	81	1	3	3	X
bptjm-31	81	2	.	.	X
bptjm-31	81	3	epigenetics	epigenetic	NOUN
bptjm-31	81	4	parkinson	parkinson	NOUN
bptjm-31	81	5	's	's	PART
bptjm-31	81	6	disease	disease	NOUN
bptjm-31	81	7	and	and	CCONJ
bptjm-31	81	8	dementia	dementia	NOUN
bptjm-31	81	9	with	with	ADP
bptjm-31	81	10	lewy	lewy	ADJ
bptjm-31	81	11	bodies	body	NOUN
bptjm-31	81	12	are	be	AUX
bptjm-31	81	13	deemed	deem	VERB
bptjm-31	81	14	similar	similar	ADJ
bptjm-31	81	15	based	base	VERB
bptjm-31	81	16	on	on	ADP
bptjm-31	81	17	a	a	DET
bptjm-31	81	18	neurological	neurological	ADJ
bptjm-31	81	19	overlap	overlap	NOUN
bptjm-31	81	20	between	between	ADP
bptjm-31	81	21	them	they	PRON
bptjm-31	81	22	.	.	PUNCT
bptjm-31	82	1	both	both	PRON
bptjm-31	82	2	pd	pd	PROPN
bptjm-31	82	3	and	and	CCONJ
bptjm-31	82	4	lbd	lbd	PROPN
bptjm-31	82	5	are	be	AUX
bptjm-31	82	6	distinguished	distinguish	VERB
bptjm-31	82	7	by	by	ADP
bptjm-31	82	8	an	an	DET
bptjm-31	82	9	abnormal	abnormal	ADJ
bptjm-31	82	10	accumulation	accumulation	NOUN
bptjm-31	82	11	and	and	CCONJ
bptjm-31	82	12	deposition	deposition	NOUN
bptjm-31	82	13	of	of	ADP
bptjm-31	82	14	misfolded	misfolde	VERB
bptjm-31	82	15	and	and	CCONJ
bptjm-31	82	16	aggregated	aggregate	VERB
bptjm-31	82	17	alpha	alpha	NOUN
bptjm-31	82	18	-	-	PUNCT
bptjm-31	82	19	synuclein	synuclein	NOUN
bptjm-31	82	20	which	which	PRON
bptjm-31	82	21	gives	give	VERB
bptjm-31	82	22	rise	rise	NOUN
bptjm-31	82	23	to	to	ADP
bptjm-31	82	24	lewy	lewy	PROPN
bptjm-31	82	25	bodies	body	NOUN
bptjm-31	82	26	and	and	CCONJ
bptjm-31	82	27	lewy	lewy	PROPN
bptjm-31	82	28	neurites	neurite	NOUN
bptjm-31	82	29	.	.	PUNCT
bptjm-31	83	1	the	the	DET
bptjm-31	83	2	diversity	diversity	NOUN
bptjm-31	83	3	and	and	CCONJ
bptjm-31	83	4	complexity	complexity	NOUN
bptjm-31	83	5	of	of	ADP
bptjm-31	83	6	lbd	lbd	PROPN
bptjm-31	83	7	make	make	VERB
bptjm-31	83	8	them	they	PRON
bptjm-31	83	9	complex	complex	ADJ
bptjm-31	83	10	multifactorial	multifactorial	ADJ
bptjm-31	83	11	disorders	disorder	NOUN
bptjm-31	83	12	.	.	PUNCT
bptjm-31	84	1	thus	thus	ADV
bptjm-31	84	2	,	,	PUNCT
bptjm-31	84	3	many	many	ADJ
bptjm-31	84	4	lbd	lbd	PROPN
bptjm-31	84	5	cases	case	NOUN
bptjm-31	84	6	originate	originate	VERB
bptjm-31	84	7	from	from	ADP
bptjm-31	84	8	the	the	DET
bptjm-31	84	9	interaction	interaction	NOUN
bptjm-31	84	10	of	of	ADP
bptjm-31	84	11	multiple	multiple	ADJ
bptjm-31	84	12	genetic	genetic	ADJ
bptjm-31	84	13	and	and	CCONJ
bptjm-31	84	14	environmental	environmental	ADJ
bptjm-31	84	15	,	,	PUNCT
bptjm-31	84	16	epigenetic	epigenetic	ADJ
bptjm-31	84	17	factors	factor	NOUN
bptjm-31	84	18	.	.	PUNCT
bptjm-31	85	1	there	there	PRON
bptjm-31	85	2	are	be	VERB
bptjm-31	85	3	many	many	ADJ
bptjm-31	85	4	genes	gene	NOUN
bptjm-31	85	5	of	of	ADP
bptjm-31	85	6	interest	interest	NOUN
bptjm-31	85	7	that	that	PRON
bptjm-31	85	8	are	be	AUX
bptjm-31	85	9	involved	involve	VERB
bptjm-31	85	10	in	in	ADP
bptjm-31	85	11	lbd	lbd	PROPN
bptjm-31	85	12	,	,	PUNCT
bptjm-31	85	13	one	one	NUM
bptjm-31	85	14	of	of	ADP
bptjm-31	85	15	them	they	PRON
bptjm-31	85	16	being	be	AUX
bptjm-31	85	17	snca	snca	NOUN
bptjm-31	85	18	,	,	PUNCT
bptjm-31	85	19	which	which	PRON
bptjm-31	85	20	is	be	AUX
bptjm-31	85	21	a	a	DET
bptjm-31	85	22	rare	rare	ADJ
bptjm-31	85	23	gene	gene	NOUN
bptjm-31	85	24	involved	involve	VERB
bptjm-31	85	25	in	in	ADP
bptjm-31	85	26	lbd	lbd	PROPN
bptjm-31	85	27	.	.	PUNCT
bptjm-31	86	1	it	it	PRON
bptjm-31	86	2	has	have	VERB
bptjm-31	86	3	two	two	NUM
bptjm-31	86	4	distinct	distinct	ADJ
bptjm-31	86	5	profiles	profile	NOUN
bptjm-31	86	6	within	within	ADP
bptjm-31	86	7	its	its	PRON
bptjm-31	86	8	locus	locus	NOUN
bptjm-31	86	9	,	,	PUNCT
bptjm-31	86	10	one	one	NUM
bptjm-31	86	11	pertaining	pertain	VERB
bptjm-31	86	12	to	to	ADP
bptjm-31	86	13	pd	pd	PROPN
bptjm-31	86	14	,	,	PUNCT
bptjm-31	86	15	located	locate	VERB
bptjm-31	86	16	in	in	ADP
bptjm-31	86	17	the	the	DET
bptjm-31	86	18	3	3	NUM
bptjm-31	86	19	’	'	PUNCT
bptjm-31	86	20	snca	snca	NOUN
bptjm-31	86	21	portion	portion	NOUN
bptjm-31	86	22	,	,	PUNCT
bptjm-31	86	23	and	and	CCONJ
bptjm-31	86	24	the	the	DET
bptjm-31	86	25	other	other	ADJ
bptjm-31	86	26	to	to	ADP
bptjm-31	86	27	lbd	lbd	PROPN
bptjm-31	86	28	,	,	PUNCT
bptjm-31	86	29	located	locate	VERB
bptjm-31	86	30	in	in	ADP
bptjm-31	86	31	the	the	DET
bptjm-31	86	32	5	5	NUM
bptjm-31	86	33	’	'	PUNCT
bptjm-31	86	34	snca	snca	NOUN
bptjm-31	86	35	portion12	portion12	NOUN
bptjm-31	86	36	.	.	PUNCT
bptjm-31	87	1	snca	snca	NOUN
bptjm-31	87	2	was	be	AUX
bptjm-31	87	3	the	the	DET
bptjm-31	87	4	first	first	ADJ
bptjm-31	87	5	and	and	CCONJ
bptjm-31	87	6	is	be	AUX
bptjm-31	87	7	one	one	NUM
bptjm-31	87	8	of	of	ADP
bptjm-31	87	9	the	the	DET
bptjm-31	87	10	most	most	ADV
bptjm-31	87	11	studied	study	VERB
bptjm-31	87	12	genes	gene	NOUN
bptjm-31	87	13	identified	identify	VERB
bptjm-31	87	14	as	as	ADP
bptjm-31	87	15	an	an	DET
bptjm-31	87	16	lbd	lbd	NOUN
bptjm-31	87	17	-	-	PUNCT
bptjm-31	87	18	causing	cause	VERB
bptjm-31	87	19	gene	gene	NOUN
bptjm-31	87	20	.	.	PUNCT
bptjm-31	88	1	sncb	sncb	PROPN
bptjm-31	88	2	,	,	PUNCT
bptjm-31	88	3	like	like	ADP
bptjm-31	88	4	snca	snca	NOUN
bptjm-31	88	5	,	,	PUNCT
bptjm-31	88	6	has	have	AUX
bptjm-31	88	7	been	be	AUX
bptjm-31	88	8	detected	detect	VERB
bptjm-31	88	9	in	in	ADP
bptjm-31	88	10	some	some	DET
bptjm-31	88	11	lbd	lbd	PROPN
bptjm-31	88	12	cases	case	NOUN
bptjm-31	88	13	.	.	PUNCT
bptjm-31	89	1	berkeley	berkeley	PROPN
bptjm-31	89	2	pharma	pharma	PROPN
bptjm-31	89	3	tech	tech	PROPN
bptjm-31	89	4	journal	journal	NOUN
bptjm-31	89	5	of	of	ADP
bptjm-31	89	6	medicine	medicine	NOUN
bptjm-31	89	7	|	|	ADV
bptjm-31	89	8	8	8	NUM
bptjm-31	89	9	the	the	DET
bptjm-31	89	10	b	b	PROPN
bptjm-31	89	11	-	-	PUNCT
bptjm-31	89	12	syn	syn	PROPN
bptjm-31	89	13	,	,	PUNCT
bptjm-31	89	14	from	from	ADP
bptjm-31	89	15	the	the	DET
bptjm-31	89	16	synuclein	synuclein	NOUN
bptjm-31	89	17	family	family	NOUN
bptjm-31	89	18	,	,	PUNCT
bptjm-31	89	19	has	have	AUX
bptjm-31	89	20	shown	show	VERB
bptjm-31	89	21	to	to	PART
bptjm-31	89	22	be	be	AUX
bptjm-31	89	23	a	a	DET
bptjm-31	89	24	regulator	regulator	NOUN
bptjm-31	89	25	of	of	ADP
bptjm-31	89	26	the	the	DET
bptjm-31	89	27	asyn	asyn	ADJ
bptjm-31	89	28	aggregation	aggregation	NOUN
bptjm-31	89	29	.	.	PUNCT
bptjm-31	90	1	common	common	ADJ
bptjm-31	90	2	variants	variant	NOUN
bptjm-31	90	3	,	,	PUNCT
bptjm-31	90	4	like	like	ADP
bptjm-31	90	5	rare	rare	ADJ
bptjm-31	90	6	variants	variant	NOUN
bptjm-31	90	7	,	,	PUNCT
bptjm-31	90	8	that	that	PRON
bptjm-31	90	9	could	could	AUX
bptjm-31	90	10	increase	increase	VERB
bptjm-31	90	11	the	the	DET
bptjm-31	90	12	risk	risk	NOUN
bptjm-31	90	13	of	of	ADP
bptjm-31	90	14	developing	develop	VERB
bptjm-31	90	15	lbd	lbd	PROPN
bptjm-31	90	16	have	have	AUX
bptjm-31	90	17	been	be	AUX
bptjm-31	90	18	found	find	VERB
bptjm-31	90	19	to	to	PART
bptjm-31	90	20	be	be	AUX
bptjm-31	90	21	located	locate	VERB
bptjm-31	90	22	in	in	ADP
bptjm-31	90	23	genes	gene	NOUN
bptjm-31	90	24	associated	associate	VERB
bptjm-31	90	25	with	with	ADP
bptjm-31	90	26	pd	pd	NOUN
bptjm-31	90	27	or	or	CCONJ
bptjm-31	90	28	ad	ad	NOUN
bptjm-31	90	29	.	.	PUNCT
bptjm-31	91	1	one	one	NUM
bptjm-31	91	2	of	of	ADP
bptjm-31	91	3	these	these	DET
bptjm-31	91	4	well	well	ADV
bptjm-31	91	5	recognized	recognize	VERB
bptjm-31	91	6	risk	risk	NOUN
bptjm-31	91	7	variants	variant	NOUN
bptjm-31	91	8	is	be	AUX
bptjm-31	91	9	the	the	DET
bptjm-31	91	10	allele	allele	NOUN
bptjm-31	91	11	ε4	ε4	PROPN
bptjm-31	91	12	of	of	ADP
bptjm-31	91	13	the	the	DET
bptjm-31	91	14	apolipoprotein	apolipoprotein	NOUN
bptjm-31	91	15	e	e	PROPN
bptjm-31	91	16	gene	gene	NOUN
bptjm-31	91	17	(	(	PUNCT
bptjm-31	91	18	apoe	apoe	ADJ
bptjm-31	91	19	)	)	PUNCT
bptjm-31	91	20	.	.	PUNCT
bptjm-31	92	1	apoe	apoe	NOUN
bptjm-31	92	2	poses	pose	VERB
bptjm-31	92	3	a	a	DET
bptjm-31	92	4	risk	risk	NOUN
bptjm-31	92	5	in	in	ADP
bptjm-31	92	6	lbd	lbd	PROPN
bptjm-31	92	7	patients	patient	NOUN
bptjm-31	92	8	because	because	SCONJ
bptjm-31	92	9	the	the	DET
bptjm-31	92	10	allele	allele	NOUN
bptjm-31	92	11	ε4	ε4	NOUN
bptjm-31	92	12	accumulates	accumulate	VERB
bptjm-31	92	13	and	and	CCONJ
bptjm-31	92	14	accelerates	accelerate	VERB
bptjm-31	92	15	the	the	DET
bptjm-31	92	16	disease	disease	NOUN
bptjm-31	92	17	which	which	PRON
bptjm-31	92	18	leads	lead	VERB
bptjm-31	92	19	to	to	ADP
bptjm-31	92	20	a	a	DET
bptjm-31	92	21	shorter	short	ADJ
bptjm-31	92	22	lifespan	lifespan	NOUN
bptjm-31	92	23	for	for	ADP
bptjm-31	92	24	the	the	DET
bptjm-31	92	25	patient13	patient13	NOUN
bptjm-31	92	26	.	.	PUNCT
bptjm-31	93	1	on	on	ADP
bptjm-31	93	2	the	the	DET
bptjm-31	93	3	other	other	ADJ
bptjm-31	93	4	hand	hand	NOUN
bptjm-31	93	5	,	,	PUNCT
bptjm-31	93	6	apoeε2	apoeε2	PROPN
bptjm-31	93	7	has	have	AUX
bptjm-31	93	8	been	be	AUX
bptjm-31	93	9	shown	show	VERB
bptjm-31	93	10	to	to	PART
bptjm-31	93	11	have	have	VERB
bptjm-31	93	12	protective	protective	ADJ
bptjm-31	93	13	effects	effect	NOUN
bptjm-31	93	14	against	against	ADP
bptjm-31	93	15	the	the	DET
bptjm-31	93	16	development	development	NOUN
bptjm-31	93	17	of	of	ADP
bptjm-31	93	18	lbd12	lbd12	PROPN
bptjm-31	93	19	.	.	PUNCT
bptjm-31	94	1	epigenetics	epigenetic	NOUN
bptjm-31	94	2	regulate	regulate	VERB
bptjm-31	94	3	gene	gene	NOUN
bptjm-31	94	4	expression	expression	NOUN
bptjm-31	94	5	through	through	ADP
bptjm-31	94	6	methods	method	NOUN
bptjm-31	94	7	that	that	PRON
bptjm-31	94	8	are	be	AUX
bptjm-31	94	9	independent	independent	ADJ
bptjm-31	94	10	of	of	ADP
bptjm-31	94	11	the	the	DET
bptjm-31	94	12	primary	primary	ADJ
bptjm-31	94	13	dna	dna	PROPN
bptjm-31	94	14	sequence	sequence	NOUN
bptjm-31	94	15	,	,	PUNCT
bptjm-31	94	16	even	even	ADV
bptjm-31	94	17	though	though	SCONJ
bptjm-31	94	18	they	they	PRON
bptjm-31	94	19	can	can	AUX
bptjm-31	94	20	be	be	AUX
bptjm-31	94	21	heritable	heritable	ADJ
bptjm-31	94	22	.	.	PUNCT
bptjm-31	95	1	without	without	ADP
bptjm-31	95	2	altering	alter	VERB
bptjm-31	95	3	the	the	DET
bptjm-31	95	4	dna	dna	PROPN
bptjm-31	95	5	sequence	sequence	NOUN
bptjm-31	95	6	,	,	PUNCT
bptjm-31	95	7	epigenetic	epigenetic	ADJ
bptjm-31	95	8	mechanisms	mechanism	NOUN
bptjm-31	95	9	moderate	moderate	VERB
bptjm-31	95	10	reversible	reversible	ADJ
bptjm-31	95	11	changes	change	NOUN
bptjm-31	95	12	in	in	ADP
bptjm-31	95	13	gene	gene	NOUN
bptjm-31	95	14	expression	expression	NOUN
bptjm-31	95	15	and	and	CCONJ
bptjm-31	95	16	cell	cell	NOUN
bptjm-31	95	17	phenotype	phenotype	NOUN
bptjm-31	95	18	.	.	PUNCT
bptjm-31	96	1	there	there	PRON
bptjm-31	96	2	are	be	VERB
bptjm-31	96	3	two	two	NUM
bptjm-31	96	4	major	major	ADJ
bptjm-31	96	5	mechanisms	mechanism	NOUN
bptjm-31	96	6	pertaining	pertain	VERB
bptjm-31	96	7	to	to	ADP
bptjm-31	96	8	epigenetics	epigenetic	NOUN
bptjm-31	96	9	modifications	modification	NOUN
bptjm-31	96	10	,	,	PUNCT
bptjm-31	96	11	shown	show	VERB
bptjm-31	96	12	in	in	ADP
bptjm-31	96	13	figure	figure	NOUN
bptjm-31	96	14	4	4	NUM
bptjm-31	96	15	.	.	PUNCT
bptjm-31	97	1	the	the	DET
bptjm-31	97	2	first	first	ADJ
bptjm-31	97	3	is	be	AUX
bptjm-31	97	4	dna	dna	PROPN
bptjm-31	97	5	methylation	methylation	NOUN
bptjm-31	97	6	,	,	PUNCT
bptjm-31	97	7	a	a	DET
bptjm-31	97	8	biochemical	biochemical	ADJ
bptjm-31	97	9	process	process	NOUN
bptjm-31	97	10	by	by	ADP
bptjm-31	97	11	which	which	PRON
bptjm-31	97	12	a	a	DET
bptjm-31	97	13	methyl	methyl	NOUN
bptjm-31	97	14	group	group	NOUN
bptjm-31	97	15	is	be	AUX
bptjm-31	97	16	added	add	VERB
bptjm-31	97	17	to	to	ADP
bptjm-31	97	18	dna	dna	PROPN
bptjm-31	97	19	,	,	PUNCT
bptjm-31	97	20	thereby	thereby	ADV
bptjm-31	97	21	modifying	modify	VERB
bptjm-31	97	22	the	the	DET
bptjm-31	97	23	function	function	NOUN
bptjm-31	97	24	of	of	ADP
bptjm-31	97	25	the	the	DET
bptjm-31	97	26	gene	gene	NOUN
bptjm-31	97	27	.	.	PUNCT
bptjm-31	98	1	it	it	PRON
bptjm-31	98	2	occurs	occur	VERB
bptjm-31	98	3	at	at	ADP
bptjm-31	98	4	cytosines	cytosine	NOUN
bptjm-31	98	5	located	locate	VERB
bptjm-31	98	6	5	5	NUM
bptjm-31	98	7	’	'	PUNCT
bptjm-31	98	8	to	to	ADP
bptjm-31	98	9	guanine	guanine	NOUN
bptjm-31	98	10	(	(	PUNCT
bptjm-31	98	11	cpg	cpg	NOUN
bptjm-31	98	12	)	)	PUNCT
bptjm-31	98	13	,	,	PUNCT
bptjm-31	98	14	and	and	CCONJ
bptjm-31	98	15	it	it	PRON
bptjm-31	98	16	is	be	AUX
bptjm-31	98	17	mediated	mediate	VERB
bptjm-31	98	18	by	by	ADP
bptjm-31	98	19	methyltransferases	methyltransferase	NOUN
bptjm-31	98	20	.	.	PUNCT
bptjm-31	99	1	in	in	ADP
bptjm-31	99	2	the	the	DET
bptjm-31	99	3	promoter	promoter	NOUN
bptjm-31	99	4	regions	region	NOUN
bptjm-31	99	5	,	,	PUNCT
bptjm-31	99	6	dna	dna	PROPN
bptjm-31	99	7	methylation	methylation	NOUN
bptjm-31	99	8	can	can	AUX
bptjm-31	99	9	either	either	CCONJ
bptjm-31	99	10	repress	repress	VERB
bptjm-31	99	11	gene	gene	NOUN
bptjm-31	99	12	expression	expression	NOUN
bptjm-31	99	13	,	,	PUNCT
bptjm-31	99	14	hypermethylated	hypermethylate	VERB
bptjm-31	99	15	cpg	cpg	NOUN
bptjm-31	99	16	,	,	PUNCT
bptjm-31	99	17	or	or	CCONJ
bptjm-31	99	18	increase	increase	VERB
bptjm-31	99	19	gene	gene	NOUN
bptjm-31	99	20	expression	expression	NOUN
bptjm-31	99	21	,	,	PUNCT
bptjm-31	99	22	hypomethylated	hypomethylate	VERB
bptjm-31	99	23	cpg	cpg	NOUN
bptjm-31	99	24	.	.	PUNCT
bptjm-31	100	1	this	this	DET
bptjm-31	100	2	mechanism	mechanism	NOUN
bptjm-31	100	3	plays	play	VERB
bptjm-31	100	4	a	a	DET
bptjm-31	100	5	big	big	ADJ
bptjm-31	100	6	role	role	NOUN
bptjm-31	100	7	in	in	ADP
bptjm-31	100	8	aging	aging	NOUN
bptjm-31	100	9	and	and	CCONJ
bptjm-31	100	10	development	development	NOUN
bptjm-31	100	11	.	.	PUNCT
bptjm-31	101	1	the	the	DET
bptjm-31	101	2	second	second	ADJ
bptjm-31	101	3	mechanism	mechanism	NOUN
bptjm-31	101	4	is	be	AUX
bptjm-31	101	5	histone	histone	NOUN
bptjm-31	101	6	tail	tail	NOUN
bptjm-31	101	7	modification	modification	NOUN
bptjm-31	101	8	which	which	PRON
bptjm-31	101	9	either	either	CCONJ
bptjm-31	101	10	loosens	loosen	VERB
bptjm-31	101	11	or	or	CCONJ
bptjm-31	101	12	encompasses	encompass	VERB
bptjm-31	101	13	the	the	DET
bptjm-31	101	14	tail	tail	NOUN
bptjm-31	101	15	to	to	PART
bptjm-31	101	16	turn	turn	VERB
bptjm-31	101	17	a	a	DET
bptjm-31	101	18	gene	gene	NOUN
bptjm-31	101	19	“	"	PUNCT
bptjm-31	101	20	off	off	ADV
bptjm-31	101	21	”	"	PUNCT
bptjm-31	101	22	or	or	CCONJ
bptjm-31	101	23	“	"	PUNCT
bptjm-31	101	24	on	on	ADP
bptjm-31	101	25	”	"	PUNCT
bptjm-31	101	26	or	or	CCONJ
bptjm-31	101	27	deactivate	deactivate	VERB
bptjm-31	101	28	or	or	CCONJ
bptjm-31	101	29	activate	activate	VERB
bptjm-31	101	30	a	a	DET
bptjm-31	101	31	gene	gene	NOUN
bptjm-31	101	32	,	,	PUNCT
bptjm-31	101	33	respectively	respectively	ADV
bptjm-31	101	34	.	.	PUNCT
bptjm-31	102	1	the	the	DET
bptjm-31	102	2	proteic	proteic	ADJ
bptjm-31	102	3	part	part	NOUN
bptjm-31	102	4	of	of	ADP
bptjm-31	102	5	chromatin	chromatin	NOUN
bptjm-31	102	6	is	be	AUX
bptjm-31	102	7	referred	refer	VERB
bptjm-31	102	8	to	to	ADP
bptjm-31	102	9	the	the	DET
bptjm-31	102	10	histones	histone	NOUN
bptjm-31	102	11	which	which	PRON
bptjm-31	102	12	allow	allow	VERB
bptjm-31	102	13	the	the	DET
bptjm-31	102	14	compaction	compaction	NOUN
bptjm-31	102	15	of	of	ADP
bptjm-31	102	16	dna	dna	PROPN
bptjm-31	102	17	.	.	PUNCT
bptjm-31	103	1	these	these	DET
bptjm-31	103	2	two	two	NUM
bptjm-31	103	3	mechanisms	mechanism	NOUN
bptjm-31	103	4	have	have	VERB
bptjm-31	103	5	a	a	DET
bptjm-31	103	6	fundamental	fundamental	ADJ
bptjm-31	103	7	part	part	NOUN
bptjm-31	103	8	in	in	ADP
bptjm-31	103	9	learning	learning	NOUN
bptjm-31	103	10	and	and	CCONJ
bptjm-31	103	11	memory	memory	NOUN
bptjm-31	103	12	processes	process	NOUN
bptjm-31	103	13	because	because	SCONJ
bptjm-31	103	14	they	they	PRON
bptjm-31	103	15	are	be	AUX
bptjm-31	103	16	dynamically	dynamically	ADV
bptjm-31	103	17	controlled	control	VERB
bptjm-31	103	18	in	in	ADP
bptjm-31	103	19	neurons	neuron	NOUN
bptjm-31	103	20	.	.	PUNCT
bptjm-31	104	1	epigenetic	epigenetic	ADJ
bptjm-31	104	2	mechanisms	mechanism	NOUN
bptjm-31	104	3	mediate	mediate	VERB
bptjm-31	104	4	geneenvironment	geneenvironment	ADJ
bptjm-31	104	5	interactions	interaction	NOUN
bptjm-31	104	6	because	because	SCONJ
bptjm-31	104	7	they	they	PRON
bptjm-31	104	8	can	can	AUX
bptjm-31	104	9	often	often	ADV
bptjm-31	104	10	be	be	AUX
bptjm-31	104	11	provoked	provoke	VERB
bptjm-31	104	12	by	by	ADP
bptjm-31	104	13	environmental	environmental	ADJ
bptjm-31	104	14	risk	risk	NOUN
bptjm-31	104	15	factors	factor	NOUN
bptjm-31	104	16	.	.	PUNCT
bptjm-31	105	1	this	this	PRON
bptjm-31	105	2	emphasized	emphasize	VERB
bptjm-31	105	3	the	the	DET
bptjm-31	105	4	importance	importance	NOUN
bptjm-31	105	5	of	of	ADP
bptjm-31	105	6	certain	certain	ADJ
bptjm-31	105	7	factors	factor	NOUN
bptjm-31	105	8	in	in	ADP
bptjm-31	105	9	patients	patient	NOUN
bptjm-31	105	10	with	with	ADP
bptjm-31	105	11	lbd	lbd	PROPN
bptjm-31	105	12	,	,	PUNCT
bptjm-31	105	13	such	such	ADJ
bptjm-31	105	14	as	as	ADP
bptjm-31	105	15	diet	diet	NOUN
bptjm-31	105	16	,	,	PUNCT
bptjm-31	105	17	physical	physical	ADJ
bptjm-31	105	18	activity	activity	NOUN
bptjm-31	105	19	,	,	PUNCT
bptjm-31	105	20	and	and	CCONJ
bptjm-31	105	21	lifestyle13	lifestyle13	NOUN
bptjm-31	105	22	.	.	PUNCT
bptjm-31	106	1	berkeley	berkeley	PROPN
bptjm-31	106	2	pharma	pharma	PROPN
bptjm-31	106	3	tech	tech	PROPN
bptjm-31	106	4	journal	journal	NOUN
bptjm-31	106	5	of	of	ADP
bptjm-31	106	6	medicine	medicine	NOUN
bptjm-31	106	7	|	|	ADV
bptjm-31	106	8	9	9	NUM
bptjm-31	106	9	figure	figure	NOUN
bptjm-31	106	10	4	4	NUM
bptjm-31	106	11	.	.	PUNCT
bptjm-31	107	1	the	the	DET
bptjm-31	107	2	process	process	NOUN
bptjm-31	107	3	of	of	ADP
bptjm-31	107	4	the	the	DET
bptjm-31	107	5	epigenetic	epigenetic	ADJ
bptjm-31	107	6	mechanisms	mechanism	NOUN
bptjm-31	107	7	.	.	PUNCT
bptjm-31	108	1	the	the	DET
bptjm-31	108	2	effects	effect	NOUN
bptjm-31	108	3	of	of	ADP
bptjm-31	108	4	the	the	DET
bptjm-31	108	5	environment	environment	NOUN
bptjm-31	108	6	and	and	CCONJ
bptjm-31	108	7	genetics	genetic	NOUN
bptjm-31	108	8	may	may	AUX
bptjm-31	108	9	have	have	VERB
bptjm-31	108	10	an	an	DET
bptjm-31	108	11	influence	influence	NOUN
bptjm-31	108	12	on	on	ADP
bptjm-31	108	13	changes	change	NOUN
bptjm-31	108	14	in	in	ADP
bptjm-31	108	15	gene	gene	NOUN
bptjm-31	108	16	expression	expression	NOUN
bptjm-31	108	17	and	and	CCONJ
bptjm-31	108	18	cell	cell	NOUN
bptjm-31	108	19	behavior	behavior	NOUN
bptjm-31	108	20	.	.	PUNCT
bptjm-31	109	1	lbd	lbd	PROPN
bptjm-31	109	2	studies	study	NOUN
bptjm-31	109	3	have	have	AUX
bptjm-31	109	4	mostly	mostly	ADV
bptjm-31	109	5	been	be	AUX
bptjm-31	109	6	focused	focus	VERB
bptjm-31	109	7	on	on	ADP
bptjm-31	109	8	genetics	genetic	NOUN
bptjm-31	109	9	rather	rather	ADV
bptjm-31	109	10	than	than	ADP
bptjm-31	109	11	epigenetics	epigenetic	NOUN
bptjm-31	109	12	;	;	PUNCT
bptjm-31	109	13	however	however	ADV
bptjm-31	109	14	,	,	PUNCT
bptjm-31	109	15	epigenetic	epigenetic	ADJ
bptjm-31	109	16	mechanisms	mechanism	NOUN
bptjm-31	109	17	and	and	CCONJ
bptjm-31	109	18	regulation	regulation	NOUN
bptjm-31	109	19	have	have	AUX
bptjm-31	109	20	proved	prove	VERB
bptjm-31	109	21	to	to	PART
bptjm-31	109	22	play	play	VERB
bptjm-31	109	23	an	an	DET
bptjm-31	109	24	important	important	ADJ
bptjm-31	109	25	role	role	NOUN
bptjm-31	109	26	in	in	ADP
bptjm-31	109	27	the	the	DET
bptjm-31	109	28	pathophysiology	pathophysiology	NOUN
bptjm-31	109	29	of	of	ADP
bptjm-31	109	30	the	the	DET
bptjm-31	109	31	disease	disease	NOUN
bptjm-31	109	32	and	and	CCONJ
bptjm-31	109	33	genome	genome	NOUN
bptjm-31	109	34	.	.	PUNCT
bptjm-31	110	1	even	even	ADV
bptjm-31	110	2	though	though	SCONJ
bptjm-31	110	3	there	there	PRON
bptjm-31	110	4	are	be	VERB
bptjm-31	110	5	scarce	scarce	ADJ
bptjm-31	110	6	studies	study	NOUN
bptjm-31	110	7	on	on	ADP
bptjm-31	110	8	epigenetics	epigenetic	NOUN
bptjm-31	110	9	in	in	ADP
bptjm-31	110	10	lbd	lbd	PROPN
bptjm-31	110	11	,	,	PUNCT
bptjm-31	110	12	there	there	PRON
bptjm-31	110	13	is	be	VERB
bptjm-31	110	14	evidence	evidence	NOUN
bptjm-31	110	15	of	of	ADP
bptjm-31	110	16	an	an	DET
bptjm-31	110	17	overlap	overlap	NOUN
bptjm-31	110	18	of	of	ADP
bptjm-31	110	19	apoe	apoe	NOUN
bptjm-31	110	20	and	and	CCONJ
bptjm-31	110	21	snca	snca	NOUN
bptjm-31	110	22	from	from	ADP
bptjm-31	110	23	their	their	PRON
bptjm-31	110	24	genetic	genetic	ADJ
bptjm-31	110	25	and	and	CCONJ
bptjm-31	110	26	epigenetic	epigenetic	ADJ
bptjm-31	110	27	regulation	regulation	NOUN
bptjm-31	110	28	(	(	PUNCT
bptjm-31	110	29	figure	figure	NOUN
bptjm-31	110	30	5)13	5)13	NOUN
bptjm-31	110	31	.	.	PUNCT
bptjm-31	111	1	transcriptomic	transcriptomic	ADJ
bptjm-31	111	2	and	and	CCONJ
bptjm-31	111	3	proteomic	proteomic	ADJ
bptjm-31	111	4	studies	study	NOUN
bptjm-31	111	5	analyzing	analyze	VERB
bptjm-31	111	6	the	the	DET
bptjm-31	111	7	genetic	genetic	ADJ
bptjm-31	111	8	pathway	pathway	NOUN
bptjm-31	111	9	have	have	AUX
bptjm-31	111	10	shown	show	VERB
bptjm-31	111	11	clinical	clinical	ADJ
bptjm-31	111	12	and	and	CCONJ
bptjm-31	111	13	neurological	neurological	ADJ
bptjm-31	111	14	correlates	correlate	NOUN
bptjm-31	111	15	to	to	ADP
bptjm-31	111	16	the	the	DET
bptjm-31	111	17	disorder	disorder	NOUN
bptjm-31	111	18	through	through	ADP
bptjm-31	111	19	the	the	DET
bptjm-31	111	20	synaptic	synaptic	ADJ
bptjm-31	111	21	function	function	NOUN
bptjm-31	111	22	,	,	PUNCT
bptjm-31	111	23	lysosomal	lysosomal	ADJ
bptjm-31	111	24	processing	processing	NOUN
bptjm-31	111	25	,	,	PUNCT
bptjm-31	111	26	and	and	CCONJ
bptjm-31	111	27	circadian	circadian	ADJ
bptjm-31	111	28	rhythm13	rhythm13	NOUN
bptjm-31	111	29	.	.	PUNCT
bptjm-31	112	1	the	the	DET
bptjm-31	112	2	origin	origin	NOUN
bptjm-31	112	3	of	of	ADP
bptjm-31	112	4	the	the	DET
bptjm-31	112	5	cause	cause	NOUN
bptjm-31	112	6	of	of	ADP
bptjm-31	112	7	these	these	DET
bptjm-31	112	8	changes	change	NOUN
bptjm-31	112	9	has	have	AUX
bptjm-31	112	10	not	not	PART
bptjm-31	112	11	yet	yet	ADV
bptjm-31	112	12	been	be	AUX
bptjm-31	112	13	determined	determine	VERB
bptjm-31	112	14	.	.	PUNCT
bptjm-31	113	1	there	there	PRON
bptjm-31	113	2	are	be	VERB
bptjm-31	113	3	a	a	DET
bptjm-31	113	4	few	few	ADJ
bptjm-31	113	5	limitations	limitation	NOUN
bptjm-31	113	6	in	in	ADP
bptjm-31	113	7	the	the	DET
bptjm-31	113	8	evidence	evidence	NOUN
bptjm-31	113	9	that	that	PRON
bptjm-31	113	10	exists	exist	VERB
bptjm-31	113	11	including	include	VERB
bptjm-31	113	12	small	small	ADJ
bptjm-31	113	13	sample	sample	NOUN
bptjm-31	113	14	sizes	size	NOUN
bptjm-31	113	15	,	,	PUNCT
bptjm-31	113	16	tissue	tissue	NOUN
bptjm-31	113	17	specificity	specificity	NOUN
bptjm-31	113	18	,	,	PUNCT
bptjm-31	113	19	and	and	CCONJ
bptjm-31	113	20	lack	lack	NOUN
bptjm-31	113	21	of	of	ADP
bptjm-31	113	22	information	information	NOUN
bptjm-31	113	23	.	.	PUNCT
bptjm-31	114	1	as	as	SCONJ
bptjm-31	114	2	more	more	ADJ
bptjm-31	114	3	technologies	technology	NOUN
bptjm-31	114	4	are	be	AUX
bptjm-31	114	5	developed	develop	VERB
bptjm-31	114	6	,	,	PUNCT
bptjm-31	114	7	more	more	ADJ
bptjm-31	114	8	will	will	AUX
bptjm-31	114	9	be	be	AUX
bptjm-31	114	10	discovered	discover	VERB
bptjm-31	114	11	regarding	regard	VERB
bptjm-31	114	12	this	this	DET
bptjm-31	114	13	topic	topic	NOUN
bptjm-31	114	14	.	.	PUNCT
bptjm-31	115	1	berkeley	berkeley	PROPN
bptjm-31	115	2	pharma	pharma	PROPN
bptjm-31	115	3	tech	tech	PROPN
bptjm-31	115	4	journal	journal	NOUN
bptjm-31	115	5	of	of	ADP
bptjm-31	115	6	medicine	medicine	NOUN
bptjm-31	115	7	|	|	ADV
bptjm-31	115	8	10	10	NUM
bptjm-31	115	9	figure	figure	NOUN
bptjm-31	115	10	5	5	NUM
bptjm-31	115	11	.	.	PUNCT
bptjm-31	115	12	genetic	genetic	ADJ
bptjm-31	115	13	association	association	NOUN
bptjm-31	115	14	and	and	CCONJ
bptjm-31	115	15	epigenetic	epigenetic	ADJ
bptjm-31	115	16	association	association	NOUN
bptjm-31	115	17	in	in	ADP
bptjm-31	115	18	lbd	lbd	PROPN
bptjm-31	115	19	.	.	PUNCT
bptjm-31	116	1	this	this	DET
bptjm-31	116	2	figure	figure	NOUN
bptjm-31	116	3	shows	show	VERB
bptjm-31	116	4	the	the	DET
bptjm-31	116	5	different	different	ADJ
bptjm-31	116	6	genes	gene	NOUN
bptjm-31	116	7	involved	involve	VERB
bptjm-31	116	8	in	in	ADP
bptjm-31	116	9	lbd	lbd	PROPN
bptjm-31	116	10	and	and	CCONJ
bptjm-31	116	11	how	how	SCONJ
bptjm-31	116	12	they	they	PRON
bptjm-31	116	13	are	be	AUX
bptjm-31	116	14	associated	associate	VERB
bptjm-31	116	15	with	with	ADP
bptjm-31	116	16	genetics	genetic	NOUN
bptjm-31	116	17	or	or	CCONJ
bptjm-31	116	18	epigenetics	epigenetic	NOUN
bptjm-31	116	19	.	.	PUNCT
bptjm-31	117	1	as	as	SCONJ
bptjm-31	117	2	seen	see	VERB
bptjm-31	117	3	,	,	PUNCT
bptjm-31	117	4	apoe	apoe	ADJ
bptjm-31	117	5	and	and	CCONJ
bptjm-31	117	6	snca	snca	NOUN
bptjm-31	117	7	have	have	VERB
bptjm-31	117	8	both	both	CCONJ
bptjm-31	117	9	genetic	genetic	ADJ
bptjm-31	117	10	and	and	CCONJ
bptjm-31	117	11	epigenetic	epigenetic	ADJ
bptjm-31	117	12	associations	association	NOUN
bptjm-31	117	13	.	.	PUNCT
bptjm-31	118	1	with	with	ADP
bptjm-31	118	2	the	the	DET
bptjm-31	118	3	appropriate	appropriate	ADJ
bptjm-31	118	4	information	information	NOUN
bptjm-31	118	5	,	,	PUNCT
bptjm-31	118	6	epigenetics	epigenetic	NOUN
bptjm-31	118	7	are	be	AUX
bptjm-31	118	8	an	an	DET
bptjm-31	118	9	important	important	ADJ
bptjm-31	118	10	tool	tool	NOUN
bptjm-31	118	11	and	and	CCONJ
bptjm-31	118	12	strategy	strategy	NOUN
bptjm-31	118	13	that	that	PRON
bptjm-31	118	14	can	can	AUX
bptjm-31	118	15	be	be	AUX
bptjm-31	118	16	used	use	VERB
bptjm-31	118	17	to	to	PART
bptjm-31	118	18	battle	battle	VERB
bptjm-31	118	19	a	a	DET
bptjm-31	118	20	variety	variety	NOUN
bptjm-31	118	21	of	of	ADP
bptjm-31	118	22	different	different	ADJ
bptjm-31	118	23	diseases	disease	NOUN
bptjm-31	118	24	.	.	PUNCT
bptjm-31	119	1	there	there	PRON
bptjm-31	119	2	are	be	VERB
bptjm-31	119	3	tactics	tactic	NOUN
bptjm-31	119	4	that	that	PRON
bptjm-31	119	5	would	would	AUX
bptjm-31	119	6	delay	delay	VERB
bptjm-31	119	7	the	the	DET
bptjm-31	119	8	onset	onset	NOUN
bptjm-31	119	9	and	and	CCONJ
bptjm-31	119	10	progression	progression	NOUN
bptjm-31	119	11	of	of	ADP
bptjm-31	119	12	neurodegenerative	neurodegenerative	ADJ
bptjm-31	119	13	diseases	disease	NOUN
bptjm-31	119	14	,	,	PUNCT
bptjm-31	119	15	such	such	ADJ
bptjm-31	119	16	as	as	ADP
bptjm-31	119	17	lbd	lbd	PROPN
bptjm-31	119	18	.	.	PUNCT
bptjm-31	120	1	one	one	NUM
bptjm-31	120	2	of	of	ADP
bptjm-31	120	3	these	these	DET
bptjm-31	120	4	tactics	tactic	NOUN
bptjm-31	120	5	includes	include	VERB
bptjm-31	120	6	targeting	target	VERB
bptjm-31	120	7	the	the	DET
bptjm-31	120	8	epigenome14	epigenome14	ADJ
bptjm-31	120	9	.	.	PUNCT
bptjm-31	121	1	this	this	PRON
bptjm-31	121	2	can	can	AUX
bptjm-31	121	3	be	be	AUX
bptjm-31	121	4	done	do	VERB
bptjm-31	121	5	using	use	VERB
bptjm-31	121	6	small	small	ADJ
bptjm-31	121	7	drugs	drug	NOUN
bptjm-31	121	8	,	,	PUNCT
bptjm-31	121	9	such	such	ADJ
bptjm-31	121	10	as	as	ADP
bptjm-31	121	11	hdaci	hdaci	NOUN
bptjm-31	121	12	,	,	PUNCT
bptjm-31	121	13	that	that	PRON
bptjm-31	121	14	are	be	AUX
bptjm-31	121	15	able	able	ADJ
bptjm-31	121	16	to	to	PART
bptjm-31	121	17	cross	cross	VERB
bptjm-31	121	18	the	the	DET
bptjm-31	121	19	blood	blood	NOUN
bptjm-31	121	20	brain	brain	NOUN
bptjm-31	121	21	barrier14	barrier14	PROPN
bptjm-31	121	22	.	.	PUNCT
bptjm-31	122	1	even	even	ADV
bptjm-31	122	2	though	though	SCONJ
bptjm-31	122	3	studies	study	NOUN
bptjm-31	122	4	are	be	AUX
bptjm-31	122	5	scarce	scarce	ADJ
bptjm-31	122	6	and	and	CCONJ
bptjm-31	122	7	there	there	PRON
bptjm-31	122	8	are	be	VERB
bptjm-31	122	9	concerns	concern	NOUN
bptjm-31	122	10	with	with	ADP
bptjm-31	122	11	using	use	VERB
bptjm-31	122	12	this	this	DET
bptjm-31	122	13	type	type	NOUN
bptjm-31	122	14	of	of	ADP
bptjm-31	122	15	drug	drug	NOUN
bptjm-31	122	16	,	,	PUNCT
bptjm-31	122	17	there	there	PRON
bptjm-31	122	18	are	be	VERB
bptjm-31	122	19	potential	potential	ADJ
bptjm-31	122	20	targets	target	NOUN
bptjm-31	122	21	for	for	ADP
bptjm-31	122	22	drug	drug	NOUN
bptjm-31	122	23	development	development	NOUN
bptjm-31	122	24	that	that	PRON
bptjm-31	122	25	could	could	AUX
bptjm-31	122	26	have	have	VERB
bptjm-31	122	27	a	a	DET
bptjm-31	122	28	promising	promising	ADJ
bptjm-31	122	29	result	result	NOUN
bptjm-31	122	30	for	for	ADP
bptjm-31	122	31	potential	potential	ADJ
bptjm-31	122	32	epigenetic	epigenetic	ADJ
bptjm-31	122	33	preventive	preventive	ADJ
bptjm-31	122	34	factors	factor	NOUN
bptjm-31	122	35	for	for	ADP
bptjm-31	122	36	neurodegeneration	neurodegeneration	NOUN
bptjm-31	122	37	.	.	PUNCT
bptjm-31	123	1	as	as	ADP
bptjm-31	123	2	more	more	ADV
bptjm-31	123	3	is	be	AUX
bptjm-31	123	4	discovered	discover	VERB
bptjm-31	123	5	about	about	ADP
bptjm-31	123	6	this	this	DET
bptjm-31	123	7	disease	disease	NOUN
bptjm-31	123	8	,	,	PUNCT
bptjm-31	123	9	epigenetics	epigenetic	NOUN
bptjm-31	123	10	will	will	AUX
bptjm-31	123	11	serve	serve	VERB
bptjm-31	123	12	as	as	ADP
bptjm-31	123	13	a	a	DET
bptjm-31	123	14	fundamental	fundamental	ADJ
bptjm-31	123	15	factor	factor	NOUN
bptjm-31	123	16	in	in	ADP
bptjm-31	123	17	either	either	CCONJ
bptjm-31	123	18	delaying	delay	VERB
bptjm-31	123	19	the	the	DET
bptjm-31	123	20	onset	onset	NOUN
bptjm-31	123	21	or	or	CCONJ
bptjm-31	123	22	helping	help	VERB
bptjm-31	123	23	in	in	ADP
bptjm-31	123	24	the	the	DET
bptjm-31	123	25	stratification	stratification	NOUN
bptjm-31	123	26	and	and	CCONJ
bptjm-31	123	27	improvement	improvement	NOUN
bptjm-31	123	28	of	of	ADP
bptjm-31	123	29	the	the	DET
bptjm-31	123	30	diagnosis	diagnosis	NOUN
bptjm-31	123	31	.	.	PUNCT
bptjm-31	124	1	4	4	X
bptjm-31	124	2	.	.	X
bptjm-31	124	3	cognitive	cognitive	ADJ
bptjm-31	124	4	enhancers	enhancer	NOUN
bptjm-31	124	5	cognitive	cognitive	ADJ
bptjm-31	124	6	enhancers	enhancer	NOUN
bptjm-31	124	7	,	,	PUNCT
bptjm-31	124	8	also	also	ADV
bptjm-31	124	9	called	call	VERB
bptjm-31	124	10	nootropics	nootropic	NOUN
bptjm-31	124	11	,	,	PUNCT
bptjm-31	124	12	are	be	AUX
bptjm-31	124	13	neuroprotective	neuroprotective	ADJ
bptjm-31	124	14	or	or	CCONJ
bptjm-31	124	15	extremely	extremely	ADV
bptjm-31	124	16	nontoxic	nontoxic	ADJ
bptjm-31	124	17	in	in	ADP
bptjm-31	124	18	consideration	consideration	NOUN
bptjm-31	124	19	to	to	ADP
bptjm-31	124	20	neurodegenerative	neurodegenerative	ADJ
bptjm-31	124	21	diseases	disease	NOUN
bptjm-31	124	22	like	like	ADP
bptjm-31	124	23	lbd	lbd	PROPN
bptjm-31	125	1	.	.	PROPN
bptjm-31	125	2	nootropics	nootropic	NOUN
bptjm-31	125	3	can	can	AUX
bptjm-31	125	4	be	be	AUX
bptjm-31	125	5	naturally	naturally	ADV
bptjm-31	125	6	found	find	VERB
bptjm-31	125	7	or	or	CCONJ
bptjm-31	125	8	synthetically	synthetically	ADV
bptjm-31	125	9	made	make	VERB
bptjm-31	125	10	which	which	PRON
bptjm-31	125	11	can	can	AUX
bptjm-31	125	12	enhance	enhance	VERB
bptjm-31	125	13	attentional	attentional	ADJ
bptjm-31	125	14	control	control	NOUN
bptjm-31	125	15	and	and	CCONJ
bptjm-31	125	16	memory	memory	NOUN
bptjm-31	125	17	.	.	PUNCT
bptjm-31	126	1	there	there	PRON
bptjm-31	126	2	are	be	VERB
bptjm-31	126	3	various	various	ADJ
bptjm-31	126	4	mechanisms	mechanism	NOUN
bptjm-31	126	5	by	by	ADP
bptjm-31	126	6	which	which	PRON
bptjm-31	126	7	nootropics	nootropic	NOUN
bptjm-31	126	8	acts	act	VERB
bptjm-31	126	9	,	,	PUNCT
bptjm-31	126	10	which	which	PRON
bptjm-31	126	11	are	be	AUX
bptjm-31	126	12	as	as	SCONJ
bptjm-31	126	13	follows	follow	VERB
bptjm-31	126	14	:	:	PUNCT
bptjm-31	126	15	1	1	X
bptjm-31	126	16	)	)	PUNCT
bptjm-31	126	17	increasing	increase	VERB
bptjm-31	126	18	circulation	circulation	NOUN
bptjm-31	126	19	to	to	ADP
bptjm-31	126	20	the	the	DET
bptjm-31	126	21	brain	brain	NOUN
bptjm-31	126	22	,	,	PUNCT
bptjm-31	126	23	2	2	X
bptjm-31	126	24	)	)	PUNCT
bptjm-31	126	25	providing	provide	VERB
bptjm-31	126	26	precursors	precursor	NOUN
bptjm-31	126	27	to	to	ADP
bptjm-31	126	28	neurotransmitters	neurotransmitter	NOUN
bptjm-31	126	29	(	(	PUNCT
bptjm-31	126	30	chemical	chemical	NOUN
bptjm-31	126	31	messengers	messenger	NOUN
bptjm-31	126	32	in	in	ADP
bptjm-31	126	33	the	the	DET
bptjm-31	126	34	berkeley	berkeley	PROPN
bptjm-31	126	35	pharma	pharma	PROPN
bptjm-31	126	36	tech	tech	NOUN
bptjm-31	126	37	journal	journal	NOUN
bptjm-31	126	38	of	of	ADP
bptjm-31	126	39	medicine	medicine	NOUN
bptjm-31	126	40	|	|	ADV
bptjm-31	126	41	11	11	NUM
bptjm-31	126	42	brain	brain	NOUN
bptjm-31	126	43	)	)	PUNCT
bptjm-31	126	44	,	,	PUNCT
bptjm-31	126	45	3	3	X
bptjm-31	126	46	)	)	PUNCT
bptjm-31	126	47	improving	improve	VERB
bptjm-31	126	48	neuron	neuron	NOUN
bptjm-31	126	49	function	function	NOUN
bptjm-31	126	50	,	,	PUNCT
bptjm-31	126	51	4	4	X
bptjm-31	126	52	)	)	PUNCT
bptjm-31	126	53	preventing	prevent	VERB
bptjm-31	126	54	free	free	ADJ
bptjm-31	126	55	radical	radical	ADJ
bptjm-31	126	56	and	and	CCONJ
bptjm-31	126	57	oxidative	oxidative	ADJ
bptjm-31	126	58	damage	damage	NOUN
bptjm-31	126	59	to	to	ADP
bptjm-31	126	60	brain	brain	NOUN
bptjm-31	126	61	cells	cell	NOUN
bptjm-31	126	62	,	,	PUNCT
bptjm-31	126	63	and	and	CCONJ
bptjm-31	126	64	5	5	X
bptjm-31	126	65	)	)	PUNCT
bptjm-31	126	66	providing	provide	VERB
bptjm-31	126	67	usable	usable	ADJ
bptjm-31	126	68	energy	energy	NOUN
bptjm-31	126	69	to	to	ADP
bptjm-31	126	70	the	the	DET
bptjm-31	126	71	brain15	brain15	NOUN
bptjm-31	126	72	.	.	PUNCT
bptjm-31	127	1	nootropics	nootropic	NOUN
bptjm-31	127	2	exist	exist	VERB
bptjm-31	127	3	in	in	ADP
bptjm-31	127	4	three	three	NUM
bptjm-31	127	5	main	main	ADJ
bptjm-31	127	6	categories	category	NOUN
bptjm-31	127	7	:	:	PUNCT
bptjm-31	127	8	supplements	supplement	NOUN
bptjm-31	127	9	,	,	PUNCT
bptjm-31	127	10	racetams	racetam	NOUN
bptjm-31	127	11	,	,	PUNCT
bptjm-31	127	12	and	and	CCONJ
bptjm-31	127	13	stimulants	stimulant	NOUN
bptjm-31	127	14	.	.	PUNCT
bptjm-31	128	1	supplements	supplement	NOUN
bptjm-31	128	2	or	or	CCONJ
bptjm-31	128	3	dietary	dietary	ADJ
bptjm-31	128	4	sources	source	NOUN
bptjm-31	128	5	of	of	ADP
bptjm-31	128	6	nootropics	nootropic	NOUN
bptjm-31	128	7	are	be	AUX
bptjm-31	128	8	mainly	mainly	ADV
bptjm-31	128	9	natural	natural	ADJ
bptjm-31	128	10	and	and	CCONJ
bptjm-31	128	11	can	can	AUX
bptjm-31	128	12	be	be	AUX
bptjm-31	128	13	found	find	VERB
bptjm-31	128	14	in	in	ADP
bptjm-31	128	15	fruits	fruit	NOUN
bptjm-31	128	16	and	and	CCONJ
bptjm-31	128	17	vegetables	vegetable	NOUN
bptjm-31	128	18	.	.	PUNCT
bptjm-31	129	1	natural	natural	ADJ
bptjm-31	129	2	nootropics	nootropic	NOUN
bptjm-31	129	3	come	come	VERB
bptjm-31	129	4	in	in	ADP
bptjm-31	129	5	the	the	DET
bptjm-31	129	6	form	form	NOUN
bptjm-31	129	7	of	of	ADP
bptjm-31	129	8	vitamins	vitamin	NOUN
bptjm-31	129	9	like	like	ADP
bptjm-31	129	10	omega-3	omega-3	NUM
bptjm-31	129	11	,	,	PUNCT
bptjm-31	129	12	iron	iron	NOUN
bptjm-31	129	13	,	,	PUNCT
bptjm-31	129	14	antioxidants	antioxidant	NOUN
bptjm-31	129	15	,	,	PUNCT
bptjm-31	129	16	amino	amino	NOUN
bptjm-31	129	17	acids	acid	NOUN
bptjm-31	129	18	,	,	PUNCT
bptjm-31	129	19	and	and	CCONJ
bptjm-31	129	20	caffeine	caffeine	NOUN
bptjm-31	129	21	.	.	PUNCT
bptjm-31	130	1	racetams	racetam	NOUN
bptjm-31	130	2	are	be	AUX
bptjm-31	130	3	positive	positive	ADJ
bptjm-31	130	4	allosteric	allosteric	ADJ
bptjm-31	130	5	modulators	modulator	NOUN
bptjm-31	130	6	of	of	ADP
bptjm-31	130	7	ampa	ampa	NOUN
bptjm-31	130	8	receptors	receptor	NOUN
bptjm-31	130	9	in	in	ADP
bptjm-31	130	10	the	the	DET
bptjm-31	130	11	brain	brain	NOUN
bptjm-31	130	12	and	and	CCONJ
bptjm-31	130	13	include	include	VERB
bptjm-31	130	14	piracetam	piracetam	NOUN
bptjm-31	130	15	and	and	CCONJ
bptjm-31	130	16	nefiracetam	nefiracetam	NOUN
bptjm-31	130	17	.	.	PUNCT
bptjm-31	131	1	racetams	racetam	NOUN
bptjm-31	131	2	are	be	AUX
bptjm-31	131	3	categorized	categorize	VERB
bptjm-31	131	4	and	and	CCONJ
bptjm-31	131	5	claimed	claim	VERB
bptjm-31	131	6	as	as	ADP
bptjm-31	131	7	“	"	PUNCT
bptjm-31	131	8	pharmacologically	pharmacologically	ADV
bptjm-31	131	9	safe	safe	ADJ
bptjm-31	131	10	”	"	PUNCT
bptjm-31	131	11	drugs15	drugs15	NOUN
bptjm-31	131	12	.	.	PUNCT
bptjm-31	132	1	the	the	DET
bptjm-31	132	2	amnesia	amnesia	PROPN
bptjm-31	132	3	reversal	reversal	NOUN
bptjm-31	132	4	effect	effect	NOUN
bptjm-31	132	5	with	with	ADP
bptjm-31	132	6	racetams	racetam	NOUN
bptjm-31	132	7	is	be	AUX
bptjm-31	132	8	compared	compare	VERB
bptjm-31	132	9	with	with	ADP
bptjm-31	132	10	scopolamine	scopolamine	NOUN
bptjm-31	132	11	,	,	PUNCT
bptjm-31	132	12	electroconvulsive	electroconvulsive	ADJ
bptjm-31	132	13	shock	shock	NOUN
bptjm-31	132	14	,	,	PUNCT
bptjm-31	132	15	and	and	CCONJ
bptjm-31	132	16	hypoxia	hypoxia	NOUN
bptjm-31	132	17	,	,	PUNCT
bptjm-31	132	18	which	which	PRON
bptjm-31	132	19	are	be	AUX
bptjm-31	132	20	more	more	ADV
bptjm-31	132	21	invasive	invasive	ADJ
bptjm-31	132	22	strategies	strategy	NOUN
bptjm-31	132	23	considering	consider	VERB
bptjm-31	132	24	the	the	DET
bptjm-31	132	25	safe	safe	ADJ
bptjm-31	132	26	nature	nature	NOUN
bptjm-31	132	27	of	of	ADP
bptjm-31	132	28	racetams16	racetams16	NOUN
bptjm-31	132	29	.	.	PUNCT
bptjm-31	133	1	specifically	specifically	ADV
bptjm-31	133	2	,	,	PUNCT
bptjm-31	133	3	nefiracetam	nefiracetam	NOUN
bptjm-31	133	4	has	have	AUX
bptjm-31	133	5	been	be	AUX
bptjm-31	133	6	proven	prove	VERB
bptjm-31	133	7	to	to	PART
bptjm-31	133	8	have	have	VERB
bptjm-31	133	9	more	more	ADJ
bptjm-31	133	10	affinity	affinity	NOUN
bptjm-31	133	11	for	for	ADP
bptjm-31	133	12	muscarinic	muscarinic	ADJ
bptjm-31	133	13	receptors	receptor	NOUN
bptjm-31	133	14	at	at	ADP
bptjm-31	133	15	the	the	DET
bptjm-31	133	16	nanomolar	nanomolar	ADJ
bptjm-31	133	17	range	range	NOUN
bptjm-31	133	18	than	than	ADP
bptjm-31	133	19	other	other	ADJ
bptjm-31	133	20	aniracetam	aniracetam	NOUN
bptjm-31	133	21	and	and	CCONJ
bptjm-31	133	22	nebracetam	nebracetam	NOUN
bptjm-31	133	23	.	.	PUNCT
bptjm-31	134	1	most	most	ADJ
bptjm-31	134	2	racetams	racetam	NOUN
bptjm-31	134	3	are	be	AUX
bptjm-31	134	4	safe	safe	ADJ
bptjm-31	134	5	but	but	CCONJ
bptjm-31	134	6	can	can	AUX
bptjm-31	134	7	cause	cause	VERB
bptjm-31	134	8	adverse	adverse	ADJ
bptjm-31	134	9	reactions	reaction	NOUN
bptjm-31	134	10	to	to	ADP
bptjm-31	134	11	males	male	NOUN
bptjm-31	134	12	than	than	ADP
bptjm-31	134	13	women	woman	NOUN
bptjm-31	134	14	if	if	SCONJ
bptjm-31	134	15	used	use	VERB
bptjm-31	134	16	incorrectly	incorrectly	ADV
bptjm-31	134	17	or	or	CCONJ
bptjm-31	134	18	in	in	ADP
bptjm-31	134	19	excessive	excessive	ADJ
bptjm-31	134	20	amounts15	amounts15	NOUN
bptjm-31	134	21	.	.	PUNCT
bptjm-31	135	1	lastly	lastly	ADV
bptjm-31	135	2	,	,	PUNCT
bptjm-31	135	3	stimulants	stimulant	NOUN
bptjm-31	135	4	are	be	AUX
bptjm-31	135	5	another	another	DET
bptjm-31	135	6	type	type	NOUN
bptjm-31	135	7	of	of	ADP
bptjm-31	135	8	smart	smart	ADJ
bptjm-31	135	9	drug	drug	NOUN
bptjm-31	135	10	under	under	ADP
bptjm-31	135	11	nootropics	nootropic	NOUN
bptjm-31	135	12	that	that	PRON
bptjm-31	135	13	enhance	enhance	VERB
bptjm-31	135	14	productivity	productivity	NOUN
bptjm-31	135	15	in	in	ADP
bptjm-31	135	16	the	the	DET
bptjm-31	135	17	brain	brain	NOUN
bptjm-31	135	18	.	.	PUNCT
bptjm-31	136	1	some	some	DET
bptjm-31	136	2	examples	example	NOUN
bptjm-31	136	3	include	include	VERB
bptjm-31	136	4	methylphenidate	methylphenidate	NOUN
bptjm-31	136	5	and	and	CCONJ
bptjm-31	136	6	amphetamines	amphetamine	NOUN
bptjm-31	136	7	and	and	CCONJ
bptjm-31	136	8	are	be	AUX
bptjm-31	136	9	specifically	specifically	ADV
bptjm-31	136	10	known	know	VERB
bptjm-31	136	11	to	to	PART
bptjm-31	136	12	improve	improve	VERB
bptjm-31	136	13	adhd	adhd	NOUN
bptjm-31	136	14	symptoms	symptom	NOUN
bptjm-31	136	15	in	in	ADP
bptjm-31	136	16	patients	patient	NOUN
bptjm-31	136	17	with	with	ADP
bptjm-31	136	18	adhd15	adhd15	PROPN
bptjm-31	136	19	.	.	PUNCT
bptjm-31	137	1	amphetamine	amphetamine	PROPN
bptjm-31	137	2	salts	salt	NOUN
bptjm-31	137	3	contained	contain	VERB
bptjm-31	137	4	primarily	primarily	ADV
bptjm-31	137	5	of	of	ADP
bptjm-31	137	6	dextroamphetamine	dextroamphetamine	NOUN
bptjm-31	137	7	(	(	PUNCT
bptjm-31	137	8	d	d	NOUN
bptjm-31	137	9	-	-	PUNCT
bptjm-31	137	10	amp	amp	NOUN
bptjm-31	137	11	)	)	PUNCT
bptjm-31	137	12	are	be	AUX
bptjm-31	137	13	known	know	VERB
bptjm-31	137	14	by	by	ADP
bptjm-31	137	15	the	the	DET
bptjm-31	137	16	trade	trade	NOUN
bptjm-31	137	17	name	name	NOUN
bptjm-31	137	18	adderall	adderall	NOUN
bptjm-31	137	19	that	that	PRON
bptjm-31	137	20	help	help	VERB
bptjm-31	137	21	patients	patient	NOUN
bptjm-31	137	22	with	with	ADP
bptjm-31	137	23	adhd17	adhd17	NOUN
bptjm-31	137	24	.	.	PUNCT
bptjm-31	138	1	unlike	unlike	ADP
bptjm-31	138	2	racetams	racetam	NOUN
bptjm-31	138	3	,	,	PUNCT
bptjm-31	138	4	stimulants	stimulant	NOUN
bptjm-31	138	5	can	can	AUX
bptjm-31	138	6	enhance	enhance	VERB
bptjm-31	138	7	cognitive	cognitive	ADJ
bptjm-31	138	8	abilities	ability	NOUN
bptjm-31	138	9	in	in	ADP
bptjm-31	138	10	impaired	impaired	ADJ
bptjm-31	138	11	or	or	CCONJ
bptjm-31	138	12	unprescribed	unprescribed	ADJ
bptjm-31	138	13	patients	patient	NOUN
bptjm-31	138	14	without	without	ADP
bptjm-31	138	15	causing	cause	VERB
bptjm-31	138	16	adverse	adverse	ADJ
bptjm-31	138	17	effects	effect	NOUN
bptjm-31	138	18	.	.	PUNCT
bptjm-31	139	1	similar	similar	ADJ
bptjm-31	139	2	to	to	ADP
bptjm-31	139	3	racetams	racetam	NOUN
bptjm-31	139	4	,	,	PUNCT
bptjm-31	139	5	they	they	PRON
bptjm-31	139	6	can	can	AUX
bptjm-31	139	7	be	be	AUX
bptjm-31	139	8	found	find	VERB
bptjm-31	139	9	in	in	ADP
bptjm-31	139	10	natural	natural	ADJ
bptjm-31	139	11	and	and	CCONJ
bptjm-31	139	12	synthetic	synthetic	ADJ
bptjm-31	139	13	forms	form	NOUN
bptjm-31	139	14	that	that	PRON
bptjm-31	139	15	affect	affect	VERB
bptjm-31	139	16	neurotransmitter	neurotransmitter	NOUN
bptjm-31	139	17	levels	level	NOUN
bptjm-31	139	18	,	,	PUNCT
bptjm-31	139	19	neurogenesis	neurogenesis	NOUN
bptjm-31	139	20	,	,	PUNCT
bptjm-31	139	21	and	and	CCONJ
bptjm-31	139	22	blood	blood	NOUN
bptjm-31	139	23	flow	flow	NOUN
bptjm-31	139	24	to	to	ADP
bptjm-31	139	25	the	the	DET
bptjm-31	139	26	brain17	brain17	NOUN
bptjm-31	139	27	.	.	PUNCT
bptjm-31	140	1	some	some	DET
bptjm-31	140	2	stimulants	stimulant	NOUN
bptjm-31	140	3	are	be	AUX
bptjm-31	140	4	known	know	VERB
bptjm-31	140	5	to	to	PART
bptjm-31	140	6	improve	improve	VERB
bptjm-31	140	7	symptoms	symptom	NOUN
bptjm-31	140	8	of	of	ADP
bptjm-31	140	9	lbd	lbd	PROPN
bptjm-31	140	10	and	and	CCONJ
bptjm-31	140	11	reverse	reverse	VERB
bptjm-31	140	12	the	the	DET
bptjm-31	140	13	progression	progression	NOUN
bptjm-31	140	14	of	of	ADP
bptjm-31	140	15	dementia	dementia	NOUN
bptjm-31	140	16	.	.	PUNCT
bptjm-31	141	1	additional	additional	ADJ
bptjm-31	141	2	categories	category	NOUN
bptjm-31	141	3	of	of	ADP
bptjm-31	141	4	nootropics	nootropic	NOUN
bptjm-31	141	5	include	include	VERB
bptjm-31	141	6	dopaminergics	dopaminergic	NOUN
bptjm-31	141	7	,	,	PUNCT
bptjm-31	141	8	specifically	specifically	ADV
bptjm-31	141	9	work	work	VERB
bptjm-31	141	10	to	to	PART
bptjm-31	141	11	raise	raise	VERB
bptjm-31	141	12	levels	level	NOUN
bptjm-31	141	13	of	of	ADP
bptjm-31	141	14	dopamine	dopamine	NOUN
bptjm-31	141	15	,	,	PUNCT
bptjm-31	141	16	and	and	CCONJ
bptjm-31	141	17	serotonergics	serotonergic	NOUN
bptjm-31	141	18	,	,	PUNCT
bptjm-31	141	19	specifically	specifically	ADV
bptjm-31	141	20	work	work	VERB
bptjm-31	141	21	to	to	PART
bptjm-31	141	22	raise	raise	VERB
bptjm-31	141	23	levels	level	NOUN
bptjm-31	141	24	of	of	ADP
bptjm-31	141	25	serotonin	serotonin	NOUN
bptjm-31	141	26	,	,	PUNCT
bptjm-31	141	27	which	which	PRON
bptjm-31	141	28	can	can	AUX
bptjm-31	141	29	also	also	ADV
bptjm-31	141	30	raise	raise	VERB
bptjm-31	141	31	treatments	treatment	NOUN
bptjm-31	141	32	to	to	PART
bptjm-31	141	33	reverse	reverse	VERB
bptjm-31	141	34	symptoms	symptom	NOUN
bptjm-31	141	35	of	of	ADP
bptjm-31	141	36	lbd15	lbd15	PROPN
bptjm-31	141	37	.	.	PUNCT
bptjm-31	142	1	one	one	NUM
bptjm-31	142	2	clinical	clinical	ADJ
bptjm-31	142	3	trial	trial	NOUN
bptjm-31	142	4	study	study	NOUN
bptjm-31	142	5	of	of	ADP
bptjm-31	142	6	nootropics	nootropic	NOUN
bptjm-31	142	7	has	have	AUX
bptjm-31	142	8	been	be	AUX
bptjm-31	142	9	done	do	VERB
bptjm-31	142	10	on	on	ADP
bptjm-31	142	11	patients	patient	NOUN
bptjm-31	142	12	with	with	ADP
bptjm-31	142	13	ad	ad	NOUN
bptjm-31	142	14	.	.	PUNCT
bptjm-31	143	1	researchers	researcher	NOUN
bptjm-31	143	2	were	be	AUX
bptjm-31	143	3	particularly	particularly	ADV
bptjm-31	143	4	interested	interested	ADJ
bptjm-31	143	5	in	in	ADP
bptjm-31	143	6	comparing	compare	VERB
bptjm-31	143	7	the	the	DET
bptjm-31	143	8	effects	effect	NOUN
bptjm-31	143	9	of	of	ADP
bptjm-31	143	10	specific	specific	ADJ
bptjm-31	143	11	nootropics	nootropic	NOUN
bptjm-31	143	12	that	that	PRON
bptjm-31	143	13	affected	affect	VERB
bptjm-31	143	14	behavioral	behavioral	ADJ
bptjm-31	143	15	and	and	CCONJ
bptjm-31	143	16	psychological	psychological	ADJ
bptjm-31	143	17	symptoms	symptom	NOUN
bptjm-31	143	18	of	of	ADP
bptjm-31	143	19	dementia	dementia	NOUN
bptjm-31	143	20	which	which	PRON
bptjm-31	143	21	is	be	AUX
bptjm-31	143	22	how	how	SCONJ
bptjm-31	143	23	lbd	lbd	PROPN
bptjm-31	143	24	can	can	AUX
bptjm-31	143	25	also	also	ADV
bptjm-31	143	26	be	be	AUX
bptjm-31	143	27	affected	affect	VERB
bptjm-31	143	28	in	in	ADP
bptjm-31	143	29	the	the	DET
bptjm-31	143	30	study	study	NOUN
bptjm-31	143	31	.	.	PUNCT
bptjm-31	144	1	specifically	specifically	ADV
bptjm-31	144	2	,	,	PUNCT
bptjm-31	144	3	the	the	DET
bptjm-31	144	4	study	study	NOUN
bptjm-31	144	5	looked	look	VERB
bptjm-31	144	6	at	at	ADP
bptjm-31	144	7	cholinesterase	cholinesterase	NOUN
bptjm-31	144	8	inhibitors	inhibitor	NOUN
bptjm-31	144	9	and	and	CCONJ
bptjm-31	144	10	memantine	memantine	NOUN
bptjm-31	144	11	or	or	CCONJ
bptjm-31	144	12	a	a	DET
bptjm-31	144	13	n	n	CCONJ
bptjm-31	144	14	-	-	PUNCT
bptjm-31	144	15	methyl	methyl	NOUN
bptjm-31	144	16	berkeley	berkeley	PROPN
bptjm-31	144	17	pharma	pharma	PROPN
bptjm-31	144	18	tech	tech	NOUN
bptjm-31	144	19	journal	journal	NOUN
bptjm-31	144	20	of	of	ADP
bptjm-31	144	21	medicine	medicine	NOUN
bptjm-31	145	1	|	|	ADV
bptjm-31	145	2	12	12	NUM
bptjm-31	145	3	d	d	ADJ
bptjm-31	145	4	-	-	ADJ
bptjm-31	145	5	aspartic	aspartic	ADJ
bptjm-31	145	6	acid	acid	NOUN
bptjm-31	145	7	(	(	PUNCT
bptjm-31	145	8	nmda	nmda	ADJ
bptjm-31	145	9	)	)	PUNCT
bptjm-31	145	10	receptor	receptor	NOUN
bptjm-31	145	11	antagonist	antagonist	NOUN
bptjm-31	145	12	.	.	PUNCT
bptjm-31	146	1	cholinesterase	cholinesterase	NOUN
bptjm-31	146	2	inhibitors	inhibitor	NOUN
bptjm-31	146	3	of	of	ADP
bptjm-31	146	4	donepezil	donepezil	NOUN
bptjm-31	146	5	and	and	CCONJ
bptjm-31	146	6	rivastigmine	rivastigmine	NOUN
bptjm-31	146	7	increase	increase	VERB
bptjm-31	146	8	the	the	DET
bptjm-31	146	9	concentration	concentration	NOUN
bptjm-31	146	10	of	of	ADP
bptjm-31	146	11	acetylcholine	acetylcholine	NOUN
bptjm-31	146	12	at	at	ADP
bptjm-31	146	13	the	the	DET
bptjm-31	146	14	neurotransmitter	neurotransmitter	NOUN
bptjm-31	146	15	sites	site	NOUN
bptjm-31	146	16	.	.	PUNCT
bptjm-31	147	1	the	the	DET
bptjm-31	147	2	other	other	ADJ
bptjm-31	147	3	cholinesterase	cholinesterase	NOUN
bptjm-31	147	4	inhibitor	inhibitor	NOUN
bptjm-31	147	5	tested	test	VERB
bptjm-31	147	6	was	be	AUX
bptjm-31	147	7	galantamine	galantamine	NOUN
bptjm-31	147	8	which	which	PRON
bptjm-31	147	9	is	be	AUX
bptjm-31	147	10	a	a	DET
bptjm-31	147	11	double	double	ADJ
bptjm-31	147	12	action	action	NOUN
bptjm-31	147	13	that	that	PRON
bptjm-31	147	14	not	not	PART
bptjm-31	147	15	only	only	ADV
bptjm-31	147	16	increases	increase	VERB
bptjm-31	147	17	acetylcholine	acetylcholine	NOUN
bptjm-31	147	18	at	at	ADP
bptjm-31	147	19	neurotransmitter	neurotransmitter	NOUN
bptjm-31	147	20	sites	site	NOUN
bptjm-31	147	21	like	like	ADP
bptjm-31	147	22	donepezil	donepezil	NOUN
bptjm-31	147	23	and	and	CCONJ
bptjm-31	147	24	rivastigmine	rivastigmine	NOUN
bptjm-31	147	25	,	,	PUNCT
bptjm-31	147	26	but	but	CCONJ
bptjm-31	147	27	also	also	ADV
bptjm-31	147	28	acts	act	VERB
bptjm-31	147	29	by	by	ADP
bptjm-31	147	30	modulating	modulate	VERB
bptjm-31	147	31	activity	activity	NOUN
bptjm-31	147	32	at	at	ADP
bptjm-31	147	33	nicotinic	nicotinic	ADJ
bptjm-31	147	34	receptors	receptor	NOUN
bptjm-31	147	35	.	.	PUNCT
bptjm-31	148	1	memantine	memantine	NOUN
bptjm-31	148	2	is	be	AUX
bptjm-31	148	3	a	a	DET
bptjm-31	148	4	nmda	nmda	ADJ
bptjm-31	148	5	receptor	receptor	NOUN
bptjm-31	148	6	antagonist	antagonist	NOUN
bptjm-31	148	7	modulates	modulate	NOUN
bptjm-31	148	8	glutamate	glutamate	VERB
bptjm-31	148	9	in	in	ADP
bptjm-31	148	10	the	the	DET
bptjm-31	148	11	glutamic	glutamic	ADJ
bptjm-31	148	12	system	system	NOUN
bptjm-31	148	13	of	of	ADP
bptjm-31	148	14	the	the	DET
bptjm-31	148	15	brain	brain	NOUN
bptjm-31	148	16	.	.	PUNCT
bptjm-31	149	1	the	the	DET
bptjm-31	149	2	study	study	NOUN
bptjm-31	149	3	had	have	AUX
bptjm-31	149	4	selected	select	VERB
bptjm-31	149	5	patients	patient	NOUN
bptjm-31	149	6	with	with	ADP
bptjm-31	149	7	ad	ad	NOUN
bptjm-31	149	8	and	and	CCONJ
bptjm-31	149	9	had	have	AUX
bptjm-31	149	10	given	give	VERB
bptjm-31	149	11	a	a	DET
bptjm-31	149	12	placebo	placebo	NOUN
bptjm-31	149	13	to	to	ADP
bptjm-31	149	14	some	some	DET
bptjm-31	149	15	patients	patient	NOUN
bptjm-31	149	16	and	and	CCONJ
bptjm-31	149	17	others	other	NOUN
bptjm-31	149	18	received	receive	VERB
bptjm-31	149	19	a	a	DET
bptjm-31	149	20	cognitive	cognitive	ADJ
bptjm-31	149	21	enhancer	enhancer	NOUN
bptjm-31	149	22	.	.	PUNCT
bptjm-31	150	1	observations	observation	NOUN
bptjm-31	150	2	were	be	AUX
bptjm-31	150	3	made	make	VERB
bptjm-31	150	4	with	with	ADP
bptjm-31	150	5	the	the	DET
bptjm-31	150	6	efficacy	efficacy	NOUN
bptjm-31	150	7	and	and	CCONJ
bptjm-31	150	8	reversal	reversal	NOUN
bptjm-31	150	9	of	of	ADP
bptjm-31	150	10	dementia	dementia	NOUN
bptjm-31	150	11	in	in	ADP
bptjm-31	150	12	these	these	DET
bptjm-31	150	13	patients	patient	NOUN
bptjm-31	150	14	.	.	PUNCT
bptjm-31	151	1	this	this	DET
bptjm-31	151	2	clinical	clinical	ADJ
bptjm-31	151	3	trial	trial	NOUN
bptjm-31	151	4	has	have	VERB
bptjm-31	151	5	potential	potential	NOUN
bptjm-31	151	6	to	to	PART
bptjm-31	151	7	show	show	VERB
bptjm-31	151	8	that	that	SCONJ
bptjm-31	151	9	more	more	ADJ
bptjm-31	151	10	than	than	ADP
bptjm-31	151	11	100,000	100,000	NUM
bptjm-31	151	12	patients	patient	NOUN
bptjm-31	151	13	are	be	AUX
bptjm-31	151	14	eligible	eligible	ADJ
bptjm-31	151	15	for	for	ADP
bptjm-31	151	16	cognitive	cognitive	ADJ
bptjm-31	151	17	enhancers	enhancer	NOUN
bptjm-31	151	18	in	in	ADP
bptjm-31	151	19	canada	canada	PROPN
bptjm-31	151	20	alone	alone	ADV
bptjm-31	151	21	as	as	ADP
bptjm-31	151	22	30	30	NUM
bptjm-31	151	23	%	%	NOUN
bptjm-31	151	24	of	of	ADP
bptjm-31	151	25	the	the	DET
bptjm-31	151	26	ad	ad	NOUN
bptjm-31	151	27	patients	patient	NOUN
bptjm-31	151	28	have	have	VERB
bptjm-31	151	29	moderate	moderate	ADJ
bptjm-31	151	30	dementia	dementia	NOUN
bptjm-31	151	31	.	.	PUNCT
bptjm-31	152	1	these	these	DET
bptjm-31	152	2	medications	medication	NOUN
bptjm-31	152	3	have	have	AUX
bptjm-31	152	4	been	be	AUX
bptjm-31	152	5	approved	approve	VERB
bptjm-31	152	6	for	for	ADP
bptjm-31	152	7	the	the	DET
bptjm-31	152	8	treatment	treatment	NOUN
bptjm-31	152	9	of	of	ADP
bptjm-31	152	10	alzheimer	alzheimer	PROPN
bptjm-31	152	11	’s	’s	PART
bptjm-31	152	12	disease	disease	NOUN
bptjm-31	152	13	in	in	ADP
bptjm-31	152	14	many	many	ADJ
bptjm-31	152	15	countries	country	NOUN
bptjm-31	152	16	as	as	ADP
bptjm-31	152	17	well18	well18	PROPN
bptjm-31	152	18	.	.	PUNCT
bptjm-31	153	1	another	another	DET
bptjm-31	153	2	facet	facet	NOUN
bptjm-31	153	3	to	to	PART
bptjm-31	153	4	consider	consider	VERB
bptjm-31	153	5	is	be	AUX
bptjm-31	153	6	the	the	DET
bptjm-31	153	7	administration	administration	NOUN
bptjm-31	153	8	of	of	ADP
bptjm-31	153	9	such	such	ADJ
bptjm-31	153	10	effective	effective	ADJ
bptjm-31	153	11	nootropics	nootropic	NOUN
bptjm-31	153	12	.	.	PUNCT
bptjm-31	154	1	in	in	ADP
bptjm-31	154	2	a	a	DET
bptjm-31	154	3	clinical	clinical	ADJ
bptjm-31	154	4	trial	trial	NOUN
bptjm-31	154	5	led	lead	VERB
bptjm-31	154	6	by	by	ADP
bptjm-31	154	7	dr	dr	PROPN
bptjm-31	154	8	.	.	PROPN
bptjm-31	154	9	murat	murat	PROPN
bptjm-31	154	10	emre	emre	PROPN
bptjm-31	154	11	from	from	ADP
bptjm-31	154	12	istanbul	istanbul	PROPN
bptjm-31	154	13	and	and	CCONJ
bptjm-31	154	14	published	publish	VERB
bptjm-31	154	15	in	in	ADP
bptjm-31	154	16	the	the	DET
bptjm-31	154	17	prestigious	prestigious	ADJ
bptjm-31	154	18	new	new	PROPN
bptjm-31	154	19	england	england	PROPN
bptjm-31	154	20	journal	journal	PROPN
bptjm-31	154	21	of	of	ADP
bptjm-31	154	22	medicine	medicine	NOUN
bptjm-31	154	23	in	in	ADP
bptjm-31	154	24	2005	2005	NUM
bptjm-31	154	25	had	have	AUX
bptjm-31	154	26	shown	show	VERB
bptjm-31	154	27	that	that	DET
bptjm-31	154	28	rivastigmine	rivastigmine	NOUN
bptjm-31	154	29	,	,	PUNCT
bptjm-31	154	30	as	as	SCONJ
bptjm-31	154	31	previously	previously	ADV
bptjm-31	154	32	mentioned	mention	VERB
bptjm-31	154	33	,	,	PUNCT
bptjm-31	154	34	a	a	DET
bptjm-31	154	35	cholinesterase	cholinesterase	NOUN
bptjm-31	154	36	inhibitor	inhibitor	NOUN
bptjm-31	154	37	that	that	PRON
bptjm-31	154	38	enhances	enhance	VERB
bptjm-31	154	39	ach	ach	NOUN
bptjm-31	154	40	concentration	concentration	NOUN
bptjm-31	154	41	in	in	ADP
bptjm-31	154	42	neurotransmitter	neurotransmitter	NOUN
bptjm-31	154	43	sites	site	NOUN
bptjm-31	154	44	was	be	AUX
bptjm-31	154	45	effective	effective	ADJ
bptjm-31	154	46	in	in	ADP
bptjm-31	154	47	parkinson	parkinson	NOUN
bptjm-31	154	48	’s	’s	PART
bptjm-31	154	49	disease	disease	NOUN
bptjm-31	154	50	(	(	PUNCT
bptjm-31	154	51	pdd	pdd	NOUN
bptjm-31	154	52	)	)	PUNCT
bptjm-31	154	53	.	.	PUNCT
bptjm-31	155	1	although	although	SCONJ
bptjm-31	155	2	this	this	DET
bptjm-31	155	3	drug	drug	NOUN
bptjm-31	155	4	is	be	AUX
bptjm-31	155	5	not	not	PART
bptjm-31	155	6	approved	approve	VERB
bptjm-31	155	7	for	for	ADP
bptjm-31	155	8	lbd	lbd	PROPN
bptjm-31	155	9	patients	patient	NOUN
bptjm-31	155	10	in	in	ADP
bptjm-31	155	11	the	the	DET
bptjm-31	155	12	dr	dr	PROPN
bptjm-31	155	13	.	.	PROPN
bptjm-31	155	14	emre	emre	PROPN
bptjm-31	155	15	’s	’s	PART
bptjm-31	155	16	trial19	trial19	NOUN
bptjm-31	155	17	.	.	PUNCT
bptjm-31	156	1	however	however	ADV
bptjm-31	156	2	,	,	PUNCT
bptjm-31	156	3	many	many	ADJ
bptjm-31	156	4	doctors	doctor	NOUN
bptjm-31	156	5	and	and	CCONJ
bptjm-31	156	6	providers	provider	NOUN
bptjm-31	156	7	consider	consider	VERB
bptjm-31	156	8	both	both	DET
bptjm-31	156	9	disorders	disorder	NOUN
bptjm-31	156	10	to	to	PART
bptjm-31	156	11	have	have	VERB
bptjm-31	156	12	similar	similar	ADJ
bptjm-31	156	13	enough	enough	ADJ
bptjm-31	156	14	symptoms	symptom	NOUN
bptjm-31	156	15	for	for	SCONJ
bptjm-31	156	16	the	the	DET
bptjm-31	156	17	rivastigmine	rivastigmine	NOUN
bptjm-31	156	18	medication	medication	NOUN
bptjm-31	156	19	to	to	PART
bptjm-31	156	20	be	be	AUX
bptjm-31	156	21	effective	effective	ADJ
bptjm-31	156	22	in	in	ADP
bptjm-31	156	23	both	both	DET
bptjm-31	156	24	conditions	condition	NOUN
bptjm-31	156	25	.	.	PUNCT
bptjm-31	157	1	in	in	ADP
bptjm-31	157	2	this	this	DET
bptjm-31	157	3	study	study	NOUN
bptjm-31	157	4	both	both	CCONJ
bptjm-31	157	5	the	the	DET
bptjm-31	157	6	patch	patch	NOUN
bptjm-31	157	7	,	,	PUNCT
bptjm-31	157	8	developed	develop	VERB
bptjm-31	157	9	and	and	CCONJ
bptjm-31	157	10	approved	approve	VERB
bptjm-31	157	11	for	for	ADP
bptjm-31	157	12	use	use	NOUN
bptjm-31	157	13	in	in	ADP
bptjm-31	157	14	2007	2007	NUM
bptjm-31	157	15	,	,	PUNCT
bptjm-31	157	16	and	and	CCONJ
bptjm-31	157	17	the	the	DET
bptjm-31	157	18	pill	pill	NOUN
bptjm-31	157	19	of	of	ADP
bptjm-31	157	20	rivastigmine	rivastigmine	NOUN
bptjm-31	157	21	were	be	AUX
bptjm-31	157	22	given	give	VERB
bptjm-31	157	23	along	along	ADP
bptjm-31	157	24	with	with	ADP
bptjm-31	157	25	the	the	DET
bptjm-31	157	26	placebo	placebo	NOUN
bptjm-31	157	27	to	to	ADP
bptjm-31	157	28	patients	patient	NOUN
bptjm-31	157	29	with	with	ADP
bptjm-31	157	30	pdd	pdd	NOUN
bptjm-31	157	31	.	.	PUNCT
bptjm-31	158	1	the	the	DET
bptjm-31	158	2	patch	patch	NOUN
bptjm-31	158	3	and	and	CCONJ
bptjm-31	158	4	pill	pill	NOUN
bptjm-31	158	5	of	of	ADP
bptjm-31	158	6	rivastigmine	rivastigmine	NOUN
bptjm-31	158	7	were	be	AUX
bptjm-31	158	8	proven	prove	VERB
bptjm-31	158	9	to	to	PART
bptjm-31	158	10	be	be	AUX
bptjm-31	158	11	more	more	ADV
bptjm-31	158	12	effective	effective	ADJ
bptjm-31	158	13	than	than	ADP
bptjm-31	158	14	the	the	DET
bptjm-31	158	15	placebo	placebo	NOUN
bptjm-31	158	16	and	and	CCONJ
bptjm-31	158	17	showed	show	VERB
bptjm-31	158	18	the	the	DET
bptjm-31	158	19	same	same	ADJ
bptjm-31	158	20	effectivity	effectivity	NOUN
bptjm-31	158	21	.	.	PUNCT
bptjm-31	159	1	however	however	ADV
bptjm-31	159	2	,	,	PUNCT
bptjm-31	159	3	one	one	NUM
bptjm-31	159	4	trial	trial	NOUN
bptjm-31	159	5	of	of	ADP
bptjm-31	159	6	dr	dr	PROPN
bptjm-31	159	7	.	.	PROPN
bptjm-31	159	8	emre	emre	PROPN
bptjm-31	159	9	’s	’s	PART
bptjm-31	159	10	study	study	NOUN
bptjm-31	159	11	declared	declare	VERB
bptjm-31	159	12	the	the	DET
bptjm-31	159	13	patch	patch	NOUN
bptjm-31	159	14	was	be	AUX
bptjm-31	159	15	more	more	ADV
bptjm-31	159	16	effective	effective	ADJ
bptjm-31	159	17	than	than	ADP
bptjm-31	159	18	the	the	DET
bptjm-31	159	19	pill	pill	NOUN
bptjm-31	159	20	of	of	ADP
bptjm-31	159	21	rivastigmine	rivastigmine	NOUN
bptjm-31	159	22	mainly	mainly	ADV
bptjm-31	159	23	because	because	SCONJ
bptjm-31	159	24	of	of	ADP
bptjm-31	159	25	the	the	DET
bptjm-31	159	26	lower	low	ADJ
bptjm-31	159	27	recurrence	recurrence	NOUN
bptjm-31	159	28	of	of	ADP
bptjm-31	159	29	side	side	NOUN
bptjm-31	159	30	effects	effect	NOUN
bptjm-31	159	31	of	of	ADP
bptjm-31	159	32	nausea	nausea	NOUN
bptjm-31	159	33	and	and	CCONJ
bptjm-31	159	34	vomiting	vomit	VERB
bptjm-31	159	35	in	in	ADP
bptjm-31	159	36	the	the	DET
bptjm-31	159	37	patch	patch	NOUN
bptjm-31	159	38	than	than	ADP
bptjm-31	159	39	in	in	ADP
bptjm-31	159	40	the	the	DET
bptjm-31	159	41	pill	pill	NOUN
bptjm-31	159	42	.	.	PUNCT
bptjm-31	160	1	because	because	SCONJ
bptjm-31	160	2	medications	medication	NOUN
bptjm-31	160	3	were	be	AUX
bptjm-31	160	4	taken	take	VERB
bptjm-31	160	5	by	by	ADP
bptjm-31	160	6	the	the	DET
bptjm-31	160	7	skin	skin	NOUN
bptjm-31	160	8	in	in	ADP
bptjm-31	160	9	comparison	comparison	NOUN
bptjm-31	160	10	to	to	ADP
bptjm-31	160	11	the	the	DET
bptjm-31	160	12	mouth	mouth	NOUN
bptjm-31	160	13	,	,	PUNCT
bptjm-31	160	14	gi	gi	PROPN
bptjm-31	160	15	issues	issue	NOUN
bptjm-31	160	16	decreased	decrease	VERB
bptjm-31	160	17	in	in	ADP
bptjm-31	160	18	patients	patient	NOUN
bptjm-31	160	19	who	who	PRON
bptjm-31	160	20	used	use	VERB
bptjm-31	160	21	the	the	DET
bptjm-31	160	22	patch19	patch19	NOUN
bptjm-31	160	23	.	.	PUNCT
bptjm-31	161	1	5	5	X
bptjm-31	161	2	.	.	X
bptjm-31	161	3	non	non	ADJ
bptjm-31	161	4	-	-	ADJ
bptjm-31	161	5	coding	coding	ADJ
bptjm-31	161	6	rnas	rna	NOUN
bptjm-31	161	7	as	as	SCONJ
bptjm-31	161	8	previously	previously	ADV
bptjm-31	161	9	described	describe	VERB
bptjm-31	161	10	,	,	PUNCT
bptjm-31	161	11	lbd	lbd	PROPN
bptjm-31	161	12	is	be	AUX
bptjm-31	161	13	very	very	ADV
bptjm-31	161	14	complex	complex	ADJ
bptjm-31	161	15	and	and	CCONJ
bptjm-31	161	16	has	have	AUX
bptjm-31	161	17	become	become	VERB
bptjm-31	161	18	an	an	DET
bptjm-31	161	19	increasing	increase	VERB
bptjm-31	161	20	berkeley	berkeley	PROPN
bptjm-31	161	21	pharma	pharma	PROPN
bptjm-31	161	22	tech	tech	NOUN
bptjm-31	161	23	journal	journal	NOUN
bptjm-31	161	24	of	of	ADP
bptjm-31	161	25	medicine	medicine	NOUN
bptjm-31	161	26	|	|	ADV
bptjm-31	161	27	13	13	NUM
bptjm-31	161	28	demand	demand	NOUN
bptjm-31	161	29	on	on	ADP
bptjm-31	161	30	global	global	ADJ
bptjm-31	161	31	health	health	NOUN
bptjm-31	161	32	care	care	NOUN
bptjm-31	161	33	systems	system	NOUN
bptjm-31	161	34	.	.	PUNCT
bptjm-31	162	1	because	because	SCONJ
bptjm-31	162	2	it	it	PRON
bptjm-31	162	3	is	be	AUX
bptjm-31	162	4	so	so	ADV
bptjm-31	162	5	complex	complex	ADJ
bptjm-31	162	6	,	,	PUNCT
bptjm-31	162	7	there	there	PRON
bptjm-31	162	8	are	be	VERB
bptjm-31	162	9	many	many	ADJ
bptjm-31	162	10	factors	factor	NOUN
bptjm-31	162	11	that	that	PRON
bptjm-31	162	12	need	need	VERB
bptjm-31	162	13	to	to	PART
bptjm-31	162	14	be	be	AUX
bptjm-31	162	15	researched	research	VERB
bptjm-31	162	16	to	to	PART
bptjm-31	162	17	create	create	VERB
bptjm-31	162	18	possible	possible	ADJ
bptjm-31	162	19	therapies	therapy	NOUN
bptjm-31	162	20	or	or	CCONJ
bptjm-31	162	21	treatments	treatment	NOUN
bptjm-31	162	22	.	.	PUNCT
bptjm-31	163	1	non	non	ADJ
bptjm-31	163	2	-	-	ADJ
bptjm-31	163	3	coding	coding	ADJ
bptjm-31	163	4	rnas	rna	NOUN
bptjm-31	163	5	(	(	PUNCT
bptjm-31	163	6	ncrnas	ncrnas	PROPN
bptjm-31	163	7	)	)	PUNCT
bptjm-31	163	8	are	be	AUX
bptjm-31	163	9	rna	rna	NOUN
bptjm-31	163	10	sequences	sequence	NOUN
bptjm-31	163	11	that	that	PRON
bptjm-31	163	12	can	can	AUX
bptjm-31	163	13	not	not	PART
bptjm-31	163	14	be	be	AUX
bptjm-31	163	15	translated	translate	VERB
bptjm-31	163	16	into	into	ADP
bptjm-31	163	17	proteins	protein	NOUN
bptjm-31	163	18	.	.	PUNCT
bptjm-31	164	1	there	there	PRON
bptjm-31	164	2	is	be	VERB
bptjm-31	164	3	a	a	DET
bptjm-31	164	4	vast	vast	ADJ
bptjm-31	164	5	variety	variety	NOUN
bptjm-31	164	6	of	of	ADP
bptjm-31	164	7	different	different	ADJ
bptjm-31	164	8	ncrna	ncrna	NOUN
bptjm-31	164	9	families	family	NOUN
bptjm-31	164	10	;	;	PUNCT
bptjm-31	164	11	however	however	ADV
bptjm-31	164	12	,	,	PUNCT
bptjm-31	164	13	the	the	DET
bptjm-31	164	14	two	two	NUM
bptjm-31	164	15	most	most	ADV
bptjm-31	164	16	valuable	valuable	ADJ
bptjm-31	164	17	to	to	ADP
bptjm-31	164	18	this	this	DET
bptjm-31	164	19	topic	topic	NOUN
bptjm-31	164	20	are	be	AUX
bptjm-31	164	21	the	the	DET
bptjm-31	164	22	mirna	mirna	NOUN
bptjm-31	164	23	and	and	CCONJ
bptjm-31	164	24	lncrna	lncrna	NOUN
bptjm-31	164	25	families	family	NOUN
bptjm-31	164	26	.	.	PUNCT
bptjm-31	165	1	these	these	DET
bptjm-31	165	2	two	two	NUM
bptjm-31	165	3	families	family	NOUN
bptjm-31	165	4	have	have	VERB
bptjm-31	165	5	the	the	DET
bptjm-31	165	6	capacity	capacity	NOUN
bptjm-31	165	7	to	to	PART
bptjm-31	165	8	provoke	provoke	VERB
bptjm-31	165	9	gene	gene	NOUN
bptjm-31	165	10	regulation	regulation	NOUN
bptjm-31	165	11	across	across	ADP
bptjm-31	165	12	cellular	cellular	ADJ
bptjm-31	165	13	physiological	physiological	ADJ
bptjm-31	165	14	pathways	pathway	NOUN
bptjm-31	165	15	.	.	PUNCT
bptjm-31	166	1	since	since	SCONJ
bptjm-31	166	2	mirnas	mirna	NOUN
bptjm-31	166	3	and	and	CCONJ
bptjm-31	166	4	lncrnas	lncrnas	PROPN
bptjm-31	166	5	influence	influence	NOUN
bptjm-31	166	6	disease	disease	NOUN
bptjm-31	166	7	pathways	pathway	NOUN
bptjm-31	166	8	,	,	PUNCT
bptjm-31	166	9	it	it	PRON
bptjm-31	166	10	is	be	AUX
bptjm-31	166	11	important	important	ADJ
bptjm-31	166	12	to	to	PART
bptjm-31	166	13	research	research	VERB
bptjm-31	166	14	ncrnas	ncrna	NOUN
bptjm-31	166	15	for	for	ADP
bptjm-31	166	16	possible	possible	ADJ
bptjm-31	166	17	therapies	therapy	NOUN
bptjm-31	166	18	and	and	CCONJ
bptjm-31	166	19	for	for	ADP
bptjm-31	166	20	more	more	ADJ
bptjm-31	166	21	information	information	NOUN
bptjm-31	166	22	on	on	ADP
bptjm-31	166	23	the	the	DET
bptjm-31	166	24	pathogenesis20	pathogenesis20	NOUN
bptjm-31	166	25	.	.	PUNCT
bptjm-31	167	1	mirna	mirna	PROPN
bptjm-31	167	2	and	and	CCONJ
bptjm-31	167	3	lncrna	lncrna	NOUN
bptjm-31	167	4	families	family	NOUN
bptjm-31	167	5	have	have	VERB
bptjm-31	167	6	different	different	ADJ
bptjm-31	167	7	influences	influence	NOUN
bptjm-31	167	8	on	on	ADP
bptjm-31	167	9	dementia20	dementia20	PROPN
bptjm-31	167	10	.	.	PUNCT
bptjm-31	168	1	mirna	mirna	PROPN
bptjm-31	168	2	,	,	PUNCT
bptjm-31	168	3	short	short	ADJ
bptjm-31	168	4	for	for	ADP
bptjm-31	168	5	microrna	microrna	PROPN
bptjm-31	168	6	,	,	PUNCT
bptjm-31	168	7	refers	refer	VERB
bptjm-31	168	8	to	to	ADP
bptjm-31	168	9	a	a	DET
bptjm-31	168	10	small	small	ADJ
bptjm-31	168	11	single	single	ADJ
bptjm-31	168	12	stranded	strand	VERB
bptjm-31	168	13	ncrna	ncrna	NOUN
bptjm-31	168	14	molecule	molecule	NOUN
bptjm-31	168	15	.	.	PUNCT
bptjm-31	169	1	it	it	PRON
bptjm-31	169	2	comprises	comprise	VERB
bptjm-31	169	3	22	22	NUM
bptjm-31	169	4	nucleotides	nucleotide	NOUN
bptjm-31	169	5	and	and	CCONJ
bptjm-31	169	6	functions	function	NOUN
bptjm-31	169	7	in	in	ADP
bptjm-31	169	8	rna	rna	NOUN
bptjm-31	169	9	silencing	silencing	NOUN
bptjm-31	169	10	and	and	CCONJ
bptjm-31	169	11	posttranscriptional	posttranscriptional	ADJ
bptjm-31	169	12	regulation	regulation	NOUN
bptjm-31	169	13	of	of	ADP
bptjm-31	169	14	gene	gene	NOUN
bptjm-31	169	15	expression	expression	NOUN
bptjm-31	169	16	.	.	PUNCT
bptjm-31	170	1	mirna	mirna	PROPN
bptjm-31	170	2	inhibits	inhibit	VERB
bptjm-31	170	3	the	the	DET
bptjm-31	170	4	translation	translation	NOUN
bptjm-31	170	5	of	of	ADP
bptjm-31	170	6	proteins	protein	NOUN
bptjm-31	170	7	coded	code	VERB
bptjm-31	170	8	by	by	ADP
bptjm-31	170	9	mrna	mrna	PROPN
bptjm-31	170	10	transcript	transcript	NOUN
bptjm-31	170	11	by	by	ADP
bptjm-31	170	12	acting	act	VERB
bptjm-31	170	13	as	as	ADP
bptjm-31	170	14	a	a	DET
bptjm-31	170	15	physical	physical	ADJ
bptjm-31	170	16	obstruction	obstruction	NOUN
bptjm-31	170	17	for	for	ADP
bptjm-31	170	18	ribosomal	ribosomal	NOUN
bptjm-31	170	19	action	action	NOUN
bptjm-31	170	20	.	.	PUNCT
bptjm-31	171	1	there	there	PRON
bptjm-31	171	2	are	be	VERB
bptjm-31	171	3	many	many	ADJ
bptjm-31	171	4	studies	study	NOUN
bptjm-31	171	5	attributing	attribute	VERB
bptjm-31	171	6	and	and	CCONJ
bptjm-31	171	7	demonstrating	demonstrate	VERB
bptjm-31	171	8	the	the	DET
bptjm-31	171	9	effects	effect	NOUN
bptjm-31	171	10	of	of	ADP
bptjm-31	171	11	mirna	mirna	NOUN
bptjm-31	171	12	defects	defect	NOUN
bptjm-31	171	13	on	on	ADP
bptjm-31	171	14	multiple	multiple	ADJ
bptjm-31	171	15	forms	form	NOUN
bptjm-31	171	16	of	of	ADP
bptjm-31	171	17	dementia	dementia	NOUN
bptjm-31	171	18	,	,	PUNCT
bptjm-31	171	19	however	however	ADV
bptjm-31	171	20	because	because	SCONJ
bptjm-31	171	21	lbd	lbd	PROPN
bptjm-31	171	22	has	have	AUX
bptjm-31	171	23	not	not	PART
bptjm-31	171	24	been	be	AUX
bptjm-31	171	25	deeply	deeply	ADV
bptjm-31	171	26	studied	study	VERB
bptjm-31	171	27	there	there	PRON
bptjm-31	171	28	are	be	VERB
bptjm-31	171	29	no	no	DET
bptjm-31	171	30	details	detail	NOUN
bptjm-31	171	31	on	on	ADP
bptjm-31	171	32	the	the	DET
bptjm-31	171	33	influence	influence	NOUN
bptjm-31	171	34	of	of	ADP
bptjm-31	171	35	mirna	mirna	NOUN
bptjm-31	171	36	on	on	ADP
bptjm-31	171	37	lbd21	lbd21	PROPN
bptjm-31	171	38	.	.	PUNCT
bptjm-31	172	1	specifically	specifically	ADV
bptjm-31	172	2	,	,	PUNCT
bptjm-31	172	3	lncrna	lncrna	NOUN
bptjm-31	172	4	,	,	PUNCT
bptjm-31	172	5	short	short	ADJ
bptjm-31	172	6	for	for	ADP
bptjm-31	172	7	long	long	ADJ
bptjm-31	172	8	noncoding	noncoding	ADJ
bptjm-31	172	9	rna	rna	NOUN
bptjm-31	172	10	,	,	PUNCT
bptjm-31	172	11	refers	refer	VERB
bptjm-31	172	12	to	to	ADP
bptjm-31	172	13	a	a	DET
bptjm-31	172	14	single	single	ADJ
bptjm-31	172	15	rna	rna	NOUN
bptjm-31	172	16	sequence	sequence	NOUN
bptjm-31	172	17	composed	compose	VERB
bptjm-31	172	18	of	of	ADP
bptjm-31	172	19	at	at	ADV
bptjm-31	172	20	least	least	ADV
bptjm-31	172	21	200	200	NUM
bptjm-31	172	22	nucleotides	nucleotide	NOUN
bptjm-31	172	23	.	.	PUNCT
bptjm-31	173	1	lncrna	lncrna	NOUN
bptjm-31	173	2	regulates	regulate	VERB
bptjm-31	173	3	gene	gene	NOUN
bptjm-31	173	4	expression	expression	NOUN
bptjm-31	173	5	in	in	ADP
bptjm-31	173	6	several	several	ADJ
bptjm-31	173	7	levels	level	NOUN
bptjm-31	173	8	such	such	ADJ
bptjm-31	173	9	as	as	ADP
bptjm-31	173	10	epigenetics	epigenetic	NOUN
bptjm-31	173	11	and	and	CCONJ
bptjm-31	173	12	transcriptional	transcriptional	ADJ
bptjm-31	173	13	levels	level	NOUN
bptjm-31	173	14	.	.	PUNCT
bptjm-31	174	1	most	most	ADJ
bptjm-31	174	2	lncrnas	lncrna	NOUN
bptjm-31	174	3	are	be	AUX
bptjm-31	174	4	detrimental	detrimental	ADJ
bptjm-31	174	5	to	to	ADP
bptjm-31	174	6	pathways	pathway	NOUN
bptjm-31	174	7	in	in	ADP
bptjm-31	174	8	neurodegenerative	neurodegenerative	ADJ
bptjm-31	174	9	diseases21	diseases21	NOUN
bptjm-31	174	10	.	.	PUNCT
bptjm-31	175	1	just	just	ADV
bptjm-31	175	2	as	as	SCONJ
bptjm-31	175	3	in	in	ADP
bptjm-31	175	4	mirna	mirna	NOUN
bptjm-31	175	5	,	,	PUNCT
bptjm-31	175	6	there	there	PRON
bptjm-31	175	7	are	be	VERB
bptjm-31	175	8	no	no	DET
bptjm-31	175	9	studies	study	NOUN
bptjm-31	175	10	on	on	ADP
bptjm-31	175	11	the	the	DET
bptjm-31	175	12	specific	specific	ADJ
bptjm-31	175	13	effect	effect	NOUN
bptjm-31	175	14	of	of	ADP
bptjm-31	175	15	lncrnas	lncrnas	PROPN
bptjm-31	175	16	on	on	ADP
bptjm-31	175	17	lbd	lbd	PROPN
bptjm-31	175	18	.	.	PROPN
bptjm-31	176	1	as	as	SCONJ
bptjm-31	176	2	stated	state	VERB
bptjm-31	176	3	previously	previously	ADV
bptjm-31	176	4	,	,	PUNCT
bptjm-31	176	5	small	small	ADJ
bptjm-31	176	6	molecule	molecule	NOUN
bptjm-31	176	7	drugs	drug	NOUN
bptjm-31	176	8	show	show	VERB
bptjm-31	176	9	potential	potential	NOUN
bptjm-31	176	10	for	for	ADP
bptjm-31	176	11	the	the	DET
bptjm-31	176	12	future	future	NOUN
bptjm-31	176	13	of	of	ADP
bptjm-31	176	14	this	this	DET
bptjm-31	176	15	disease	disease	NOUN
bptjm-31	176	16	.	.	PUNCT
bptjm-31	177	1	one	one	NUM
bptjm-31	177	2	of	of	ADP
bptjm-31	177	3	the	the	DET
bptjm-31	177	4	few	few	ADJ
bptjm-31	177	5	studies	study	NOUN
bptjm-31	177	6	that	that	PRON
bptjm-31	177	7	has	have	AUX
bptjm-31	177	8	been	be	AUX
bptjm-31	177	9	done	do	VERB
bptjm-31	177	10	using	use	VERB
bptjm-31	177	11	ncrnas	ncrna	NOUN
bptjm-31	177	12	is	be	AUX
bptjm-31	177	13	the	the	DET
bptjm-31	177	14	use	use	NOUN
bptjm-31	177	15	of	of	ADP
bptjm-31	177	16	small	small	ADJ
bptjm-31	177	17	molecule	molecule	NOUN
bptjm-31	177	18	drugs	drug	NOUN
bptjm-31	177	19	targeting	target	VERB
bptjm-31	177	20	ncrnas	ncrna	NOUN
bptjm-31	177	21	as	as	ADP
bptjm-31	177	22	treatments	treatment	NOUN
bptjm-31	177	23	for	for	ADP
bptjm-31	177	24	dementias22	dementias22	NOUN
bptjm-31	177	25	.	.	PUNCT
bptjm-31	178	1	ncrnas	ncrnas	PROPN
bptjm-31	178	2	could	could	AUX
bptjm-31	178	3	function	function	VERB
bptjm-31	178	4	as	as	ADP
bptjm-31	178	5	therapeutic	therapeutic	ADJ
bptjm-31	178	6	targets	target	NOUN
bptjm-31	178	7	because	because	SCONJ
bptjm-31	178	8	they	they	PRON
bptjm-31	178	9	are	be	AUX
bptjm-31	178	10	enriched	enrich	VERB
bptjm-31	178	11	in	in	ADP
bptjm-31	178	12	the	the	DET
bptjm-31	178	13	central	central	ADJ
bptjm-31	178	14	nervous	nervous	ADJ
bptjm-31	178	15	system	system	NOUN
bptjm-31	178	16	.	.	PUNCT
bptjm-31	179	1	a	a	DET
bptjm-31	179	2	small	small	ADJ
bptjm-31	179	3	molecule	molecule	NOUN
bptjm-31	179	4	can	can	AUX
bptjm-31	179	5	bind	bind	VERB
bptjm-31	179	6	to	to	ADP
bptjm-31	179	7	ncrna	ncrna	NOUN
bptjm-31	179	8	,	,	PUNCT
bptjm-31	179	9	changing	change	VERB
bptjm-31	179	10	its	its	PRON
bptjm-31	179	11	conformation	conformation	NOUN
bptjm-31	179	12	,	,	PUNCT
bptjm-31	179	13	to	to	PART
bptjm-31	179	14	regulate	regulate	VERB
bptjm-31	179	15	it	it	PRON
bptjm-31	179	16	.	.	PUNCT
bptjm-31	180	1	there	there	PRON
bptjm-31	180	2	has	have	AUX
bptjm-31	180	3	been	be	AUX
bptjm-31	180	4	extensive	extensive	ADJ
bptjm-31	180	5	work	work	NOUN
bptjm-31	180	6	in	in	ADP
bptjm-31	180	7	developing	develop	VERB
bptjm-31	180	8	oligonucleotides	oligonucleotide	NOUN
bptjm-31	180	9	to	to	PART
bptjm-31	180	10	target	target	VERB
bptjm-31	180	11	mrnas	mrna	NOUN
bptjm-31	180	12	and	and	CCONJ
bptjm-31	180	13	ncrnas	ncrna	NOUN
bptjm-31	180	14	,	,	PUNCT
bptjm-31	180	15	however	however	ADV
bptjm-31	180	16	there	there	PRON
bptjm-31	180	17	are	be	VERB
bptjm-31	180	18	many	many	ADJ
bptjm-31	180	19	obstacles	obstacle	NOUN
bptjm-31	180	20	that	that	PRON
bptjm-31	180	21	have	have	AUX
bptjm-31	180	22	not	not	PART
bptjm-31	180	23	yet	yet	ADV
bptjm-31	180	24	been	be	AUX
bptjm-31	180	25	researched	research	VERB
bptjm-31	180	26	which	which	PRON
bptjm-31	180	27	block	block	VERB
bptjm-31	180	28	the	the	DET
bptjm-31	180	29	entry	entry	NOUN
bptjm-31	180	30	,	,	PUNCT
bptjm-31	180	31	specifically	specifically	ADV
bptjm-31	180	32	in	in	ADP
bptjm-31	180	33	the	the	DET
bptjm-31	180	34	blood	blood	NOUN
bptjm-31	180	35	brain	brain	NOUN
bptjm-31	180	36	barrier	barrier	NOUN
bptjm-31	180	37	.	.	PUNCT
bptjm-31	181	1	another	another	DET
bptjm-31	181	2	tactic	tactic	NOUN
bptjm-31	181	3	that	that	PRON
bptjm-31	181	4	needs	needs	AUX
bptjm-31	181	5	further	far	ADV
bptjm-31	181	6	studying	study	VERB
bptjm-31	181	7	is	be	AUX
bptjm-31	181	8	the	the	DET
bptjm-31	181	9	use	use	NOUN
bptjm-31	181	10	of	of	ADP
bptjm-31	181	11	gene	gene	NOUN
bptjm-31	181	12	therapy	therapy	NOUN
bptjm-31	181	13	.	.	PUNCT
bptjm-31	182	1	using	use	VERB
bptjm-31	182	2	gene	gene	NOUN
bptjm-31	182	3	therapy	therapy	NOUN
bptjm-31	182	4	with	with	ADP
bptjm-31	182	5	viral	viral	ADJ
bptjm-31	182	6	vectors	vector	NOUN
bptjm-31	182	7	can	can	AUX
bptjm-31	182	8	edit	edit	VERB
bptjm-31	182	9	ncrnas	ncrna	NOUN
bptjm-31	182	10	and	and	CCONJ
bptjm-31	182	11	can	can	AUX
bptjm-31	182	12	allow	allow	VERB
bptjm-31	182	13	for	for	ADP
bptjm-31	182	14	more	more	ADV
bptjm-31	182	15	durable	durable	ADJ
bptjm-31	182	16	ncrna	ncrna	NOUN
bptjm-31	182	17	modulation	modulation	NOUN
bptjm-31	182	18	.	.	PUNCT
bptjm-31	183	1	however	however	ADV
bptjm-31	183	2	,	,	PUNCT
bptjm-31	183	3	this	this	DET
bptjm-31	183	4	also	also	ADV
bptjm-31	183	5	berkeley	berkeley	PROPN
bptjm-31	183	6	pharma	pharma	PROPN
bptjm-31	183	7	tech	tech	NOUN
bptjm-31	183	8	journal	journal	NOUN
bptjm-31	183	9	of	of	ADP
bptjm-31	183	10	medicine	medicine	NOUN
bptjm-31	183	11	|	|	ADV
bptjm-31	183	12	14	14	NUM
bptjm-31	183	13	comes	come	VERB
bptjm-31	183	14	with	with	ADP
bptjm-31	183	15	obstacles	obstacle	NOUN
bptjm-31	183	16	regarding	regard	VERB
bptjm-31	183	17	the	the	DET
bptjm-31	183	18	delivery	delivery	NOUN
bptjm-31	183	19	and	and	CCONJ
bptjm-31	183	20	expression	expression	NOUN
bptjm-31	183	21	of	of	ADP
bptjm-31	183	22	the	the	DET
bptjm-31	183	23	target	target	NOUN
bptjm-31	183	24	genes	gene	NOUN
bptjm-31	183	25	,	,	PUNCT
bptjm-31	183	26	making	make	VERB
bptjm-31	183	27	the	the	DET
bptjm-31	183	28	therapy	therapy	NOUN
bptjm-31	183	29	ineffective	ineffective	ADJ
bptjm-31	183	30	.	.	PUNCT
bptjm-31	184	1	more	more	ADJ
bptjm-31	184	2	research	research	NOUN
bptjm-31	184	3	and	and	CCONJ
bptjm-31	184	4	knowledge	knowledge	NOUN
bptjm-31	184	5	could	could	AUX
bptjm-31	184	6	lead	lead	VERB
bptjm-31	184	7	to	to	ADP
bptjm-31	184	8	identifying	identify	VERB
bptjm-31	184	9	novel	novel	ADJ
bptjm-31	184	10	diagnostic	diagnostic	ADJ
bptjm-31	184	11	procedures	procedure	NOUN
bptjm-31	184	12	and/or	and/or	CCONJ
bptjm-31	184	13	drug	drug	NOUN
bptjm-31	184	14	targets	target	NOUN
bptjm-31	184	15	.	.	PUNCT
bptjm-31	185	1	while	while	SCONJ
bptjm-31	185	2	these	these	DET
bptjm-31	185	3	possible	possible	ADJ
bptjm-31	185	4	therapies	therapy	NOUN
bptjm-31	185	5	or	or	CCONJ
bptjm-31	185	6	drugs	drug	NOUN
bptjm-31	185	7	may	may	AUX
bptjm-31	185	8	not	not	PART
bptjm-31	185	9	be	be	AUX
bptjm-31	185	10	able	able	ADJ
bptjm-31	185	11	to	to	PART
bptjm-31	185	12	cure	cure	VERB
bptjm-31	185	13	a	a	DET
bptjm-31	185	14	patient	patient	NOUN
bptjm-31	185	15	,	,	PUNCT
bptjm-31	185	16	they	they	PRON
bptjm-31	185	17	can	can	AUX
bptjm-31	185	18	help	help	VERB
bptjm-31	185	19	with	with	ADP
bptjm-31	185	20	the	the	DET
bptjm-31	185	21	control	control	NOUN
bptjm-31	185	22	of	of	ADP
bptjm-31	185	23	the	the	DET
bptjm-31	185	24	patient	patient	NOUN
bptjm-31	185	25	’s	’s	PART
bptjm-31	185	26	mental	mental	ADJ
bptjm-31	185	27	condition	condition	NOUN
bptjm-31	185	28	,	,	PUNCT
bptjm-31	185	29	disease	disease	NOUN
bptjm-31	185	30	progression	progression	NOUN
bptjm-31	185	31	,	,	PUNCT
bptjm-31	185	32	and	and	CCONJ
bptjm-31	185	33	cognitive	cognitive	ADJ
bptjm-31	185	34	decline	decline	NOUN
bptjm-31	185	35	.	.	PUNCT
bptjm-31	186	1	6	6	X
bptjm-31	186	2	.	.	X
bptjm-31	186	3	other	other	ADJ
bptjm-31	186	4	factors	factor	NOUN
bptjm-31	186	5	in	in	ADP
bptjm-31	186	6	effect	effect	NOUN
bptjm-31	186	7	6.1	6.1	NUM
bptjm-31	186	8	inflammation	inflammation	NOUN
bptjm-31	186	9	as	as	ADP
bptjm-31	186	10	lbd	lbd	PROPN
bptjm-31	186	11	and	and	CCONJ
bptjm-31	186	12	ad	ad	NOUN
bptjm-31	186	13	have	have	VERB
bptjm-31	186	14	similar	similar	ADJ
bptjm-31	186	15	symptoms	symptom	NOUN
bptjm-31	186	16	and	and	CCONJ
bptjm-31	186	17	neuroinflammatory	neuroinflammatory	ADJ
bptjm-31	186	18	mechanisms	mechanism	NOUN
bptjm-31	186	19	involving	involve	VERB
bptjm-31	186	20	the	the	DET
bptjm-31	186	21	activation	activation	NOUN
bptjm-31	186	22	of	of	ADP
bptjm-31	186	23	microglia	microglia	ADJ
bptjm-31	186	24	,	,	PUNCT
bptjm-31	186	25	overexpression	overexpression	NOUN
bptjm-31	186	26	of	of	ADP
bptjm-31	186	27	interleukin-1	interleukin-1	NUM
bptjm-31	186	28	and	and	CCONJ
bptjm-31	186	29	other	other	ADJ
bptjm-31	186	30	inflammatory	inflammatory	ADJ
bptjm-31	186	31	mediators	mediator	NOUN
bptjm-31	186	32	,	,	PUNCT
bptjm-31	186	33	and	and	CCONJ
bptjm-31	186	34	inflammatory	inflammatory	ADJ
bptjm-31	186	35	toxicity	toxicity	NOUN
bptjm-31	186	36	to	to	ADP
bptjm-31	186	37	neurons	neuron	NOUN
bptjm-31	186	38	.	.	PUNCT
bptjm-31	187	1	the	the	DET
bptjm-31	187	2	activation	activation	NOUN
bptjm-31	187	3	of	of	ADP
bptjm-31	187	4	microglia	microglia	NOUN
bptjm-31	187	5	are	be	AUX
bptjm-31	187	6	also	also	ADV
bptjm-31	187	7	resultants	resultant	NOUN
bptjm-31	187	8	from	from	ADP
bptjm-31	187	9	the	the	DET
bptjm-31	187	10	overexpression	overexpression	NOUN
bptjm-31	187	11	with	with	ADP
bptjm-31	187	12	α	α	NOUN
bptjm-31	187	13	-	-	PUNCT
bptjm-31	187	14	synuclein	synuclein	NOUN
bptjm-31	187	15	-	-	PUNCT
bptjm-31	187	16	containing	contain	VERB
bptjm-31	187	17	neurons	neuron	NOUN
bptjm-31	187	18	and	and	CCONJ
bptjm-31	187	19	glia	glia	NOUN
bptjm-31	187	20	in	in	ADP
bptjm-31	187	21	pd	pd	PROPN
bptjm-31	187	22	.	.	PUNCT
bptjm-31	188	1	these	these	DET
bptjm-31	188	2	connections	connection	NOUN
bptjm-31	188	3	are	be	AUX
bptjm-31	188	4	also	also	ADV
bptjm-31	188	5	associated	associate	VERB
bptjm-31	188	6	with	with	ADP
bptjm-31	188	7	the	the	DET
bptjm-31	188	8	microglial	microglial	ADJ
bptjm-31	188	9	associations	association	NOUN
bptjm-31	188	10	with	with	ADP
bptjm-31	188	11	neurofibrillary	neurofibrillary	ADJ
bptjm-31	188	12	tangle	tangle	NOUN
bptjm-31	188	13	-	-	PUNCT
bptjm-31	188	14	containing	contain	VERB
bptjm-31	188	15	neurons	neuron	NOUN
bptjm-31	188	16	in	in	ADP
bptjm-31	188	17	ad	ad	NOUN
bptjm-31	188	18	.	.	PUNCT
bptjm-31	189	1	it	it	PRON
bptjm-31	189	2	is	be	AUX
bptjm-31	189	3	shown	show	VERB
bptjm-31	189	4	that	that	SCONJ
bptjm-31	189	5	there	there	PRON
bptjm-31	189	6	is	be	VERB
bptjm-31	189	7	a	a	DET
bptjm-31	189	8	reciprocal	reciprocal	ADJ
bptjm-31	189	9	induction	induction	NOUN
bptjm-31	189	10	between	between	ADP
bptjm-31	189	11	α	α	NOUN
bptjm-31	189	12	-	-	PUNCT
bptjm-31	189	13	synuclein	synuclein	NOUN
bptjm-31	189	14	and	and	CCONJ
bptjm-31	189	15	injured	injure	VERB
bptjm-31	189	16	neurons	neuron	NOUN
bptjm-31	189	17	on	on	ADP
bptjm-31	189	18	one	one	NUM
bptjm-31	189	19	hand	hand	NOUN
bptjm-31	189	20	and	and	CCONJ
bptjm-31	189	21	activated	activate	VERB
bptjm-31	189	22	microglia	microglia	ADJ
bptjm-31	189	23	and	and	CCONJ
bptjm-31	189	24	cytokine	cytokine	ADJ
bptjm-31	189	25	overexpression	overexpression	NOUN
bptjm-31	189	26	with	with	ADP
bptjm-31	189	27	in	in	ADP
bptjm-31	189	28	vivo	vivo	NOUN
bptjm-31	189	29	and	and	CCONJ
bptjm-31	189	30	in	in	ADP
bptjm-31	189	31	vitro	vitro	X
bptjm-31	189	32	experiments	experiment	NOUN
bptjm-31	189	33	.	.	PUNCT
bptjm-31	190	1	this	this	DET
bptjm-31	190	2	mechanism	mechanism	NOUN
bptjm-31	190	3	of	of	ADP
bptjm-31	190	4	inflammation	inflammation	NOUN
bptjm-31	190	5	can	can	AUX
bptjm-31	190	6	lead	lead	VERB
bptjm-31	190	7	to	to	ADP
bptjm-31	190	8	more	more	ADV
bptjm-31	190	9	injured	injure	VERB
bptjm-31	190	10	neurons	neuron	NOUN
bptjm-31	190	11	which	which	PRON
bptjm-31	190	12	can	can	AUX
bptjm-31	190	13	activate	activate	VERB
bptjm-31	190	14	microglia	microglia	NOUN
bptjm-31	190	15	and	and	CCONJ
bptjm-31	190	16	cause	cause	VERB
bptjm-31	190	17	a	a	DET
bptjm-31	190	18	cycle	cycle	NOUN
bptjm-31	190	19	of	of	ADP
bptjm-31	190	20	inflammation	inflammation	NOUN
bptjm-31	190	21	beneficial	beneficial	ADJ
bptjm-31	190	22	to	to	ADP
bptjm-31	190	23	the	the	DET
bptjm-31	190	24	neuron	neuron	NOUN
bptjm-31	190	25	which	which	PRON
bptjm-31	190	26	can	can	AUX
bptjm-31	190	27	cause	cause	VERB
bptjm-31	190	28	neuronal	neuronal	ADJ
bptjm-31	190	29	death	death	NOUN
bptjm-31	190	30	.	.	PUNCT
bptjm-31	191	1	this	this	DET
bptjm-31	191	2	concept	concept	NOUN
bptjm-31	191	3	can	can	AUX
bptjm-31	191	4	show	show	VERB
bptjm-31	191	5	the	the	DET
bptjm-31	191	6	progression	progression	NOUN
bptjm-31	191	7	and	and	CCONJ
bptjm-31	191	8	overlap	overlap	NOUN
bptjm-31	191	9	between	between	ADP
bptjm-31	191	10	both	both	DET
bptjm-31	191	11	ad	ad	NOUN
bptjm-31	191	12	and	and	CCONJ
bptjm-31	191	13	lbd25	lbd25	NOUN
bptjm-31	191	14	.	.	PUNCT
bptjm-31	192	1	6.2	6.2	NUM
bptjm-31	192	2	risk	risk	NOUN
bptjm-31	192	3	factors	factor	NOUN
bptjm-31	192	4	there	there	PRON
bptjm-31	192	5	are	be	VERB
bptjm-31	192	6	several	several	ADJ
bptjm-31	192	7	factors	factor	NOUN
bptjm-31	192	8	that	that	PRON
bptjm-31	192	9	contribute	contribute	VERB
bptjm-31	192	10	to	to	ADP
bptjm-31	192	11	a	a	DET
bptjm-31	192	12	person	person	NOUN
bptjm-31	192	13	's	's	PART
bptjm-31	192	14	risk	risk	NOUN
bptjm-31	192	15	for	for	ADP
bptjm-31	192	16	developing	develop	VERB
bptjm-31	192	17	lbd	lbd	PROPN
bptjm-31	192	18	.	.	PUNCT
bptjm-31	193	1	a	a	DET
bptjm-31	193	2	history	history	NOUN
bptjm-31	193	3	of	of	ADP
bptjm-31	193	4	high	high	ADJ
bptjm-31	193	5	caffeine	caffeine	NOUN
bptjm-31	193	6	intake	intake	NOUN
bptjm-31	193	7	,	,	PUNCT
bptjm-31	193	8	for	for	ADP
bptjm-31	193	9	example	example	NOUN
bptjm-31	193	10	,	,	PUNCT
bptjm-31	193	11	is	be	AUX
bptjm-31	193	12	associated	associate	VERB
bptjm-31	193	13	with	with	ADP
bptjm-31	193	14	a	a	DET
bptjm-31	193	15	lower	low	ADJ
bptjm-31	193	16	risk	risk	NOUN
bptjm-31	193	17	of	of	ADP
bptjm-31	193	18	lbd	lbd	PROPN
bptjm-31	193	19	.	.	PROPN
bptjm-31	194	1	research	research	PROPN
bptjm-31	194	2	has	have	AUX
bptjm-31	194	3	suggested	suggest	VERB
bptjm-31	194	4	that	that	SCONJ
bptjm-31	194	5	the	the	DET
bptjm-31	194	6	benefits	benefit	NOUN
bptjm-31	194	7	increase	increase	VERB
bptjm-31	194	8	in	in	ADP
bptjm-31	194	9	tandem	tandem	NOUN
bptjm-31	194	10	with	with	ADP
bptjm-31	194	11	the	the	DET
bptjm-31	194	12	amount	amount	NOUN
bptjm-31	194	13	of	of	ADP
bptjm-31	194	14	caffeine	caffeine	NOUN
bptjm-31	194	15	a	a	DET
bptjm-31	194	16	person	person	NOUN
bptjm-31	194	17	drinks	drink	VERB
bptjm-31	194	18	per	per	ADP
bptjm-31	194	19	day	day	NOUN
bptjm-31	194	20	and	and	CCONJ
bptjm-31	194	21	may	may	AUX
bptjm-31	194	22	reduce	reduce	VERB
bptjm-31	194	23	the	the	DET
bptjm-31	194	24	risk	risk	NOUN
bptjm-31	194	25	of	of	ADP
bptjm-31	194	26	lbd	lbd	NOUN
bptjm-31	194	27	by	by	ADP
bptjm-31	194	28	as	as	ADV
bptjm-31	194	29	much	much	ADJ
bptjm-31	194	30	as	as	ADP
bptjm-31	194	31	29%26	29%26	NUM
bptjm-31	194	32	.	.	PUNCT
bptjm-31	195	1	genetics	genetic	NOUN
bptjm-31	195	2	and	and	CCONJ
bptjm-31	195	3	heredity	heredity	NOUN
bptjm-31	195	4	appear	appear	VERB
bptjm-31	195	5	to	to	PART
bptjm-31	195	6	play	play	VERB
bptjm-31	195	7	a	a	DET
bptjm-31	195	8	role	role	NOUN
bptjm-31	195	9	in	in	ADP
bptjm-31	195	10	the	the	DET
bptjm-31	195	11	risk	risk	NOUN
bptjm-31	195	12	of	of	ADP
bptjm-31	195	13	lbd	lbd	PROPN
bptjm-31	195	14	as	as	ADV
bptjm-31	195	15	well	well	ADV
bptjm-31	195	16	.	.	PUNCT
bptjm-31	196	1	generally	generally	ADV
bptjm-31	196	2	,	,	PUNCT
bptjm-31	196	3	if	if	SCONJ
bptjm-31	196	4	you	you	PRON
bptjm-31	196	5	have	have	VERB
bptjm-31	196	6	a	a	DET
bptjm-31	196	7	first	first	ADJ
bptjm-31	196	8	-	-	PUNCT
bptjm-31	196	9	degree	degree	NOUN
bptjm-31	196	10	family	family	NOUN
bptjm-31	196	11	member	member	NOUN
bptjm-31	196	12	with	with	ADP
bptjm-31	196	13	lewy	lewy	PROPN
bptjm-31	196	14	body	body	NOUN
bptjm-31	196	15	dementia	dementia	NOUN
bptjm-31	196	16	or	or	CCONJ
bptjm-31	196	17	pd	pd	PROPN
bptjm-31	196	18	,	,	PUNCT
bptjm-31	196	19	your	your	PRON
bptjm-31	196	20	risk	risk	NOUN
bptjm-31	196	21	of	of	ADP
bptjm-31	196	22	lewy	lewy	ADJ
bptjm-31	196	23	body	body	NOUN
bptjm-31	196	24	dementia	dementia	NOUN
bptjm-31	196	25	increases	increase	NOUN
bptjm-31	196	26	.	.	PUNCT
bptjm-31	197	1	additionally	additionally	ADV
bptjm-31	197	2	,	,	PUNCT
bptjm-31	197	3	for	for	ADP
bptjm-31	197	4	reasons	reason	NOUN
bptjm-31	197	5	not	not	PART
bptjm-31	197	6	entirely	entirely	ADV
bptjm-31	197	7	clear	clear	ADJ
bptjm-31	197	8	,	,	PUNCT
bptjm-31	197	9	a	a	DET
bptjm-31	197	10	history	history	NOUN
bptjm-31	197	11	of	of	ADP
bptjm-31	197	12	depression	depression	NOUN
bptjm-31	197	13	and	and	CCONJ
bptjm-31	197	14	anxiety	anxiety	NOUN
bptjm-31	197	15	is	be	AUX
bptjm-31	197	16	linked	link	VERB
bptjm-31	197	17	to	to	ADP
bptjm-31	197	18	an	an	DET
bptjm-31	197	19	increased	increase	VERB
bptjm-31	197	20	risk	risk	NOUN
bptjm-31	197	21	of	of	ADP
bptjm-31	197	22	lewy	lewy	PROPN
bptjm-31	197	23	body	body	NOUN
bptjm-31	197	24	dementia27	dementia27	NOUN
bptjm-31	197	25	.	.	PUNCT
bptjm-31	198	1	metabolic	metabolic	PROPN
bptjm-31	198	2	berkeley	berkeley	PROPN
bptjm-31	198	3	pharma	pharma	PROPN
bptjm-31	198	4	tech	tech	NOUN
bptjm-31	198	5	journal	journal	NOUN
bptjm-31	198	6	of	of	ADP
bptjm-31	198	7	medicine	medicine	NOUN
bptjm-31	198	8	|	|	ADV
bptjm-31	198	9	15	15	NUM
bptjm-31	198	10	disorders	disorder	NOUN
bptjm-31	198	11	hypertension	hypertension	NOUN
bptjm-31	198	12	(	(	PUNCT
bptjm-31	198	13	high	high	ADJ
bptjm-31	198	14	blood	blood	NOUN
bptjm-31	198	15	pressure	pressure	NOUN
bptjm-31	198	16	)	)	PUNCT
bptjm-31	198	17	is	be	AUX
bptjm-31	198	18	linked	link	VERB
bptjm-31	198	19	to	to	ADP
bptjm-31	198	20	an	an	DET
bptjm-31	198	21	increased	increase	VERB
bptjm-31	198	22	risk	risk	NOUN
bptjm-31	198	23	of	of	ADP
bptjm-31	198	24	lewy	lewy	PROPN
bptjm-31	198	25	body	body	NOUN
bptjm-31	198	26	dementia	dementia	NOUN
bptjm-31	198	27	.	.	PUNCT
bptjm-31	199	1	the	the	DET
bptjm-31	199	2	incidence	incidence	NOUN
bptjm-31	199	3	of	of	ADP
bptjm-31	199	4	hypertension	hypertension	NOUN
bptjm-31	199	5	among	among	ADP
bptjm-31	199	6	people	people	NOUN
bptjm-31	199	7	with	with	ADP
bptjm-31	199	8	lewy	lewy	ADJ
bptjm-31	199	9	body	body	NOUN
bptjm-31	199	10	dementia	dementia	NOUN
bptjm-31	199	11	is	be	AUX
bptjm-31	199	12	roughly	roughly	ADV
bptjm-31	199	13	65	65	NUM
bptjm-31	199	14	%	%	NOUN
bptjm-31	199	15	.	.	PUNCT
bptjm-31	200	1	having	have	VERB
bptjm-31	200	2	high	high	ADJ
bptjm-31	200	3	blood	blood	NOUN
bptjm-31	200	4	pressure	pressure	NOUN
bptjm-31	200	5	,	,	PUNCT
bptjm-31	200	6	in	in	ADP
bptjm-31	200	7	turn	turn	NOUN
bptjm-31	200	8	,	,	PUNCT
bptjm-31	200	9	increases	increase	VERB
bptjm-31	200	10	the	the	DET
bptjm-31	200	11	risk	risk	NOUN
bptjm-31	200	12	of	of	ADP
bptjm-31	200	13	lewy	lewy	ADJ
bptjm-31	200	14	body	body	NOUN
bptjm-31	200	15	dementia	dementia	NOUN
bptjm-31	200	16	by	by	ADP
bptjm-31	200	17	60.5	60.5	NUM
bptjm-31	200	18	%	%	NOUN
bptjm-31	200	19	.	.	PUNCT
bptjm-31	201	1	type	type	NOUN
bptjm-31	201	2	2	2	NUM
bptjm-31	201	3	diabetes	diabetes	NOUN
bptjm-31	201	4	,	,	PUNCT
bptjm-31	201	5	a	a	DET
bptjm-31	201	6	form	form	NOUN
bptjm-31	201	7	of	of	ADP
bptjm-31	201	8	diabetes	diabetes	NOUN
bptjm-31	201	9	strongly	strongly	ADV
bptjm-31	201	10	linked	link	VERB
bptjm-31	201	11	to	to	ADP
bptjm-31	201	12	lifestyle	lifestyle	NOUN
bptjm-31	201	13	,	,	PUNCT
bptjm-31	201	14	is	be	AUX
bptjm-31	201	15	associated	associate	VERB
bptjm-31	201	16	with	with	ADP
bptjm-31	201	17	a	a	DET
bptjm-31	201	18	25	25	NUM
bptjm-31	201	19	%	%	NOUN
bptjm-31	201	20	increased	increase	VERB
bptjm-31	201	21	risk	risk	NOUN
bptjm-31	201	22	of	of	ADP
bptjm-31	201	23	lewy	lewy	PROPN
bptjm-31	201	24	body	body	NOUN
bptjm-31	201	25	dementia	dementia	NOUN
bptjm-31	201	26	.	.	PUNCT
bptjm-31	202	1	high	high	ADJ
bptjm-31	202	2	cholesterol	cholesterol	NOUN
bptjm-31	202	3	also	also	ADV
bptjm-31	202	4	increases	increase	VERB
bptjm-31	202	5	the	the	DET
bptjm-31	202	6	risk	risk	NOUN
bptjm-31	202	7	of	of	ADP
bptjm-31	202	8	lewy	lewy	ADJ
bptjm-31	202	9	body	body	NOUN
bptjm-31	202	10	dementia	dementia	NOUN
bptjm-31	202	11	by	by	ADP
bptjm-31	202	12	roughly	roughly	ADV
bptjm-31	202	13	25%28	25%28	NUM
bptjm-31	202	14	.	.	PUNCT
bptjm-31	203	1	6.3	6.3	NUM
bptjm-31	203	2	micronutrients	micronutrient	NOUN
bptjm-31	203	3	micronutrients	micronutrient	NOUN
bptjm-31	203	4	are	be	AUX
bptjm-31	203	5	a	a	DET
bptjm-31	203	6	fundamental	fundamental	ADJ
bptjm-31	203	7	part	part	NOUN
bptjm-31	203	8	to	to	ADP
bptjm-31	203	9	healthy	healthy	ADJ
bptjm-31	203	10	development	development	NOUN
bptjm-31	203	11	,	,	PUNCT
bptjm-31	203	12	disease	disease	NOUN
bptjm-31	203	13	prevention	prevention	NOUN
bptjm-31	203	14	,	,	PUNCT
bptjm-31	203	15	and	and	CCONJ
bptjm-31	203	16	a	a	DET
bptjm-31	203	17	good	good	ADJ
bptjm-31	203	18	lifestyle	lifestyle	NOUN
bptjm-31	203	19	.	.	PUNCT
bptjm-31	204	1	no	no	DET
bptjm-31	204	2	micronutrients	micronutrient	NOUN
bptjm-31	204	3	,	,	PUNCT
bptjm-31	204	4	except	except	SCONJ
bptjm-31	204	5	vitamin	vitamin	NOUN
bptjm-31	204	6	d	d	PROPN
bptjm-31	204	7	,	,	PUNCT
bptjm-31	204	8	are	be	AUX
bptjm-31	204	9	produced	produce	VERB
bptjm-31	204	10	in	in	ADP
bptjm-31	204	11	the	the	DET
bptjm-31	204	12	body	body	NOUN
bptjm-31	204	13	therefore	therefore	ADV
bptjm-31	204	14	they	they	PRON
bptjm-31	204	15	must	must	AUX
bptjm-31	204	16	come	come	VERB
bptjm-31	204	17	from	from	ADP
bptjm-31	204	18	a	a	DET
bptjm-31	204	19	person	person	NOUN
bptjm-31	204	20	’s	’s	PART
bptjm-31	204	21	diet	diet	NOUN
bptjm-31	204	22	and	and	CCONJ
bptjm-31	204	23	intake	intake	NOUN
bptjm-31	204	24	.	.	PUNCT
bptjm-31	205	1	micronutrients	micronutrient	NOUN
bptjm-31	205	2	are	be	AUX
bptjm-31	205	3	important	important	ADJ
bptjm-31	205	4	for	for	ADP
bptjm-31	205	5	healthy	healthy	ADJ
bptjm-31	205	6	people	people	NOUN
bptjm-31	205	7	but	but	CCONJ
bptjm-31	205	8	even	even	ADV
bptjm-31	205	9	more	more	ADV
bptjm-31	205	10	important	important	ADJ
bptjm-31	205	11	for	for	ADP
bptjm-31	205	12	those	those	PRON
bptjm-31	205	13	who	who	PRON
bptjm-31	205	14	have	have	VERB
bptjm-31	205	15	a	a	DET
bptjm-31	205	16	disease	disease	NOUN
bptjm-31	205	17	or	or	CCONJ
bptjm-31	205	18	are	be	AUX
bptjm-31	205	19	genetically	genetically	ADV
bptjm-31	205	20	prone	prone	ADJ
bptjm-31	205	21	to	to	ADP
bptjm-31	205	22	developing	develop	VERB
bptjm-31	205	23	a	a	DET
bptjm-31	205	24	disease23	disease23	NOUN
bptjm-31	205	25	.	.	PUNCT
bptjm-31	206	1	those	those	PRON
bptjm-31	206	2	who	who	PRON
bptjm-31	206	3	do	do	AUX
bptjm-31	206	4	not	not	PART
bptjm-31	206	5	supply	supply	VERB
bptjm-31	206	6	their	their	PRON
bptjm-31	206	7	body	body	NOUN
bptjm-31	206	8	with	with	ADP
bptjm-31	206	9	sufficient	sufficient	ADJ
bptjm-31	206	10	nutrients	nutrient	NOUN
bptjm-31	206	11	can	can	AUX
bptjm-31	206	12	suffer	suffer	VERB
bptjm-31	206	13	from	from	ADP
bptjm-31	206	14	malnutrition	malnutrition	NOUN
bptjm-31	206	15	,	,	PUNCT
bptjm-31	206	16	which	which	PRON
bptjm-31	206	17	has	have	AUX
bptjm-31	206	18	been	be	AUX
bptjm-31	206	19	found	find	VERB
bptjm-31	206	20	to	to	PART
bptjm-31	206	21	be	be	AUX
bptjm-31	206	22	tied	tie	VERB
bptjm-31	206	23	to	to	ADP
bptjm-31	206	24	cognitive	cognitive	ADJ
bptjm-31	206	25	function	function	NOUN
bptjm-31	206	26	.	.	PUNCT
bptjm-31	207	1	deficiency	deficiency	NOUN
bptjm-31	207	2	of	of	ADP
bptjm-31	207	3	nutrients	nutrient	NOUN
bptjm-31	207	4	,	,	PUNCT
bptjm-31	207	5	specifically	specifically	ADV
bptjm-31	207	6	vitamin	vitamin	VERB
bptjm-31	207	7	b12	b12	NOUN
bptjm-31	207	8	and	and	CCONJ
bptjm-31	207	9	folate	folate	NOUN
bptjm-31	207	10	,	,	PUNCT
bptjm-31	207	11	can	can	AUX
bptjm-31	207	12	lead	lead	VERB
bptjm-31	207	13	to	to	ADP
bptjm-31	207	14	decreased	decrease	VERB
bptjm-31	207	15	cognitive	cognitive	ADJ
bptjm-31	207	16	function	function	NOUN
bptjm-31	207	17	.	.	PUNCT
bptjm-31	208	1	in	in	ADP
bptjm-31	208	2	addition	addition	NOUN
bptjm-31	208	3	,	,	PUNCT
bptjm-31	208	4	weight	weight	NOUN
bptjm-31	208	5	loss	loss	NOUN
bptjm-31	208	6	associated	associate	VERB
bptjm-31	208	7	with	with	ADP
bptjm-31	208	8	malnutrition	malnutrition	NOUN
bptjm-31	208	9	will	will	AUX
bptjm-31	208	10	often	often	ADV
bptjm-31	208	11	occur	occur	VERB
bptjm-31	208	12	prior	prior	ADV
bptjm-31	208	13	to	to	ADP
bptjm-31	208	14	the	the	DET
bptjm-31	208	15	onset	onset	NOUN
bptjm-31	208	16	of	of	ADP
bptjm-31	208	17	dementia23	dementia23	NOUN
bptjm-31	208	18	.	.	PUNCT
bptjm-31	209	1	as	as	SCONJ
bptjm-31	209	2	the	the	DET
bptjm-31	209	3	disease	disease	NOUN
bptjm-31	209	4	progresses	progress	VERB
bptjm-31	209	5	,	,	PUNCT
bptjm-31	209	6	weight	weight	NOUN
bptjm-31	209	7	loss	loss	NOUN
bptjm-31	209	8	can	can	AUX
bptjm-31	209	9	also	also	ADV
bptjm-31	209	10	progress	progress	VERB
bptjm-31	209	11	and	and	CCONJ
bptjm-31	209	12	vice	vice	ADV
bptjm-31	209	13	versa	versa	ADV
bptjm-31	209	14	.	.	PUNCT
bptjm-31	210	1	while	while	SCONJ
bptjm-31	210	2	there	there	PRON
bptjm-31	210	3	are	be	VERB
bptjm-31	210	4	several	several	ADJ
bptjm-31	210	5	diets	diet	NOUN
bptjm-31	210	6	that	that	PRON
bptjm-31	210	7	are	be	AUX
bptjm-31	210	8	said	say	VERB
bptjm-31	210	9	to	to	PART
bptjm-31	210	10	prevent	prevent	VERB
bptjm-31	210	11	,	,	PUNCT
bptjm-31	210	12	or	or	CCONJ
bptjm-31	210	13	help	help	VERB
bptjm-31	210	14	with	with	ADP
bptjm-31	210	15	,	,	PUNCT
bptjm-31	210	16	cognitive	cognitive	ADJ
bptjm-31	210	17	decline	decline	NOUN
bptjm-31	210	18	and	and	CCONJ
bptjm-31	210	19	dementia	dementia	NOUN
bptjm-31	210	20	,	,	PUNCT
bptjm-31	210	21	there	there	PRON
bptjm-31	210	22	are	be	VERB
bptjm-31	210	23	no	no	DET
bptjm-31	210	24	studies	study	NOUN
bptjm-31	210	25	that	that	PRON
bptjm-31	210	26	directly	directly	ADV
bptjm-31	210	27	prove	prove	VERB
bptjm-31	210	28	one	one	NUM
bptjm-31	210	29	diet	diet	NOUN
bptjm-31	210	30	to	to	PART
bptjm-31	210	31	help	help	VERB
bptjm-31	210	32	with	with	ADP
bptjm-31	210	33	lbd24	lbd24	PROPN
bptjm-31	210	34	.	.	PUNCT
bptjm-31	211	1	finding	find	VERB
bptjm-31	211	2	the	the	DET
bptjm-31	211	3	correct	correct	ADJ
bptjm-31	211	4	micronutrients	micronutrient	NOUN
bptjm-31	211	5	that	that	PRON
bptjm-31	211	6	could	could	AUX
bptjm-31	211	7	help	help	VERB
bptjm-31	211	8	patients	patient	NOUN
bptjm-31	211	9	who	who	PRON
bptjm-31	211	10	have	have	VERB
bptjm-31	211	11	lbd	lbd	NOUN
bptjm-31	211	12	or	or	CCONJ
bptjm-31	211	13	are	be	AUX
bptjm-31	211	14	predisposed	predispose	VERB
bptjm-31	211	15	to	to	ADP
bptjm-31	211	16	it	it	PRON
bptjm-31	211	17	could	could	AUX
bptjm-31	211	18	have	have	VERB
bptjm-31	211	19	a	a	DET
bptjm-31	211	20	huge	huge	ADJ
bptjm-31	211	21	impact	impact	NOUN
bptjm-31	211	22	on	on	ADP
bptjm-31	211	23	this	this	DET
bptjm-31	211	24	area	area	NOUN
bptjm-31	211	25	of	of	ADP
bptjm-31	211	26	health	health	NOUN
bptjm-31	211	27	.	.	PUNCT
bptjm-31	212	1	7	7	X
bptjm-31	212	2	.	.	X
bptjm-31	212	3	conclusion	conclusion	NOUN
bptjm-31	212	4	from	from	ADP
bptjm-31	212	5	the	the	DET
bptjm-31	212	6	progression	progression	NOUN
bptjm-31	212	7	of	of	ADP
bptjm-31	212	8	research	research	NOUN
bptjm-31	212	9	of	of	ADP
bptjm-31	212	10	lbd	lbd	PROPN
bptjm-31	212	11	in	in	ADP
bptjm-31	212	12	clinical	clinical	ADJ
bptjm-31	212	13	trials	trial	NOUN
bptjm-31	212	14	,	,	PUNCT
bptjm-31	212	15	in	in	ADP
bptjm-31	212	16	vivo	vivo	NOUN
bptjm-31	212	17	,	,	PUNCT
bptjm-31	212	18	and	and	CCONJ
bptjm-31	212	19	in	in	ADP
bptjm-31	212	20	vitro	vitro	X
bptjm-31	212	21	experiments	experiment	NOUN
bptjm-31	212	22	,	,	PUNCT
bptjm-31	212	23	the	the	DET
bptjm-31	212	24	potential	potential	NOUN
bptjm-31	212	25	of	of	ADP
bptjm-31	212	26	epigenetic	epigenetic	ADJ
bptjm-31	212	27	therapy	therapy	NOUN
bptjm-31	212	28	should	should	AUX
bptjm-31	212	29	be	be	AUX
bptjm-31	212	30	examined	examine	VERB
bptjm-31	212	31	more	more	ADV
bptjm-31	212	32	thoroughly	thoroughly	ADV
bptjm-31	212	33	.	.	PUNCT
bptjm-31	213	1	future	future	ADJ
bptjm-31	213	2	directions	direction	NOUN
bptjm-31	213	3	of	of	ADP
bptjm-31	213	4	the	the	DET
bptjm-31	213	5	use	use	NOUN
bptjm-31	213	6	of	of	ADP
bptjm-31	213	7	deep	deep	ADJ
bptjm-31	213	8	brain	brain	NOUN
bptjm-31	213	9	stimulation29	stimulation29	NOUN
bptjm-31	213	10	and	and	CCONJ
bptjm-31	213	11	repetitive	repetitive	ADJ
bptjm-31	213	12	transcranial	transcranial	ADJ
bptjm-31	213	13	magnetic	magnetic	ADJ
bptjm-31	213	14	stimulation	stimulation	NOUN
bptjm-31	213	15	(	(	PUNCT
bptjm-31	213	16	rtms	rtms	NOUN
bptjm-31	213	17	)	)	PUNCT
bptjm-31	213	18	has	have	AUX
bptjm-31	213	19	shown	show	VERB
bptjm-31	213	20	potential	potential	NOUN
bptjm-31	213	21	in	in	ADP
bptjm-31	213	22	other	other	ADJ
bptjm-31	213	23	neurodegenerative	neurodegenerative	ADJ
bptjm-31	213	24	diseases	disease	NOUN
bptjm-31	213	25	and	and	CCONJ
bptjm-31	213	26	could	could	AUX
bptjm-31	213	27	be	be	AUX
bptjm-31	213	28	applicable	applicable	ADJ
bptjm-31	213	29	to	to	ADP
bptjm-31	213	30	lbd30	lbd30	ADJ
bptjm-31	213	31	.	.	PUNCT
bptjm-31	214	1	the	the	DET
bptjm-31	214	2	effects	effect	NOUN
bptjm-31	214	3	of	of	ADP
bptjm-31	214	4	epigenetics	epigenetic	NOUN
bptjm-31	214	5	,	,	PUNCT
bptjm-31	214	6	age	age	NOUN
bptjm-31	214	7	,	,	PUNCT
bptjm-31	214	8	diet	diet	NOUN
bptjm-31	214	9	,	,	PUNCT
bptjm-31	214	10	and	and	CCONJ
bptjm-31	214	11	inflammation	inflammation	NOUN
bptjm-31	214	12	within	within	ADP
bptjm-31	214	13	the	the	DET
bptjm-31	214	14	body	body	NOUN
bptjm-31	214	15	can	can	AUX
bptjm-31	214	16	enhance	enhance	VERB
bptjm-31	214	17	other	other	ADJ
bptjm-31	214	18	scientists	scientist	NOUN
bptjm-31	214	19	’	'	PUNCT
bptjm-31	214	20	knowledge	knowledge	NOUN
bptjm-31	214	21	when	when	SCONJ
bptjm-31	214	22	designing	design	VERB
bptjm-31	214	23	therapies	therapy	NOUN
bptjm-31	214	24	for	for	ADP
bptjm-31	214	25	lbd	lbd	PROPN
bptjm-31	214	26	in	in	ADP
bptjm-31	214	27	the	the	DET
bptjm-31	214	28	future	future	NOUN
bptjm-31	214	29	.	.	PUNCT
bptjm-31	215	1	as	as	SCONJ
bptjm-31	215	2	this	this	DET
bptjm-31	215	3	article	article	NOUN
bptjm-31	215	4	has	have	AUX
bptjm-31	215	5	mentioned	mention	VERB
bptjm-31	215	6	many	many	ADJ
bptjm-31	215	7	current	current	ADJ
bptjm-31	215	8	therapies	therapy	NOUN
bptjm-31	215	9	and	and	CCONJ
bptjm-31	215	10	potential	potential	ADJ
bptjm-31	215	11	therapies	therapy	NOUN
bptjm-31	215	12	it	it	PRON
bptjm-31	215	13	is	be	AUX
bptjm-31	215	14	important	important	ADJ
bptjm-31	215	15	to	to	PART
bptjm-31	215	16	note	note	VERB
bptjm-31	215	17	the	the	DET
bptjm-31	215	18	limitations	limitation	NOUN
bptjm-31	215	19	and	and	CCONJ
bptjm-31	215	20	drawbacks	drawback	NOUN
bptjm-31	215	21	of	of	ADP
bptjm-31	215	22	the	the	DET
bptjm-31	215	23	research	research	NOUN
bptjm-31	215	24	berkeley	berkeley	PROPN
bptjm-31	215	25	pharma	pharma	PROPN
bptjm-31	215	26	tech	tech	NOUN
bptjm-31	215	27	journal	journal	NOUN
bptjm-31	215	28	of	of	ADP
bptjm-31	215	29	medicine	medicine	NOUN
bptjm-31	215	30	|	|	ADV
bptjm-31	215	31	16	16	NUM
bptjm-31	215	32	presented	present	VERB
bptjm-31	215	33	.	.	PUNCT
bptjm-31	216	1	one	one	NUM
bptjm-31	216	2	drawback	drawback	NOUN
bptjm-31	216	3	is	be	AUX
bptjm-31	216	4	that	that	SCONJ
bptjm-31	216	5	many	many	ADJ
bptjm-31	216	6	of	of	ADP
bptjm-31	216	7	the	the	DET
bptjm-31	216	8	clinical	clinical	ADJ
bptjm-31	216	9	trials	trial	NOUN
bptjm-31	216	10	are	be	AUX
bptjm-31	216	11	research	research	NOUN
bptjm-31	216	12	alongside	alongside	ADP
bptjm-31	216	13	alzheimer	alzheimer	PROPN
bptjm-31	216	14	's	's	PART
bptjm-31	216	15	disease	disease	NOUN
bptjm-31	216	16	and	and	CCONJ
bptjm-31	216	17	or	or	CCONJ
bptjm-31	216	18	parkinson	parkinson	NOUN
bptjm-31	216	19	’s	’s	PART
bptjm-31	216	20	disease	disease	NOUN
bptjm-31	216	21	so	so	SCONJ
bptjm-31	216	22	there	there	PRON
bptjm-31	216	23	is	be	VERB
bptjm-31	216	24	no	no	DET
bptjm-31	216	25	precise	precise	ADJ
bptjm-31	216	26	way	way	NOUN
bptjm-31	216	27	to	to	PART
bptjm-31	216	28	isolate	isolate	VERB
bptjm-31	216	29	lbd	lbd	PROPN
bptjm-31	216	30	research	research	PROPN
bptjm-31	216	31	and	and	CCONJ
bptjm-31	216	32	progression	progression	NOUN
bptjm-31	216	33	.	.	PUNCT
bptjm-31	217	1	additionally	additionally	ADV
bptjm-31	217	2	,	,	PUNCT
bptjm-31	217	3	many	many	ADJ
bptjm-31	217	4	of	of	ADP
bptjm-31	217	5	the	the	DET
bptjm-31	217	6	clinical	clinical	ADJ
bptjm-31	217	7	trials	trial	NOUN
bptjm-31	217	8	and	and	CCONJ
bptjm-31	217	9	experimental	experimental	ADJ
bptjm-31	217	10	data	datum	NOUN
bptjm-31	217	11	found	find	VERB
bptjm-31	217	12	were	be	AUX
bptjm-31	217	13	said	say	VERB
bptjm-31	217	14	to	to	PART
bptjm-31	217	15	be	be	AUX
bptjm-31	217	16	inconclusive	inconclusive	ADJ
bptjm-31	217	17	as	as	SCONJ
bptjm-31	217	18	the	the	DET
bptjm-31	217	19	data	datum	NOUN
bptjm-31	217	20	was	be	AUX
bptjm-31	217	21	little	little	ADJ
bptjm-31	217	22	or	or	CCONJ
bptjm-31	217	23	had	have	VERB
bptjm-31	217	24	little	little	ADJ
bptjm-31	217	25	to	to	PART
bptjm-31	217	26	no	no	DET
bptjm-31	217	27	value	value	NOUN
bptjm-31	217	28	of	of	ADP
bptjm-31	217	29	measurement	measurement	NOUN
bptjm-31	217	30	.	.	PUNCT
bptjm-31	218	1	protocols	protocol	NOUN
bptjm-31	218	2	on	on	ADP
bptjm-31	218	3	how	how	SCONJ
bptjm-31	218	4	to	to	PART
bptjm-31	218	5	measure	measure	VERB
bptjm-31	218	6	the	the	DET
bptjm-31	218	7	data	datum	NOUN
bptjm-31	218	8	obtained	obtain	VERB
bptjm-31	218	9	in	in	ADP
bptjm-31	218	10	experimental	experimental	ADJ
bptjm-31	218	11	trials	trial	NOUN
bptjm-31	218	12	are	be	AUX
bptjm-31	218	13	still	still	ADV
bptjm-31	218	14	being	be	AUX
bptjm-31	218	15	researched	research	VERB
bptjm-31	218	16	upon	upon	SCONJ
bptjm-31	218	17	.	.	PUNCT
bptjm-31	219	1	to	to	PART
bptjm-31	219	2	combat	combat	VERB
bptjm-31	219	3	these	these	DET
bptjm-31	219	4	terms	term	NOUN
bptjm-31	219	5	,	,	PUNCT
bptjm-31	219	6	this	this	DET
bptjm-31	219	7	article	article	NOUN
bptjm-31	219	8	took	take	VERB
bptjm-31	219	9	a	a	DET
bptjm-31	219	10	holistic	holistic	ADJ
bptjm-31	219	11	review	review	NOUN
bptjm-31	219	12	of	of	ADP
bptjm-31	219	13	each	each	DET
bptjm-31	219	14	article	article	NOUN
bptjm-31	219	15	and	and	CCONJ
bptjm-31	219	16	applied	apply	VERB
bptjm-31	219	17	most	most	ADJ
bptjm-31	219	18	information	information	NOUN
bptjm-31	219	19	back	back	ADV
bptjm-31	219	20	to	to	ADP
bptjm-31	219	21	lbd	lbd	PROPN
bptjm-31	219	22	with	with	ADP
bptjm-31	219	23	reason	reason	NOUN
bptjm-31	219	24	.	.	PUNCT
bptjm-31	220	1	nevertheless	nevertheless	ADV
bptjm-31	220	2	,	,	PUNCT
bptjm-31	220	3	the	the	DET
bptjm-31	220	4	research	research	NOUN
bptjm-31	220	5	presented	present	VERB
bptjm-31	220	6	is	be	AUX
bptjm-31	220	7	to	to	PART
bptjm-31	220	8	enhance	enhance	VERB
bptjm-31	220	9	the	the	DET
bptjm-31	220	10	knowledge	knowledge	NOUN
bptjm-31	220	11	of	of	ADP
bptjm-31	220	12	other	other	ADJ
bptjm-31	220	13	scientists	scientist	NOUN
bptjm-31	220	14	researching	research	VERB
bptjm-31	220	15	lbd	lbd	PROPN
bptjm-31	220	16	therapies	therapy	NOUN
bptjm-31	220	17	to	to	PART
bptjm-31	220	18	give	give	VERB
bptjm-31	220	19	a	a	DET
bptjm-31	220	20	foundation	foundation	NOUN
bptjm-31	220	21	about	about	ADP
bptjm-31	220	22	the	the	DET
bptjm-31	220	23	current	current	ADJ
bptjm-31	220	24	and	and	CCONJ
bptjm-31	220	25	probable	probable	ADJ
bptjm-31	220	26	therapies	therapy	NOUN
bptjm-31	220	27	available	available	ADJ
bptjm-31	220	28	.	.	PUNCT
bptjm-31	221	1	conflicts	conflict	NOUN
bptjm-31	221	2	of	of	ADP
bptjm-31	221	3	interest	interest	NOUN
bptjm-31	221	4	the	the	DET
bptjm-31	221	5	authors	author	NOUN
bptjm-31	221	6	declare	declare	VERB
bptjm-31	221	7	that	that	SCONJ
bptjm-31	221	8	there	there	PRON
bptjm-31	221	9	is	be	VERB
bptjm-31	221	10	no	no	DET
bptjm-31	221	11	conflict	conflict	NOUN
bptjm-31	221	12	of	of	ADP
bptjm-31	221	13	interest	interest	NOUN
bptjm-31	221	14	regarding	regard	VERB
bptjm-31	221	15	the	the	DET
bptjm-31	221	16	publication	publication	NOUN
bptjm-31	221	17	of	of	ADP
bptjm-31	221	18	this	this	DET
bptjm-31	221	19	paper	paper	NOUN
bptjm-31	221	20	.	.	PUNCT
bptjm-31	222	1	references	reference	NOUN
bptjm-31	222	2	1	1	NUM
bptjm-31	222	3	.	.	PUNCT
bptjm-31	222	4	national	national	PROPN
bptjm-31	222	5	institute	institute	PROPN
bptjm-31	222	6	on	on	ADP
bptjm-31	222	7	aging	age	VERB
bptjm-31	222	8	.	.	PUNCT
bptjm-31	223	1	what	what	PRON
bptjm-31	223	2	is	be	AUX
bptjm-31	223	3	lewy	lewy	ADJ
bptjm-31	223	4	body	body	NOUN
bptjm-31	223	5	dementia	dementia	NOUN
bptjm-31	223	6	?	?	PUNCT
bptjm-31	224	1	causes	cause	NOUN
bptjm-31	224	2	,	,	PUNCT
bptjm-31	224	3	symptoms	symptom	NOUN
bptjm-31	224	4	,	,	PUNCT
bptjm-31	224	5	and	and	CCONJ
bptjm-31	224	6	treatments	treatment	NOUN
bptjm-31	224	7	.	.	PUNCT
bptjm-31	225	1	national	national	PROPN
bptjm-31	225	2	institute	institute	PROPN
bptjm-31	225	3	on	on	ADP
bptjm-31	225	4	aging	aging	NOUN
bptjm-31	225	5	.	.	PUNCT
bptjm-31	226	1	published	publish	VERB
bptjm-31	226	2	july	july	PROPN
bptjm-31	226	3	29	29	NUM
bptjm-31	226	4	,	,	PUNCT
bptjm-31	226	5	2021	2021	NUM
bptjm-31	226	6	.	.	PUNCT
bptjm-31	227	1	https://www.nia.nih.gov/health/what-lewy-bo	https://www.nia.nih.gov/health/what-lewy-bo	PROPN
bptjm-31	227	2	dy	dy	NOUN
bptjm-31	227	3	-	-	PUNCT
bptjm-31	227	4	dementia	dementia	NOUN
bptjm-31	227	5	-	-	PUNCT
bptjm-31	227	6	causes	cause	NOUN
bptjm-31	227	7	-	-	PUNCT
bptjm-31	227	8	symptoms	symptom	NOUN
bptjm-31	227	9	-	-	PUNCT
bptjm-31	227	10	and	and	CCONJ
bptjm-31	227	11	-	-	PUNCT
bptjm-31	227	12	treatme	treatme	NOUN
bptjm-31	227	13	nts	nt	NOUN
bptjm-31	227	14	2	2	NUM
bptjm-31	227	15	.	.	PUNCT
bptjm-31	228	1	schumacher	schumacher	PROPN
bptjm-31	228	2	j	j	PROPN
bptjm-31	228	3	,	,	PUNCT
bptjm-31	228	4	peraza	peraza	PROPN
bptjm-31	228	5	lr	lr	PROPN
bptjm-31	228	6	,	,	PUNCT
bptjm-31	228	7	firbank	firbank	PROPN
bptjm-31	228	8	m	m	PROPN
bptjm-31	228	9	,	,	PUNCT
bptjm-31	228	10	et	et	PROPN
bptjm-31	228	11	al	al	PROPN
bptjm-31	228	12	.	.	PROPN
bptjm-31	228	13	dysfunctional	dysfunctional	ADJ
bptjm-31	228	14	brain	brain	NOUN
bptjm-31	228	15	dynamics	dynamic	NOUN
bptjm-31	228	16	and	and	CCONJ
bptjm-31	228	17	their	their	PRON
bptjm-31	228	18	origin	origin	NOUN
bptjm-31	228	19	in	in	ADP
bptjm-31	228	20	lewy	lewy	PROPN
bptjm-31	228	21	body	body	NOUN
bptjm-31	228	22	dementia	dementia	NOUN
bptjm-31	228	23	.	.	PUNCT
bptjm-31	229	1	brain	brain	NOUN
bptjm-31	229	2	.	.	PUNCT
bptjm-31	230	1	2019	2019	NUM
bptjm-31	230	2	;	;	PUNCT
bptjm-31	230	3	142(6):1767	142(6):1767	X
bptjm-31	230	4	-	-	SYM
bptjm-31	230	5	1782	1782	NUM
bptjm-31	230	6	.	.	PUNCT
bptjm-31	231	1	doi:10.1093	doi:10.1093	NOUN
bptjm-31	231	2	/	/	SYM
bptjm-31	231	3	brain	brain	NOUN
bptjm-31	231	4	/	/	SYM
bptjm-31	231	5	awz069	awz069	PROPN
bptjm-31	231	6	3	3	NUM
bptjm-31	231	7	.	.	PUNCT
bptjm-31	231	8	food	food	NOUN
bptjm-31	231	9	and	and	CCONJ
bptjm-31	231	10	drug	drug	NOUN
bptjm-31	231	11	administration	administration	NOUN
bptjm-31	231	12	.	.	PUNCT
bptjm-31	232	1	highlights	highlight	NOUN
bptjm-31	232	2	of	of	ADP
bptjm-31	232	3	prescribing	prescribe	VERB
bptjm-31	232	4	information	information	NOUN
bptjm-31	232	5	.	.	PUNCT
bptjm-31	232	6	;	;	PUNCT
bptjm-31	232	7	2007	2007	NUM
bptjm-31	232	8	.	.	PUNCT
bptjm-31	233	1	https://www.accessdata.fda.gov/drugsatfda_docs	https://www.accessdata.fda.gov/drugsatfda_doc	NOUN
bptjm-31	233	2	/label/2007/022083lbl.pdf	/label/2007/022083lbl.pdf	PUNCT
bptjm-31	233	3	4	4	X
bptjm-31	233	4	.	.	X
bptjm-31	233	5	food	food	NOUN
bptjm-31	233	6	and	and	CCONJ
bptjm-31	233	7	drug	drug	NOUN
bptjm-31	233	8	administration	administration	NOUN
bptjm-31	233	9	.	.	PUNCT
bptjm-31	234	1	sinemet	sinemet	PROPN
bptjm-31	234	2	®	®	PROPN
bptjm-31	234	3	(	(	PUNCT
bptjm-31	234	4	carbidopa	carbidopa	NOUN
bptjm-31	234	5	-	-	PUNCT
bptjm-31	234	6	levodopa	levodopa	NOUN
bptjm-31	234	7	)	)	PUNCT
bptjm-31	234	8	.	.	PUNCT
bptjm-31	234	9	;	;	PUNCT
bptjm-31	234	10	2008	2008	NUM
bptjm-31	234	11	.	.	PUNCT
bptjm-31	235	1	https://www.accessdata.fda.gov/drugsatfda_d	https://www.accessdata.fda.gov/drugsatfda_d	PROPN
bptjm-31	235	2	ocs	ocs	PROPN
bptjm-31	235	3	/	/	SYM
bptjm-31	235	4	label/2008/017555s069lbl.pdf	label/2008/017555s069lbl.pdf	PROPN
bptjm-31	235	5	5	5	NUM
bptjm-31	235	6	.	.	PUNCT
bptjm-31	235	7	tiraboschi	tiraboschi	PROPN
bptjm-31	236	1	p	p	X
bptjm-31	236	2	,	,	PUNCT
bptjm-31	236	3	salmon	salmon	NOUN
bptjm-31	236	4	dp	dp	PROPN
bptjm-31	236	5	,	,	PUNCT
bptjm-31	236	6	hansen	hansen	PROPN
bptjm-31	236	7	la	la	PROPN
bptjm-31	236	8	,	,	PUNCT
bptjm-31	236	9	richard	richard	PROPN
bptjm-31	236	10	c.	c.	PROPN
bptjm-31	236	11	hofstetter	hofstetter	PROPN
bptjm-31	236	12	,	,	PUNCT
bptjm-31	236	13	thal	thal	PROPN
bptjm-31	236	14	lj	lj	PROPN
bptjm-31	236	15	,	,	PUNCT
bptjm-31	236	16	corey	corey	PROPN
bptjm-31	236	17	-	-	PUNCT
bptjm-31	236	18	bloom	bloom	PROPN
bptjm-31	236	19	j	j	PROPN
bptjm-31	236	20	,	,	PUNCT
bptjm-31	236	21	what	what	PRON
bptjm-31	236	22	best	good	ADJ
bptjm-31	236	23	di	di	X
bptjm-31	236	24	�	�	PROPN
bptjm-31	236	25	erentiates	erentiate	VERB
bptjm-31	236	26	lewy	lewy	PROPN
bptjm-31	236	27	body	body	PROPN
bptjm-31	236	28	from	from	ADP
bptjm-31	236	29	alzheimer	alzheimer	PROPN
bptjm-31	236	30	's	's	PART
bptjm-31	236	31	disease	disease	NOUN
bptjm-31	236	32	in	in	ADP
bptjm-31	236	33	early	early	ADJ
bptjm-31	236	34	-	-	PUNCT
bptjm-31	236	35	stage	stage	NOUN
bptjm-31	236	36	dementia	dementia	NOUN
bptjm-31	236	37	?	?	PUNCT
bptjm-31	236	38	,	,	PUNCT
bptjm-31	236	39	brain	brain	NOUN
bptjm-31	236	40	,	,	PUNCT
bptjm-31	236	41	2006;129(3):729	2006;129(3):729	NUM
bptjm-31	236	42	-	-	SYM
bptjm-31	236	43	735	735	NUM
bptjm-31	236	44	.	.	PUNCT
bptjm-31	237	1	https://doi.org/10.1093/brain/awh725	https://doi.org/10.1093/brain/awh725	PROPN
bptjm-31	237	2	6	6	NUM
bptjm-31	237	3	.	.	PUNCT
bptjm-31	238	1	goldman	goldman	PROPN
bptjm-31	238	2	,	,	PUNCT
bptjm-31	238	3	jg	jg	PROPN
bptjm-31	238	4	,	,	PUNCT
bptjm-31	238	5	williams	williams	PROPN
bptjm-31	238	6	-	-	PUNCT
bptjm-31	238	7	gray	gray	ADJ
bptjm-31	238	8	,	,	PUNCT
bptjm-31	238	9	c	c	PROPN
bptjm-31	238	10	,	,	PUNCT
bptjm-31	238	11	barker	barker	PROPN
bptjm-31	238	12	,	,	PUNCT
bptjm-31	238	13	ra	ra	PROPN
bptjm-31	238	14	,	,	PUNCT
bptjm-31	238	15	duda	duda	PROPN
bptjm-31	238	16	,	,	PUNCT
bptjm-31	238	17	je	je	PROPN
bptjm-31	238	18	and	and	CCONJ
bptjm-31	238	19	galvin	galvin	PROPN
bptjm-31	238	20	,	,	PUNCT
bptjm-31	238	21	je	je	PROPN
bptjm-31	238	22	,	,	PUNCT
bptjm-31	238	23	the	the	DET
bptjm-31	238	24	spectrum	spectrum	NOUN
bptjm-31	238	25	of	of	ADP
bptjm-31	238	26	cognitive	cognitive	ADJ
bptjm-31	238	27	impairment	impairment	NOUN
bptjm-31	238	28	in	in	ADP
bptjm-31	238	29	lewy	lewy	ADJ
bptjm-31	238	30	body	body	NOUN
bptjm-31	238	31	diseases	disease	NOUN
bptjm-31	238	32	.	.	PUNCT
bptjm-31	239	1	mov	mov	NOUN
bptjm-31	239	2	disord	disord	NOUN
bptjm-31	239	3	.	.	PUNCT
bptjm-31	239	4	,	,	PUNCT
bptjm-31	239	5	2014;29	2014;29	NUM
bptjm-31	239	6	:	:	PUNCT
bptjm-31	239	7	608	608	NUM
bptjm-31	239	8	-	-	SYM
bptjm-31	239	9	621	621	NUM
bptjm-31	239	10	.	.	PUNCT
bptjm-31	240	1	https://doi.org/10.1002/mds.25866	https://doi.org/10.1002/mds.25866	PROPN
bptjm-31	240	2	7	7	NUM
bptjm-31	240	3	.	.	PUNCT
bptjm-31	240	4	walker	walker	PROPN
bptjm-31	240	5	z	z	PROPN
bptjm-31	240	6	,	,	PUNCT
bptjm-31	240	7	possin	possin	PROPN
bptjm-31	240	8	kl	kl	PROPN
bptjm-31	240	9	,	,	PUNCT
bptjm-31	240	10	boeve	boeve	NOUN
bptjm-31	240	11	bf	bf	NOUN
bptjm-31	240	12	,	,	PUNCT
bptjm-31	240	13	aarsland	aarsland	PROPN
bptjm-31	240	14	d	d	PROPN
bptjm-31	240	15	,	,	PUNCT
bptjm-31	240	16	lewy	lewy	PROPN
bptjm-31	240	17	body	body	NOUN
bptjm-31	240	18	dementias	dementia	VERB
bptjm-31	240	19	,	,	PUNCT
bptjm-31	240	20	the	the	DET
bptjm-31	240	21	lancet	lancet	NOUN
bptjm-31	240	22	,	,	PUNCT
bptjm-31	240	23	2015;386(10004):1683	2015;386(10004):1683	NUM
bptjm-31	240	24	-	-	SYM
bptjm-31	240	25	1697	1697	NUM
bptjm-31	240	26	.	.	PUNCT
bptjm-31	241	1	issn	issn	PROPN
bptjm-31	241	2	0140	0140	NUM
bptjm-31	241	3	-	-	SYM
bptjm-31	241	4	6736	6736	NUM
bptjm-31	241	5	,	,	PUNCT
bptjm-31	241	6	https://doi.org/10.1016/s0140-6736(15)00462-6	https://doi.org/10.1016/s0140-6736(15)00462-6	PROPN
bptjm-31	241	7	.	.	PROPN
bptjm-31	242	1	8	8	NUM
bptjm-31	242	2	.	.	X
bptjm-31	243	1	trojanowski	trojanowski	PROPN
bptjm-31	243	2	j	j	PROPN
bptjm-31	243	3	,	,	PUNCT
bptjm-31	243	4	goedert	goedert	PROPN
bptjm-31	243	5	m	m	PROPN
bptjm-31	243	6	,	,	PUNCT
bptjm-31	243	7	iwatsubo	iwatsubo	ADJ
bptjm-31	243	8	t.	t.	PROPN
bptjm-31	243	9	et	et	PROPN
bptjm-31	243	10	al	al	PROPN
bptjm-31	243	11	.	.	PROPN
bptjm-31	244	1	fatal	fatal	ADJ
bptjm-31	244	2	attractions	attraction	NOUN
bptjm-31	244	3	:	:	PUNCT
bptjm-31	244	4	abnormal	abnormal	ADJ
bptjm-31	244	5	protein	protein	NOUN
bptjm-31	244	6	aggregation	aggregation	NOUN
bptjm-31	244	7	and	and	CCONJ
bptjm-31	244	8	neuron	neuron	PROPN
bptjm-31	244	9	death	death	NOUN
bptjm-31	244	10	in	in	ADP
bptjm-31	244	11	parkinson	parkinson	NOUN
bptjm-31	244	12	's	's	PART
bptjm-31	244	13	disease	disease	NOUN
bptjm-31	244	14	and	and	CCONJ
bptjm-31	244	15	lewy	lewy	ADJ
bptjm-31	244	16	body	body	NOUN
bptjm-31	244	17	dementia	dementia	NOUN
bptjm-31	244	18	.	.	PUNCT
bptjm-31	245	1	cell	cell	NOUN
bptjm-31	245	2	death	death	NOUN
bptjm-31	245	3	differ	differ	VERB
bptjm-31	245	4	5	5	NUM
bptjm-31	245	5	,	,	PUNCT
bptjm-31	245	6	1998;832–837	1998;832–837	NUM
bptjm-31	245	7	.	.	PUNCT
bptjm-31	246	1	https://doi.org/10.1038/sj.cdd.4400432	https://doi.org/10.1038/sj.cdd.4400432	NOUN
bptjm-31	246	2	9	9	NUM
bptjm-31	246	3	.	.	PUNCT
bptjm-31	247	1	beyer	beyer	PROPN
bptjm-31	247	2	k	k	PROPN
bptjm-31	247	3	,	,	PUNCT
bptjm-31	247	4	domingo	domingo	PROPN
bptjm-31	247	5	-	-	PUNCT
bptjm-31	247	6	sàbat	sàbat	NOUN
bptjm-31	247	7	m	m	PROPN
bptjm-31	247	8	,	,	PUNCT
bptjm-31	247	9	ariza	ariza	PROPN
bptjm-31	247	10	a.	a.	PROPN
bptjm-31	247	11	molecular	molecular	PROPN
bptjm-31	247	12	pathology	pathology	NOUN
bptjm-31	247	13	of	of	ADP
bptjm-31	247	14	lewy	lewy	PROPN
bptjm-31	247	15	body	body	NOUN
bptjm-31	247	16	diseases	disease	NOUN
bptjm-31	247	17	.	.	PUNCT
bptjm-31	248	1	international	international	ADJ
bptjm-31	248	2	journal	journal	NOUN
bptjm-31	248	3	of	of	ADP
bptjm-31	248	4	molecular	molecular	ADJ
bptjm-31	248	5	sciences	science	NOUN
bptjm-31	248	6	.	.	PUNCT
bptjm-31	248	7	2009	2009	NUM
bptjm-31	248	8	;	;	PUNCT
bptjm-31	248	9	10(3):724	10(3):724	NUM
bptjm-31	248	10	-	-	SYM
bptjm-31	248	11	745	745	NUM
bptjm-31	248	12	.	.	PUNCT
bptjm-31	249	1	https://doi.org/10.3390/ijms10030724	https://doi.org/10.3390/ijms10030724	PROPN
bptjm-31	249	2	10	10	NUM
bptjm-31	249	3	.	.	PUNCT
bptjm-31	250	1	chia	chia	NOUN
bptjm-31	250	2	r	r	NOUN
bptjm-31	250	3	et	et	PROPN
bptjm-31	250	4	al	al	PROPN
bptjm-31	250	5	.	.	PUNCT
bptjm-31	250	6	genome	genome	NOUN
bptjm-31	250	7	sequencing	sequence	VERB
bptjm-31	250	8	analysis	analysis	NOUN
bptjm-31	250	9	identi	identi	X
bptjm-31	250	10	�	�	NOUN
bptjm-31	250	11	es	es	ADJ
bptjm-31	250	12	new	new	ADJ
bptjm-31	250	13	loci	loci	NOUN
bptjm-31	250	14	associated	associate	VERB
bptjm-31	250	15	with	with	ADP
bptjm-31	250	16	lewy	lewy	PROPN
bptjm-31	250	17	body	body	NOUN
bptjm-31	250	18	dementia	dementia	NOUN
bptjm-31	250	19	and	and	CCONJ
bptjm-31	250	20	provides	provide	VERB
bptjm-31	250	21	insights	insight	NOUN
bptjm-31	250	22	into	into	ADP
bptjm-31	250	23	the	the	DET
bptjm-31	250	24	complex	complex	ADJ
bptjm-31	250	25	genetic	genetic	ADJ
bptjm-31	250	26	architecture	architecture	NOUN
bptjm-31	250	27	.	.	PUNCT
bptjm-31	251	1	nature	nature	NOUN
bptjm-31	251	2	genetics	genetic	NOUN
bptjm-31	251	3	,	,	PUNCT
bptjm-31	251	4	2021	2021	NUM
bptjm-31	251	5	.	.	PUNCT
bptjm-31	252	1	https://doi	https://doi	ADJ
bptjm-31	252	2	:	:	PUNCT
bptjm-31	252	3	10.1038	10.1038	NUM
bptjm-31	252	4	/	/	SYM
bptjm-31	252	5	s41588	s41588	VERB
bptjm-31	252	6	-	-	PUNCT
bptjm-31	252	7	021	021	NUM
bptjm-31	252	8	-	-	PUNCT
bptjm-31	252	9	00785	00785	NUM
bptjm-31	252	10	-	-	SYM
bptjm-31	252	11	3	3	NUM
bptjm-31	252	12	11	11	NUM
bptjm-31	252	13	.	.	PUNCT
bptjm-31	253	1	takahashi	takahashi	PROPN
bptjm-31	253	2	h	h	PROPN
bptjm-31	253	3	and	and	CCONJ
bptjm-31	253	4	wakabayashi	wakabayashi	PROPN
bptjm-31	253	5	k.	k.	PROPN
bptjm-31	254	1	the	the	DET
bptjm-31	254	2	cellular	cellular	ADJ
bptjm-31	254	3	pathology	pathology	NOUN
bptjm-31	254	4	of	of	ADP
bptjm-31	254	5	parkinson	parkinson	NOUN
bptjm-31	254	6	's	's	PART
bptjm-31	254	7	disease	disease	NOUN
bptjm-31	254	8	.	.	PUNCT
bptjm-31	255	1	neuropathology	neuropathology	NOUN
bptjm-31	255	2	.	.	PUNCT
bptjm-31	256	1	2001;21:315	2001;21:315	PROPN
bptjm-31	256	2	-	-	SYM
bptjm-31	256	3	322	322	NUM
bptjm-31	256	4	.	.	PUNCT
bptjm-31	257	1	https://doi.org/10.1046/j.1440-1789.2001.004	https://doi.org/10.1046/j.1440-1789.2001.004	VERB
bptjm-31	257	2	03.x	03.x	NOUN
bptjm-31	257	3	12	12	NUM
bptjm-31	257	4	.	.	PUNCT
bptjm-31	258	1	urbizu	urbizu	PROPN
bptjm-31	258	2	a	a	PROPN
bptjm-31	258	3	,	,	PUNCT
bptjm-31	258	4	beyer	beyer	PROPN
bptjm-31	258	5	k.	k.	PROPN
bptjm-31	258	6	epigenetics	epigenetics	PROPN
bptjm-31	258	7	in	in	ADP
bptjm-31	258	8	lewy	lewy	ADJ
bptjm-31	258	9	body	body	NOUN
bptjm-31	258	10	diseases	disease	NOUN
bptjm-31	258	11	:	:	PUNCT
bptjm-31	258	12	impact	impact	NOUN
bptjm-31	258	13	on	on	ADP
bptjm-31	258	14	gene	gene	NOUN
bptjm-31	258	15	expression	expression	NOUN
bptjm-31	258	16	,	,	PUNCT
bptjm-31	258	17	utility	utility	NOUN
bptjm-31	258	18	as	as	ADP
bptjm-31	258	19	a	a	DET
bptjm-31	258	20	biomarker	biomarker	NOUN
bptjm-31	258	21	,	,	PUNCT
bptjm-31	258	22	and	and	CCONJ
bptjm-31	258	23	possibilities	possibility	NOUN
bptjm-31	258	24	for	for	ADP
bptjm-31	258	25	therapy	therapy	NOUN
bptjm-31	258	26	.	.	PUNCT
bptjm-31	259	1	int	int	PROPN
bptjm-31	259	2	j	j	PROPN
bptjm-31	259	3	mol	mol	ADP
bptjm-31	259	4	sci	sci	PROPN
bptjm-31	259	5	.	.	PUNCT
bptjm-31	260	1	2020;21(13):4718	2020;21(13):4718	PROPN
bptjm-31	260	2	.	.	PUNCT
bptjm-31	260	3	published	publish	VERB
bptjm-31	260	4	2020	2020	NUM
bptjm-31	260	5	jul	jul	PROPN
bptjm-31	260	6	2	2	NUM
bptjm-31	260	7	.	.	PUNCT
bptjm-31	261	1	doi:10.3390	doi:10.3390	NOUN
bptjm-31	261	2	/	/	SYM
bptjm-31	261	3	ijms21134718	ijms21134718	PROPN
bptjm-31	261	4	13	13	NUM
bptjm-31	261	5	.	.	PUNCT
bptjm-31	262	1	chouliaras	chouliaras	PROPN
bptjm-31	262	2	l	l	PROPN
bptjm-31	262	3	,	,	PUNCT
bptjm-31	262	4	kumar	kumar	PROPN
bptjm-31	262	5	gs	gs	PROPN
bptjm-31	262	6	,	,	PUNCT
bptjm-31	262	7	thomas	thomas	PROPN
bptjm-31	262	8	aj	aj	PROPN
bptjm-31	262	9	,	,	PUNCT
bptjm-31	262	10	lunnon	lunnon	PROPN
bptjm-31	262	11	k	k	PROPN
bptjm-31	262	12	,	,	PUNCT
bptjm-31	262	13	chinnery	chinnery	PROPN
bptjm-31	262	14	pf	pf	PROPN
bptjm-31	262	15	,	,	PUNCT
bptjm-31	262	16	o'brien	o'brien	PROPN
bptjm-31	262	17	jt	jt	PROPN
bptjm-31	262	18	.	.	PUNCT
bptjm-31	263	1	epigenetic	epigenetic	ADJ
bptjm-31	263	2	regulation	regulation	NOUN
bptjm-31	263	3	in	in	ADP
bptjm-31	263	4	the	the	DET
bptjm-31	263	5	pathophysiology	pathophysiology	NOUN
bptjm-31	263	6	of	of	ADP
bptjm-31	263	7	lewy	lewy	PROPN
bptjm-31	263	8	body	body	NOUN
bptjm-31	263	9	dementia	dementia	NOUN
bptjm-31	263	10	.	.	PUNCT
bptjm-31	264	1	prog	prog	PROPN
bptjm-31	264	2	neurobiol	neurobiol	PROPN
bptjm-31	264	3	.	.	PUNCT
bptjm-31	265	1	13	13	NUM
bptjm-31	265	2	.	.	X
bptjm-31	266	1	2020;192:101822	2020;192:101822	NUM
bptjm-31	266	2	.	.	PUNCT
bptjm-31	267	1	doi:10.1016	doi:10.1016	PROPN
bptjm-31	267	2	/	/	SYM
bptjm-31	267	3	j.pneurobio.2020.101822	j.pneurobio.2020.101822	NOUN
bptjm-31	267	4	14	14	NUM
bptjm-31	267	5	.	.	PUNCT
bptjm-31	268	1	coppedè	coppedè	PROPN
bptjm-31	268	2	f.	f.	PROPN
bptjm-31	269	1	the	the	DET
bptjm-31	269	2	potential	potential	NOUN
bptjm-31	269	3	of	of	ADP
bptjm-31	269	4	epigenetic	epigenetic	ADJ
bptjm-31	269	5	therapies	therapy	NOUN
bptjm-31	269	6	in	in	ADP
bptjm-31	269	7	neurodegenerative	neurodegenerative	ADJ
bptjm-31	269	8	diseases	disease	NOUN
bptjm-31	269	9	.	.	PUNCT
bptjm-31	270	1	front	front	ADJ
bptjm-31	270	2	berkeley	berkeley	PROPN
bptjm-31	270	3	pharma	pharma	PROPN
bptjm-31	270	4	tech	tech	NOUN
bptjm-31	270	5	journal	journal	NOUN
bptjm-31	270	6	of	of	ADP
bptjm-31	270	7	medicine	medicine	NOUN
bptjm-31	270	8	|	|	ADV
bptjm-31	270	9	17	17	NUM
bptjm-31	270	10	genet	genet	NOUN
bptjm-31	270	11	.	.	PUNCT
bptjm-31	271	1	2014;5:220	2014;5:220	X
bptjm-31	271	2	.	.	PROPN
bptjm-31	272	1	published	publish	VERB
bptjm-31	272	2	2014	2014	NUM
bptjm-31	272	3	jul	jul	PROPN
bptjm-31	272	4	14	14	NUM
bptjm-31	272	5	.	.	PUNCT
bptjm-31	273	1	doi:10.3389	doi:10.3389	NOUN
bptjm-31	273	2	/	/	SYM
bptjm-31	273	3	fgene.2014.00220	fgene.2014.00220	ADJ
bptjm-31	273	4	15	15	NUM
bptjm-31	273	5	.	.	PUNCT
bptjm-31	274	1	joshi	joshi	PROPN
bptjm-31	274	2	p.	p.	PROPN
bptjm-31	274	3	a	a	DET
bptjm-31	274	4	review	review	NOUN
bptjm-31	274	5	on	on	ADP
bptjm-31	274	6	natural	natural	ADJ
bptjm-31	274	7	memory	memory	NOUN
bptjm-31	274	8	enhancers	enhancer	NOUN
bptjm-31	274	9	(	(	PUNCT
bptjm-31	274	10	nootropics	nootropic	NOUN
bptjm-31	274	11	)	)	PUNCT
bptjm-31	274	12	.	.	PUNCT
bptjm-31	275	1	unique	unique	ADJ
bptjm-31	275	2	journal	journal	NOUN
bptjm-31	275	3	of	of	ADP
bptjm-31	275	4	engineering	engineering	NOUN
bptjm-31	275	5	and	and	CCONJ
bptjm-31	275	6	advanced	advanced	ADJ
bptjm-31	275	7	sciences	science	NOUN
bptjm-31	275	8	.	.	PUNCT
bptjm-31	276	1	2013;1(1):8	2013;1(1):8	PROPN
bptjm-31	276	2	-	-	PUNCT
bptjm-31	276	3	18	18	NUM
bptjm-31	276	4	.	.	PUNCT
bptjm-31	276	5	accessed	access	VERB
bptjm-31	276	6	july	july	PROPN
bptjm-31	276	7	25	25	NUM
bptjm-31	276	8	,	,	PUNCT
bptjm-31	276	9	2022	2022	NUM
bptjm-31	276	10	.	.	PUNCT
bptjm-31	277	1	http://ujconline.net/wp-content/uploads/2013/	http://ujconline.net/wp-content/uploads/2013/	ADJ
bptjm-31	277	2	09/3	09/3	ADJ
bptjm-31	277	3	-	-	PUNCT
bptjm-31	277	4	ujeas-1314	ujeas-1314	ADJ
bptjm-31	277	5	-	-	PUNCT
bptjm-31	277	6	rv.pdf	rv.pdf	ADJ
bptjm-31	277	7	16	16	NUM
bptjm-31	277	8	.	.	PUNCT
bptjm-31	278	1	gouliaev	gouliaev	PROPN
bptjm-31	278	2	ah	ah	INTJ
bptjm-31	278	3	,	,	PUNCT
bptjm-31	278	4	senning	senne	VERB
bptjm-31	278	5	a.	a.	NOUN
bptjm-31	278	6	piracetam	piracetam	NOUN
bptjm-31	278	7	and	and	CCONJ
bptjm-31	278	8	other	other	ADJ
bptjm-31	278	9	structurally	structurally	ADV
bptjm-31	278	10	related	relate	VERB
bptjm-31	278	11	nootropics	nootropic	NOUN
bptjm-31	278	12	.	.	PUNCT
bptjm-31	279	1	brain	brain	NOUN
bptjm-31	279	2	research	research	NOUN
bptjm-31	279	3	reviews	review	NOUN
bptjm-31	279	4	.	.	PUNCT
bptjm-31	280	1	1994;19(2):180	1994;19(2):180	NUM
bptjm-31	280	2	-	-	PUNCT
bptjm-31	280	3	222	222	NUM
bptjm-31	280	4	.	.	PUNCT
bptjm-31	281	1	doi:10.1016/0165	doi:10.1016/0165	NOUN
bptjm-31	281	2	-	-	PUNCT
bptjm-31	281	3	0173(94)90011	0173(94)90011	NUM
bptjm-31	281	4	-	-	PUNCT
bptjm-31	281	5	6	6	NUM
bptjm-31	281	6	17	17	NUM
bptjm-31	281	7	.	.	PUNCT
bptjm-31	282	1	smith	smith	PROPN
bptjm-31	282	2	me	i	PRON
bptjm-31	282	3	,	,	PUNCT
bptjm-31	282	4	farah	farah	PROPN
bptjm-31	282	5	mj	mj	PROPN
bptjm-31	282	6	.	.	PROPN
bptjm-31	282	7	are	be	AUX
bptjm-31	282	8	prescription	prescription	NOUN
bptjm-31	282	9	stimulants	stimulant	NOUN
bptjm-31	282	10	"	"	PUNCT
bptjm-31	282	11	smart	smart	ADJ
bptjm-31	282	12	pills	pill	NOUN
bptjm-31	282	13	"	"	PUNCT
bptjm-31	282	14	?	?	PUNCT
bptjm-31	283	1	the	the	DET
bptjm-31	283	2	epidemiology	epidemiology	NOUN
bptjm-31	283	3	and	and	CCONJ
bptjm-31	283	4	cognitive	cognitive	ADJ
bptjm-31	283	5	neuroscience	neuroscience	NOUN
bptjm-31	283	6	of	of	ADP
bptjm-31	283	7	prescription	prescription	NOUN
bptjm-31	283	8	stimulant	stimulant	ADJ
bptjm-31	283	9	use	use	NOUN
bptjm-31	283	10	by	by	ADP
bptjm-31	283	11	normal	normal	ADJ
bptjm-31	283	12	healthy	healthy	ADJ
bptjm-31	283	13	individuals	individual	NOUN
bptjm-31	283	14	.	.	PUNCT
bptjm-31	284	1	psychol	psychol	NOUN
bptjm-31	284	2	bull	bull	PROPN
bptjm-31	284	3	.	.	PUNCT
bptjm-31	285	1	2011;137(5):717	2011;137(5):717	NUM
bptjm-31	285	2	-	-	SYM
bptjm-31	285	3	741	741	NUM
bptjm-31	285	4	.	.	PUNCT
bptjm-31	286	1	doi:10.1037	doi:10.1037	NOUN
bptjm-31	286	2	/	/	SYM
bptjm-31	286	3	a0023825	a0023825	PROPN
bptjm-31	286	4	18	18	NUM
bptjm-31	286	5	.	.	PUNCT
bptjm-31	287	1	tricco	tricco	PROPN
bptjm-31	287	2	ac	ac	PROPN
bptjm-31	287	3	,	,	PUNCT
bptjm-31	287	4	vandervaart	vandervaart	NOUN
bptjm-31	287	5	s	s	PROPN
bptjm-31	287	6	,	,	PUNCT
bptjm-31	287	7	soobiah	soobiah	PROPN
bptjm-31	287	8	c	c	AUX
bptjm-31	287	9	,	,	PUNCT
bptjm-31	287	10	et	et	PROPN
bptjm-31	287	11	al	al	PROPN
bptjm-31	287	12	.	.	PUNCT
bptjm-31	288	1	e	e	X
bptjm-31	288	2	�	�	PROPN
bptjm-31	288	3	cacy	cacy	NOUN
bptjm-31	288	4	of	of	ADP
bptjm-31	288	5	cognitive	cognitive	ADJ
bptjm-31	288	6	enhancers	enhancer	NOUN
bptjm-31	288	7	for	for	ADP
bptjm-31	288	8	alzheimer	alzheimer	PROPN
bptjm-31	288	9	's	's	PART
bptjm-31	288	10	disease	disease	NOUN
bptjm-31	288	11	:	:	PUNCT
bptjm-31	288	12	protocol	protocol	NOUN
bptjm-31	288	13	for	for	ADP
bptjm-31	288	14	a	a	DET
bptjm-31	288	15	systematic	systematic	ADJ
bptjm-31	288	16	review	review	NOUN
bptjm-31	288	17	and	and	CCONJ
bptjm-31	288	18	network	network	NOUN
bptjm-31	288	19	meta	meta	ADJ
bptjm-31	288	20	-	-	PUNCT
bptjm-31	288	21	analysis	analysis	NOUN
bptjm-31	288	22	.	.	PUNCT
bptjm-31	289	1	syst	syst	PROPN
bptjm-31	289	2	rev	rev	PROPN
bptjm-31	289	3	.	.	PROPN
bptjm-31	289	4	2012;1:31	2012;1:31	PROPN
bptjm-31	289	5	.	.	PUNCT
bptjm-31	290	1	published	publish	VERB
bptjm-31	290	2	2012	2012	NUM
bptjm-31	290	3	jun	jun	PROPN
bptjm-31	290	4	28	28	NUM
bptjm-31	290	5	.	.	PUNCT
bptjm-31	291	1	doi:10.1186/2046	doi:10.1186/2046	NOUN
bptjm-31	291	2	-	-	PUNCT
bptjm-31	291	3	4053	4053	NUM
bptjm-31	291	4	-	-	PUNCT
bptjm-31	291	5	1	1	NUM
bptjm-31	291	6	-	-	SYM
bptjm-31	291	7	31	31	NUM
bptjm-31	291	8	19	19	NUM
bptjm-31	291	9	.	.	PUNCT
bptjm-31	292	1	fernandes	fernandes	PROPN
bptjm-31	292	2	c.	c.	PROPN
bptjm-31	292	3	which	which	DET
bptjm-31	292	4	cognitive	cognitive	ADJ
bptjm-31	292	5	medication	medication	NOUN
bptjm-31	292	6	delivery	delivery	NOUN
bptjm-31	292	7	is	be	AUX
bptjm-31	292	8	more	more	ADJ
bptjm-31	292	9	e	e	NOUN
bptjm-31	292	10	�	�	NOUN
bptjm-31	292	11	ective?lbda	ective?lbda	NOUN
bptjm-31	292	12	.	.	PUNCT
bptjm-31	293	1	lewy	lewy	PROPN
bptjm-31	293	2	19	19	NUM
bptjm-31	293	3	.	.	PUNCT
bptjm-31	293	4	body	body	NOUN
bptjm-31	293	5	dementia	dementia	PROPN
bptjm-31	293	6	association	association	PROPN
bptjm-31	293	7	.	.	PUNCT
bptjm-31	294	1	published	publish	VERB
bptjm-31	294	2	october	october	PROPN
bptjm-31	294	3	23	23	NUM
bptjm-31	294	4	,	,	PUNCT
bptjm-31	294	5	2013	2013	NUM
bptjm-31	294	6	.	.	PUNCT
bptjm-31	295	1	accessed	access	VERB
bptjm-31	295	2	july	july	PROPN
bptjm-31	295	3	26	26	NUM
bptjm-31	295	4	,	,	PUNCT
bptjm-31	295	5	2022	2022	NUM
bptjm-31	295	6	.	.	PUNCT
bptjm-31	296	1	19	19	NUM
bptjm-31	296	2	.	.	X
bptjm-31	297	1	https://www.lbda.org/ask-the-expert-which-cogniti	https://www.lbda.org/ask-the-expert-which-cogniti	PROPN
bptjm-31	297	2	ve	ve	PROPN
bptjm-31	297	3	-	-	PUNCT
bptjm-31	297	4	medication	medication	NOUN
bptjm-31	297	5	-	-	PUNCT
bptjm-31	297	6	delivery	delivery	NOUN
bptjm-31	297	7	-	-	PUNCT
bptjm-31	297	8	is	be	AUX
bptjm-31	297	9	-	-	PUNCT
bptjm-31	297	10	more	more	ADJ
bptjm-31	297	11	-	-	PUNCT
bptjm-31	297	12	e	e	NOUN
bptjm-31	297	13	�	�	NOUN
bptjm-31	297	14	ecti	ecti	ADJ
bptjm-31	297	15	ve	ve	NOUN
bptjm-31	297	16	-	-	PUNCT
bptjm-31	297	17	a	a	DET
bptjm-31	297	18	-	-	PUNCT
bptjm-31	297	19	patch	patch	NOUN
bptjm-31	297	20	-	-	PUNCT
bptjm-31	297	21	or	or	CCONJ
bptjm-31	297	22	-	-	PUNCT
bptjm-31	297	23	pill/#:~:text	pill/#:~:text	NOUN
bptjm-31	297	24	=	=	NOUN
bptjm-31	297	25	studies%20of%20the%2	studies%20of%20the%2	ADJ
bptjm-31	297	26	0e	0e	NOUN
bptjm-31	297	27	�	�	NOUN
bptjm-31	297	28	ectiveness%20of	ectiveness%20of	NOUN
bptjm-31	297	29	20	20	NUM
bptjm-31	297	30	.	.	PUNCT
bptjm-31	298	1	ayers	ayers	PROPN
bptjm-31	298	2	d	d	PROPN
bptjm-31	298	3	,	,	PUNCT
bptjm-31	298	4	scerri	scerri	PROPN
bptjm-31	298	5	c.	c.	PROPN
bptjm-31	298	6	non	non	ADJ
bptjm-31	298	7	-	-	ADJ
bptjm-31	298	8	coding	code	VERB
bptjm-31	298	9	rna	rna	NOUN
bptjm-31	298	10	in	in	ADP
bptjm-31	298	11	�	�	NOUN
bptjm-31	298	12	uences	uence	NOUN
bptjm-31	298	13	in	in	ADP
bptjm-31	298	14	dementia	dementia	NOUN
bptjm-31	298	15	.	.	PUNCT
bptjm-31	299	1	noncoding	noncode	VERB
bptjm-31	299	2	rna	rna	NOUN
bptjm-31	299	3	res	re	NOUN
bptjm-31	299	4	.	.	PUNCT
bptjm-31	300	1	2018;3(4):188	2018;3(4):188	NUM
bptjm-31	300	2	-	-	SYM
bptjm-31	300	3	194	194	NUM
bptjm-31	300	4	.	.	PUNCT
bptjm-31	301	1	published	publish	VERB
bptjm-31	301	2	2018	2018	NUM
bptjm-31	301	3	sep	sep	PROPN
bptjm-31	301	4	29	29	NUM
bptjm-31	301	5	.	.	PUNCT
bptjm-31	302	1	doi:10.1016	doi:10.1016	PROPN
bptjm-31	302	2	/	/	SYM
bptjm-31	302	3	j.ncrna.2018.09.002	j.ncrna.2018.09.002	PROPN
bptjm-31	302	4	21	21	NUM
bptjm-31	302	5	.	.	PUNCT
bptjm-31	303	1	nguyen	nguyen	PROPN
bptjm-31	303	2	ld	ld	PROPN
bptjm-31	303	3	,	,	PUNCT
bptjm-31	303	4	chau	chau	VERB
bptjm-31	303	5	rk	rk	PRON
bptjm-31	303	6	,	,	PUNCT
bptjm-31	303	7	krichevsky	krichevsky	PROPN
bptjm-31	303	8	am	be	AUX
bptjm-31	303	9	.	.	PUNCT
bptjm-31	304	1	small	small	ADJ
bptjm-31	304	2	molecule	molecule	NOUN
bptjm-31	304	3	drugs	drug	NOUN
bptjm-31	304	4	targeting	target	VERB
bptjm-31	304	5	non	non	ADJ
bptjm-31	304	6	-	-	ADJ
bptjm-31	304	7	coding	coding	ADJ
bptjm-31	304	8	rnas	rna	NOUN
bptjm-31	304	9	as	as	ADP
bptjm-31	304	10	treatments	treatment	NOUN
bptjm-31	304	11	for	for	ADP
bptjm-31	304	12	alzheimer	alzheimer	PROPN
bptjm-31	304	13	's	's	PART
bptjm-31	304	14	disease	disease	NOUN
bptjm-31	304	15	and	and	CCONJ
bptjm-31	304	16	related	related	ADJ
bptjm-31	304	17	dementias	dementia	NOUN
bptjm-31	304	18	.	.	PUNCT
bptjm-31	305	1	genes	gene	NOUN
bptjm-31	305	2	(	(	PUNCT
bptjm-31	305	3	basel	basel	PROPN
bptjm-31	305	4	)	)	PUNCT
bptjm-31	305	5	.	.	PUNCT
bptjm-31	306	1	2021;12(12):2005	2021;12(12):2005	NUM
bptjm-31	306	2	.	.	PUNCT
bptjm-31	306	3	published	publish	VERB
bptjm-31	306	4	2021	2021	NUM
bptjm-31	306	5	dec	dec	PROPN
bptjm-31	306	6	17	17	NUM
bptjm-31	306	7	.	.	PUNCT
bptjm-31	307	1	doi:10.3390	doi:10.3390	PROPN
bptjm-31	307	2	/	/	SYM
bptjm-31	307	3	genes12122005	genes12122005	PROPN
bptjm-31	307	4	22	22	NUM
bptjm-31	307	5	.	.	PUNCT
bptjm-31	308	1	watson	watson	PROPN
bptjm-31	308	2	cn	cn	PROPN
bptjm-31	308	3	,	,	PUNCT
bptjm-31	308	4	belli	belli	PROPN
bptjm-31	308	5	a	a	PROPN
bptjm-31	308	6	,	,	PUNCT
bptjm-31	308	7	di	di	NOUN
bptjm-31	308	8	pietro	pietro	NOUN
bptjm-31	308	9	v.	v.	ADP
bptjm-31	308	10	small	small	ADJ
bptjm-31	308	11	non	non	ADJ
bptjm-31	308	12	-	-	ADJ
bptjm-31	308	13	coding	coding	ADJ
bptjm-31	308	14	rnas	rna	NOUN
bptjm-31	308	15	:	:	PUNCT
bptjm-31	308	16	new	new	ADJ
bptjm-31	308	17	class	class	NOUN
bptjm-31	308	18	of	of	ADP
bptjm-31	308	19	biomarkers	biomarker	NOUN
bptjm-31	308	20	and	and	CCONJ
bptjm-31	308	21	potential	potential	ADJ
bptjm-31	308	22	therapeutic	therapeutic	ADJ
bptjm-31	308	23	targets	target	NOUN
bptjm-31	308	24	in	in	ADP
bptjm-31	308	25	neurodegenerative	neurodegenerative	ADJ
bptjm-31	308	26	disease	disease	NOUN
bptjm-31	308	27	.	.	PUNCT
bptjm-31	309	1	front	front	ADJ
bptjm-31	309	2	genet	genet	PROPN
bptjm-31	309	3	.	.	PUNCT
bptjm-31	310	1	22	22	NUM
bptjm-31	310	2	.	.	PUNCT
bptjm-31	311	1	2019;10:364	2019;10:364	X
bptjm-31	311	2	.	.	PUNCT
bptjm-31	312	1	published	publish	VERB
bptjm-31	312	2	2019	2019	NUM
bptjm-31	312	3	apr	apr	NOUN
bptjm-31	312	4	26	26	NUM
bptjm-31	312	5	.	.	PUNCT
bptjm-31	312	6	doi:10.3389	doi:10.3389	NOUN
bptjm-31	312	7	/	/	SYM
bptjm-31	312	8	fgene.2019.00364	fgene.2019.00364	PROPN
bptjm-31	312	9	23	23	NUM
bptjm-31	312	10	.	.	PUNCT
bptjm-31	313	1	koyama	koyama	PROPN
bptjm-31	313	2	a	a	DET
bptjm-31	313	3	,	,	PUNCT
bptjm-31	313	4	hashimoto	hashimoto	NOUN
bptjm-31	313	5	m	m	PROPN
bptjm-31	313	6	,	,	PUNCT
bptjm-31	313	7	tanaka	tanaka	PROPN
bptjm-31	313	8	h	h	PROPN
bptjm-31	313	9	,	,	PUNCT
bptjm-31	313	10	et	et	PROPN
bptjm-31	313	11	al	al	PROPN
bptjm-31	313	12	.	.	PROPN
bptjm-31	313	13	malnutrition	malnutrition	PROPN
bptjm-31	313	14	in	in	ADP
bptjm-31	313	15	alzheimer	alzheimer	PROPN
bptjm-31	313	16	's	's	PART
bptjm-31	313	17	disease	disease	NOUN
bptjm-31	313	18	,	,	PUNCT
bptjm-31	313	19	dementia	dementia	NOUN
bptjm-31	313	20	with	with	ADP
bptjm-31	313	21	lewy	lewy	PROPN
bptjm-31	313	22	bodies	body	NOUN
bptjm-31	313	23	,	,	PUNCT
bptjm-31	313	24	and	and	CCONJ
bptjm-31	313	25	frontotemporal	frontotemporal	ADJ
bptjm-31	313	26	lobar	lobar	ADJ
bptjm-31	313	27	degeneration	degeneration	NOUN
bptjm-31	313	28	:	:	PUNCT
bptjm-31	313	29	comparison	comparison	NOUN
bptjm-31	313	30	using	use	VERB
bptjm-31	313	31	serum	serum	NOUN
bptjm-31	313	32	albumin	albumin	NOUN
bptjm-31	313	33	,	,	PUNCT
bptjm-31	313	34	total	total	ADJ
bptjm-31	313	35	protein	protein	NOUN
bptjm-31	313	36	,	,	PUNCT
bptjm-31	313	37	and	and	CCONJ
bptjm-31	313	38	hemoglobin	hemoglobin	NOUN
bptjm-31	313	39	level	level	NOUN
bptjm-31	313	40	.	.	PUNCT
bptjm-31	314	1	plos	plos	PROPN
bptjm-31	314	2	one	one	NUM
bptjm-31	314	3	.	.	PUNCT
bptjm-31	315	1	2016;11(6):e0157053	2016;11(6):e0157053	NUM
bptjm-31	315	2	.	.	PUNCT
bptjm-31	316	1	published	publish	VERB
bptjm-31	316	2	2016	2016	NUM
bptjm-31	316	3	jun	jun	PROPN
bptjm-31	316	4	23	23	NUM
bptjm-31	316	5	.	.	PUNCT
bptjm-31	317	1	doi:10.1371	doi:10.1371	PROPN
bptjm-31	317	2	/	/	PUNCT
bptjm-31	318	1	journal.pone.0157053	journal.pone.0157053	PROPN
bptjm-31	318	2	24	24	NUM
bptjm-31	318	3	.	.	PUNCT
bptjm-31	319	1	dominguez	dominguez	PROPN
bptjm-31	319	2	lj	lj	PROPN
bptjm-31	319	3	,	,	PUNCT
bptjm-31	319	4	barbagallo	barbagallo	PROPN
bptjm-31	319	5	m.	m.	NOUN
bptjm-31	319	6	nutritional	nutritional	PROPN
bptjm-31	319	7	prevention	prevention	NOUN
bptjm-31	319	8	of	of	ADP
bptjm-31	319	9	cognitive	cognitive	ADJ
bptjm-31	319	10	decline	decline	NOUN
bptjm-31	319	11	and	and	CCONJ
bptjm-31	319	12	dementia	dementia	NOUN
bptjm-31	319	13	.	.	PUNCT
bptjm-31	320	1	24	24	NUM
bptjm-31	320	2	.	.	PUNCT
bptjm-31	321	1	acta	acta	PROPN
bptjm-31	321	2	biomed	biome	VERB
bptjm-31	321	3	.	.	PUNCT
bptjm-31	322	1	2018;89(2):276	2018;89(2):276	NUM
bptjm-31	322	2	-	-	SYM
bptjm-31	322	3	290	290	NUM
bptjm-31	322	4	.	.	PUNCT
bptjm-31	323	1	published	publish	VERB
bptjm-31	323	2	2018	2018	NUM
bptjm-31	323	3	jun	jun	PROPN
bptjm-31	323	4	7	7	NUM
bptjm-31	323	5	.	.	PUNCT
bptjm-31	323	6	doi:10.23750	doi:10.23750	PROPN
bptjm-31	323	7	/	/	SYM
bptjm-31	323	8	abm.v89i2.7401	abm.v89i2.7401	PROPN
bptjm-31	323	9	25	25	NUM
bptjm-31	323	10	.	.	PUNCT
bptjm-31	323	11	mrak	mrak	PROPN
bptjm-31	323	12	re	re	PROPN
bptjm-31	323	13	,	,	PUNCT
bptjm-31	323	14	md	md	PROPN
bptjm-31	323	15	,	,	PUNCT
bptjm-31	323	16	w.	w.	PROPN
bptjm-31	323	17	sue	sue	PROPN
bptjm-31	323	18	t.	t.	PROPN
bptjm-31	323	19	gri	gri	PROPN
bptjm-31	323	20	�	�	PROPN
bptjm-31	323	21	n	n	PROPN
bptjm-31	323	22	wst	wst	PROPN
bptjm-31	323	23	.	.	PUNCT
bptjm-31	324	1	common	common	ADJ
bptjm-31	324	2	in	in	ADP
bptjm-31	324	3	�	�	NOUN
bptjm-31	324	4	ammatory	ammatory	NOUN
bptjm-31	324	5	mechanisms	mechanism	NOUN
bptjm-31	324	6	in	in	ADP
bptjm-31	324	7	lewy	lewy	ADJ
bptjm-31	324	8	body	body	NOUN
bptjm-31	324	9	disease	disease	NOUN
bptjm-31	324	10	and	and	CCONJ
bptjm-31	324	11	alzheimer	alzheimer	PROPN
bptjm-31	324	12	disease	disease	NOUN
bptjm-31	324	13	.	.	PUNCT
bptjm-31	325	1	journ	journ	PROPN
bptjm-31	325	2	neuropath	neuropath	NOUN
bptjm-31	325	3	&	&	CCONJ
bptjm-31	325	4	exp	exp	NOUN
bptjm-31	325	5	neur	neur	PROPN
bptjm-31	325	6	.	.	PUNCT
bptjm-31	326	1	2007;66(8):683	2007;66(8):683	NUM
bptjm-31	326	2	-	-	PUNCT
bptjm-31	326	3	686	686	NUM
bptjm-31	326	4	.	.	PUNCT
bptjm-31	327	1	https://doi.org/10.1097/nen.0b013e31812503e	https://doi.org/10.1097/nen.0b013e31812503e	NOUN
bptjm-31	327	2	1	1	NUM
bptjm-31	327	3	26	26	NUM
bptjm-31	327	4	.	.	PUNCT
bptjm-31	328	1	brendon	brendon	PROPN
bptjm-31	328	2	p.	p.	PROPN
bptjm-31	328	3	boot	boot	PROPN
bptjm-31	328	4	,	,	PUNCT
bptjm-31	328	5	carolyn	carolyn	PROPN
bptjm-31	328	6	f.	f.	PROPN
bptjm-31	328	7	orr	orr	PROPN
bptjm-31	328	8	,	,	PUNCT
bptjm-31	328	9	j.	j.	PROPN
bptjm-31	328	10	eric	eric	PROPN
bptjm-31	328	11	ahlskog	ahlskog	PROPN
bptjm-31	328	12	,	,	PUNCT
bptjm-31	328	13	tanis	tanis	PROPN
bptjm-31	328	14	j.	j.	PROPN
bptjm-31	328	15	ferman	ferman	PROPN
bptjm-31	328	16	,	,	PUNCT
bptjm-31	328	17	rosebud	rosebud	NOUN
bptjm-31	328	18	roberts	roberts	PROPN
bptjm-31	328	19	,	,	PUNCT
bptjm-31	328	20	vernon	vernon	PROPN
bptjm-31	328	21	s.	s.	PROPN
bptjm-31	328	22	pankratz	pankratz	PROPN
bptjm-31	328	23	,	,	PUNCT
bptjm-31	328	24	dennis	dennis	PROPN
bptjm-31	328	25	w.	w.	PROPN
bptjm-31	328	26	dickson	dickson	PROPN
bptjm-31	328	27	,	,	PUNCT
bptjm-31	328	28	joseph	joseph	PROPN
bptjm-31	328	29	parisi	parisi	PROPN
bptjm-31	328	30	,	,	PUNCT
bptjm-31	329	1	jeremiah	jeremiah	PROPN
bptjm-31	329	2	a.	a.	PROPN
bptjm-31	329	3	aakre	aakre	PROPN
bptjm-31	329	4	,	,	PUNCT
bptjm-31	329	5	yonas	yonas	PROPN
bptjm-31	329	6	e.	e.	PROPN
bptjm-31	329	7	geda	geda	PROPN
bptjm-31	329	8	,	,	PUNCT
bptjm-31	329	9	david	david	PROPN
bptjm-31	329	10	s.	s.	PROPN
bptjm-31	329	11	knopman	knopman	PROPN
bptjm-31	329	12	,	,	PUNCT
bptjm-31	329	13	ronald	ronald	PROPN
bptjm-31	329	14	c.	c.	PROPN
bptjm-31	329	15	petersen	petersen	PROPN
bptjm-31	329	16	,	,	PUNCT
bptjm-31	329	17	bradley	bradley	PROPN
bptjm-31	329	18	f.	f.	PROPN
bptjm-31	329	19	risk	risk	PROPN
bptjm-31	329	20	factors	factor	NOUN
bptjm-31	329	21	for	for	ADP
bptjm-31	329	22	dementia	dementia	NOUN
bptjm-31	329	23	with	with	ADP
bptjm-31	329	24	lewy	lewy	ADJ
bptjm-31	329	25	bodies	body	NOUN
bptjm-31	329	26	:	:	PUNCT
bptjm-31	329	27	a	a	DET
bptjm-31	329	28	case	case	NOUN
bptjm-31	329	29	-	-	PUNCT
bptjm-31	329	30	control	control	NOUN
bptjm-31	329	31	study	study	NOUN
bptjm-31	329	32	.	.	PUNCT
bptjm-31	330	1	boeve	boeve	PROPN
bptjm-31	330	2	neurology	neurology	NOUN
bptjm-31	330	3	.	.	PUNCT
bptjm-31	331	1	2013	2013	NUM
bptjm-31	331	2	;	;	PUNCT
bptjm-31	331	3	berkeley	berkeley	PROPN
bptjm-31	331	4	pharma	pharma	PROPN
bptjm-31	331	5	tech	tech	NOUN
bptjm-31	331	6	journal	journal	NOUN
bptjm-31	331	7	of	of	ADP
bptjm-31	331	8	medicine	medicine	NOUN
bptjm-31	331	9	|	|	ADV
bptjm-31	331	10	18	18	NUM
bptjm-31	331	11	81(9):833	81(9):833	NOUN
bptjm-31	331	12	-	-	PUNCT
bptjm-31	331	13	840	840	NUM
bptjm-31	331	14	;	;	PUNCT
bptjm-31	331	15	doi:10.1212	doi:10.1212	PROPN
bptjm-31	331	16	/	/	SYM
bptjm-31	332	1	wnl.0b013e3182a2cbd1	wnl.0b013e3182a2cbd1	PROPN
bptjm-31	332	2	27	27	NUM
bptjm-31	332	3	.	.	PUNCT
bptjm-31	333	1	mata	mata	PROPN
bptjm-31	333	2	if	if	SCONJ
bptjm-31	333	3	,	,	PUNCT
bptjm-31	333	4	samii	samii	NOUN
bptjm-31	333	5	a	a	PRON
bptjm-31	333	6	,	,	PUNCT
bptjm-31	333	7	schneer	schneer	NOUN
bptjm-31	333	8	sh	sh	PROPN
bptjm-31	333	9	,	,	PUNCT
bptjm-31	333	10	et	et	PROPN
bptjm-31	333	11	al	al	PROPN
bptjm-31	333	12	.	.	PUNCT
bptjm-31	334	1	glucocerebrosidase	glucocerebrosidase	PROPN
bptjm-31	334	2	gene	gene	NOUN
bptjm-31	334	3	mutations	mutation	NOUN
bptjm-31	334	4	:	:	PUNCT
bptjm-31	334	5	a	a	DET
bptjm-31	334	6	risk	risk	NOUN
bptjm-31	334	7	factor	factor	NOUN
bptjm-31	334	8	for	for	ADP
bptjm-31	334	9	lewy	lewy	ADJ
bptjm-31	334	10	body	body	NOUN
bptjm-31	334	11	disorders	disorder	NOUN
bptjm-31	334	12	.	.	PUNCT
bptjm-31	335	1	arch	arch	ADJ
bptjm-31	335	2	neurol	neurol	NOUN
bptjm-31	335	3	.	.	PUNCT
bptjm-31	336	1	2008;65(3):379–382	2008;65(3):379–382	X
bptjm-31	336	2	.	.	PUNCT
bptjm-31	337	1	doi:10.1001	doi:10.1001	PROPN
bptjm-31	337	2	/	/	SYM
bptjm-31	337	3	archneurol.2007.68	archneurol.2007.68	PROPN
bptjm-31	337	4	28	28	NUM
bptjm-31	337	5	.	.	PUNCT
bptjm-31	338	1	woodru	woodru	PROPN
bptjm-31	338	2	�	�	PROPN
bptjm-31	338	3	bk	bk	PROPN
bptjm-31	338	4	,	,	PUNCT
bptjm-31	338	5	gra	gra	PROPN
bptjm-31	338	6	�	�	PROPN
bptjm-31	338	7	-radford	-radford	PROPN
bptjm-31	338	8	nr	nr	PROPN
bptjm-31	338	9	,	,	PUNCT
bptjm-31	338	10	ferman	ferman	PROPN
bptjm-31	338	11	tj	tj	PROPN
bptjm-31	338	12	,	,	PUNCT
bptjm-31	338	13	dickson	dickson	PROPN
bptjm-31	338	14	dw	dw	PROPN
bptjm-31	338	15	,	,	PUNCT
bptjm-31	338	16	delucia	delucia	PROPN
bptjm-31	338	17	mw	mw	PROPN
bptjm-31	338	18	,	,	PUNCT
bptjm-31	338	19	crook	crook	NOUN
bptjm-31	338	20	je	je	PROPN
bptjm-31	338	21	,	,	PUNCT
bptjm-31	338	22	arvanitakis	arvanitakis	PROPN
bptjm-31	338	23	z	z	PROPN
bptjm-31	338	24	,	,	PUNCT
bptjm-31	338	25	brassler	brassler	NOUN
bptjm-31	338	26	s	s	PROPN
bptjm-31	338	27	,	,	PUNCT
bptjm-31	338	28	waters	water	VERB
bptjm-31	338	29	c	c	PROPN
bptjm-31	338	30	,	,	PUNCT
bptjm-31	338	31	barker	barker	PROPN
bptjm-31	338	32	w	w	PROPN
bptjm-31	338	33	,	,	PUNCT
bptjm-31	338	34	duara	duara	PROPN
bptjm-31	338	35	r.	r.	PROPN
bptjm-31	338	36	family	family	PROPN
bptjm-31	338	37	history	history	NOUN
bptjm-31	338	38	of	of	ADP
bptjm-31	338	39	dementia	dementia	NOUN
bptjm-31	338	40	is	be	AUX
bptjm-31	338	41	a	a	DET
bptjm-31	338	42	risk	risk	NOUN
bptjm-31	338	43	factor	factor	NOUN
bptjm-31	338	44	for	for	ADP
bptjm-31	338	45	lewy	lewy	ADJ
bptjm-31	338	46	body	body	NOUN
bptjm-31	338	47	disease	disease	NOUN
bptjm-31	338	48	.	.	PUNCT
bptjm-31	339	1	neurology	neurology	NOUN
bptjm-31	339	2	.	.	PUNCT
bptjm-31	340	1	2006	2006	NUM
bptjm-31	340	2	;	;	PUNCT
bptjm-31	340	3	66	66	NUM
bptjm-31	340	4	(	(	PUNCT
bptjm-31	340	5	12):1949	12):1949	NUM
bptjm-31	340	6	-	-	NUM
bptjm-31	340	7	1950	1950	NUM
bptjm-31	340	8	.	.	PUNCT
bptjm-31	341	1	doi:10.1212/01.wnl.0000219812.20616.b3	doi:10.1212/01.wnl.0000219812.20616.b3	NOUN
bptjm-31	341	2	29	29	NUM
bptjm-31	341	3	.	.	PUNCT
bptjm-31	342	1	liu	liu	PROPN
bptjm-31	342	2	w	w	PROPN
bptjm-31	342	3	,	,	PUNCT
bptjm-31	342	4	yu	yu	PROPN
bptjm-31	342	5	dy	dy	PROPN
bptjm-31	342	6	.	.	PROPN
bptjm-31	342	7	bilateral	bilateral	ADJ
bptjm-31	342	8	nucleus	nucleus	ADJ
bptjm-31	342	9	basalis	basali	NOUN
bptjm-31	342	10	of	of	ADP
bptjm-31	342	11	meynert	meynert	ADJ
bptjm-31	342	12	deep	deep	ADJ
bptjm-31	342	13	brain	brain	NOUN
bptjm-31	342	14	stimulation	stimulation	NOUN
bptjm-31	342	15	for	for	ADP
bptjm-31	342	16	dementia	dementia	NOUN
bptjm-31	342	17	with	with	ADP
bptjm-31	342	18	lewy	lewy	ADJ
bptjm-31	342	19	bodies	body	NOUN
bptjm-31	342	20	:	:	PUNCT
bptjm-31	342	21	a	a	DET
bptjm-31	342	22	randomised	randomised	ADJ
bptjm-31	342	23	clinical	clinical	ADJ
bptjm-31	342	24	trial	trial	NOUN
bptjm-31	342	25	.	.	PUNCT
bptjm-31	343	1	brain	brain	PROPN
bptjm-31	343	2	stimul	stimul	PROPN
bptjm-31	343	3	.	.	PUNCT
bptjm-31	344	1	2020;13(6):1612	2020;13(6):1612	PROPN
bptjm-31	344	2	-	-	SYM
bptjm-31	344	3	1613	1613	NUM
bptjm-31	344	4	.	.	PUNCT
bptjm-31	345	1	doi:10.1016	doi:10.1016	PROPN
bptjm-31	345	2	/	/	SYM
bptjm-31	345	3	j.brs.2020.09.020	j.brs.2020.09.020	PROPN
bptjm-31	345	4	30	30	NUM
bptjm-31	345	5	.	.	PUNCT
bptjm-31	346	1	liang	liang	PROPN
bptjm-31	346	2	x	x	PROPN
bptjm-31	346	3	,	,	PUNCT
bptjm-31	346	4	liu	liu	PROPN
bptjm-31	346	5	k	k	PROPN
bptjm-31	346	6	,	,	PUNCT
bptjm-31	346	7	guo	guo	PROPN
bptjm-31	346	8	l.	l.	PROPN
bptjm-31	346	9	repetitive	repetitive	ADJ
bptjm-31	346	10	transcranial	transcranial	ADJ
bptjm-31	346	11	magnetic	magnetic	ADJ
bptjm-31	346	12	stimulation	stimulation	NOUN
bptjm-31	346	13	(	(	PUNCT
bptjm-31	346	14	rtms	rtms	NOUN
bptjm-31	346	15	):	):	PUNCT
bptjm-31	346	16	a	a	DET
bptjm-31	346	17	possible	possible	ADJ
bptjm-31	346	18	novel	novel	ADJ
bptjm-31	346	19	therapeutic	therapeutic	ADJ
bptjm-31	346	20	approach	approach	NOUN
bptjm-31	346	21	to	to	ADP
bptjm-31	346	22	dementia	dementia	NOUN
bptjm-31	346	23	with	with	ADP
bptjm-31	346	24	lewy	lewy	PROPN
bptjm-31	346	25	bodies	body	NOUN
bptjm-31	346	26	.	.	PUNCT
bptjm-31	347	1	med	med	ADJ
bptjm-31	347	2	hypotheses	hypothesis	NOUN
bptjm-31	347	3	.	.	PUNCT
bptjm-31	348	1	2010;74(5):877	2010;74(5):877	NUM
bptjm-31	348	2	-	-	SYM
bptjm-31	348	3	879	879	NUM
bptjm-31	348	4	.	.	PUNCT
bptjm-31	349	1	doi:10.1016	doi:10.1016	PROPN
bptjm-31	349	2	/	/	SYM
bptjm-31	349	3	j.mehy.2009.11.020	j.mehy.2009.11.020	PROPN
bptjm-31	349	4	31	31	NUM
bptjm-31	349	5	.	.	PUNCT
bptjm-31	350	1	what	what	PRON
bptjm-31	350	2	happens	happen	VERB
bptjm-31	350	3	to	to	ADP
bptjm-31	350	4	the	the	DET
bptjm-31	350	5	brain	brain	NOUN
bptjm-31	350	6	in	in	ADP
bptjm-31	350	7	alzheimer	alzheimer	PROPN
bptjm-31	350	8	's	's	PART
bptjm-31	350	9	disease	disease	NOUN
bptjm-31	350	10	?	?	PUNCT
bptjm-31	351	1	national	national	PROPN
bptjm-31	351	2	institute	institute	PROPN
bptjm-31	351	3	on	on	ADP
bptjm-31	351	4	aging	age	VERB
bptjm-31	351	5	.	.	PUNCT
bptjm-31	352	1	https://www.nia.nih.gov/health/what-happens-b	https://www.nia.nih.gov/health/what-happens-b	X
bptjm-31	352	2	rain	rain	NOUN
bptjm-31	352	3	-	-	PUNCT
bptjm-31	352	4	alzheimers	alzheimer	NOUN
bptjm-31	352	5	-	-	PUNCT
bptjm-31	352	6	disease#:~:text	disease#:~:text	PROPN
bptjm-31	352	7	=	=	PUNCT
bptjm-31	352	8	neuro	neuro	NOUN
bptjm-31	352	9	�	�	PROPN
bptjm-31	352	10	b	b	PROPN
bptjm-31	352	11	rillary%20tangles%20are%20abnormal%20accum	rillary%20tangles%20are%20abnormal%20accum	NOUN
bptjm-31	352	12	ulations	ulation	NOUN
bptjm-31	352	13	,	,	PUNCT
bptjm-31	352	14	to%20the%20axon%20and%2	to%20the%20axon%20and%2	PROPN
bptjm-31	352	15	0dendrites	0dendrites	PROPN
bptjm-31	352	16	.	.	PUNCT
bptjm-31	352	17	accessed	access	VERB
bptjm-31	352	18	august	august	PROPN
bptjm-31	352	19	26	26	NUM
bptjm-31	352	20	,	,	PUNCT
bptjm-31	352	21	2022	2022	NUM
bptjm-31	352	22	.	.	PUNCT
bptjm-31	353	1	32	32	NUM
bptjm-31	353	2	.	.	PUNCT
bptjm-31	354	1	ubiquitin	ubiquitin	ADJ
bptjm-31	354	2	-	-	PUNCT
bptjm-31	354	3	proteasome	proteasome	NOUN
bptjm-31	354	4	pathway	pathway	NOUN
bptjm-31	354	5	.	.	PUNCT
bptjm-31	355	1	creative	creative	ADJ
bptjm-31	355	2	diagnostics	diagnostic	NOUN
bptjm-31	355	3	.	.	PUNCT
bptjm-31	356	1	https://www.creative-diagnostics.com/ubiquiti	https://www.creative-diagnostics.com/ubiquiti	ADP
bptjm-31	356	2	n-proteasome-pathway.htm	n-proteasome-pathway.htm	NUM
bptjm-31	356	3	.	.	PUNCT
bptjm-31	357	1	accessed	access	VERB
bptjm-31	357	2	august	august	PROPN
bptjm-31	357	3	26	26	NUM
bptjm-31	357	4	,	,	PUNCT
bptjm-31	357	5	2022	2022	NUM
bptjm-31	357	6	.	.	PUNCT
bptjm-31	358	1	33	33	NUM
bptjm-31	358	2	.	.	PUNCT
bptjm-31	358	3	finkbeiner	finkbeiner	PROPN
bptjm-31	358	4	s.	s.	PROPN
bptjm-31	358	5	the	the	DET
bptjm-31	358	6	autophagy	autophagy	ADJ
bptjm-31	358	7	lysosomal	lysosomal	ADJ
bptjm-31	358	8	pathway	pathway	NOUN
bptjm-31	358	9	and	and	CCONJ
bptjm-31	358	10	neurodegeneration	neurodegeneration	NOUN
bptjm-31	358	11	.	.	PUNCT
bptjm-31	359	1	cold	cold	ADJ
bptjm-31	359	2	spring	spring	NOUN
bptjm-31	359	3	harb	harb	PROPN
bptjm-31	359	4	perspect	perspect	VERB
bptjm-31	359	5	biol	biol	PROPN
bptjm-31	359	6	.	.	PUNCT
bptjm-31	360	1	2020;12(3):a033993	2020;12(3):a033993	X
bptjm-31	360	2	.	.	PUNCT
bptjm-31	361	1	published	publish	VERB
bptjm-31	361	2	2020	2020	NUM
bptjm-31	361	3	mar	mar	PROPN
bptjm-31	361	4	2	2	NUM
bptjm-31	361	5	.	.	NOUN
bptjm-31	361	6	33	33	NUM
bptjm-31	361	7	.	.	PUNCT
bptjm-31	362	1	doi:10.1101	doi:10.1101	NOUN
bptjm-31	362	2	/	/	SYM
bptjm-31	362	3	cshperspect.a033993	cshperspect.a033993	NOUN
bptjm-31	362	4	berkeley	berkeley	PROPN
bptjm-31	362	5	pharma	pharma	PROPN
bptjm-31	362	6	tech	tech	NOUN
bptjm-31	362	7	journal	journal	NOUN
bptjm-31	362	8	of	of	ADP
bptjm-31	362	9	medicine	medicine	NOUN
bptjm-31	362	10	|	|	ADV
bptjm-31	362	11	19	19	NUM
bptjm-31	362	12	front	front	ADJ
bptjm-31	362	13	page	page	NOUN
bptjm-31	362	14	repaka	repaka	ADV
bptjm-31	362	15	et	et	PROPN
bptjm-31	362	16	al	al	PROPN
bptjm-31	362	17	.	.	PROPN
bptjm-31	362	18	body	body	NOUN
bptjm-31	362	19	template_repaka	template_repaka	PROPN
bptjm-31	362	20	et	et	PROPN
bptjm-31	362	21	al	al	PROPN
bptjm-31	362	22	.	.	PUNCT
bptjm-31	363	1	references_repaka	references_repaka	PROPN
bptjm-31	363	2	et	et	PROPN
bptjm-31	363	3	al	al	PROPN
bptjm-31	363	4	.	.	PUNCT